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3H. ABSTRACT
The jp rsh is a murine recessive X-linked point mutation of the PLP gene 
characterised by a single amino-acid substitution (Ileiss -»Thr). Affected hemizygous 
males and homozygous females showed tremor and ataxia of the hindlimbs. No 
seizures, infertility or premature death of the animals occurred. Morphological 
examination of the jp rsh mutant CNS tissue revealed a noticeable hypomyelination 
which included abnormally thin and vacuolated myelin sheaths, intermingled with 
unmyelinated axons. There were appropriate oligodendrocytes numbers at the time 
of myelination, in fact, cell counts were higher than for the wild type in the spinal 
cord and were increasing progressively with age. Older mice demonstrated a gradual 
myelin production the spinal cord.
Immunocytochemistry of jp rsh CNS tissue revealed a defect in the production 
of PLP while myelin sheaths immunostained intensely for DM-20. Quantification of 
the PLP/DM-20 mRNA levels indicated that the PLP expression in individual cells 
was decreased, particularly in younger mutants. However, the total number of 
PLP/DM-20 expressing cells was higher than for age-matched wild type mice. 
PLP/DM-20 mRNA levels did not correlate with the final low amounts of protein. 
The ability of jp rs^ oligodendrocytes to differentiate was assessed by staining cell 
dissociations from the optic nerves and spinal cord taken from mice at different ages 
and cultured for variable lengths of time with specific antigenic markers. Mutant 
oligodendrocytes differentiated normally to the GalC stage. The number of MBP 
immunostained cells was decreased, particularly when mutant oligodendrocytes 
developed in vitro although the expression in individual cells was normal. The 
immunoreactivity against the C-terminal antibody recognizing both PLP and DM-20 
was also decreased. However, PLP/DM-204- mutant cells immunostained at the 
appropriate time. 010, PLP and O il  indicative of the most mature stages in wild 
type oligodendrocytes, were virtually absent. Finally, ^H-thymidine labelling in the 
spinal cord revealed that jp rs^  oligodendrocytes, identified by morphological and PLP 
expression, divide well into adulthood probably contributing to the delayed 
myelination of the spinal cord.
Asymptomatic heterozygote jp rs^ females did not reveal the predictable 
histological mosaic myelination pattern observed for other PLP mutant heterozygotes.
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CHAPTER 1: INTRODUCTION
A. CNS
17
1. THE AREAS OF STUDY
The two areas of the central nervous system (CNS) on which studies in jp rsh 
have been focused were the spinal cord and the optic nerve. The study of these tracts 
has several advantages. First, these areas of the CNS have been previously 
investigated in detail, accordingly, their embryological and cellular development, 
microscopic anatomy, ultrastructure, etc, are reasonably well documented. They are 
also areas that have been chosen for most of the work in other proteolipid protein 
(PLP) mutations. Second, the spinal cord and the optic nerve differ in their 
embryology, cell development, myelination time, fibre sizes and distribution and 
cellular content. The spinal cord represents a more complex structure than the optic 
nerve. It contains a number of different axon tracts in the peripheral white matter as 
well as a neuron cell bodies in the centrally located grey matter. On the other hand, 
the cell population of the optic nerve is comprised of only glial cell bodies and blood 
vessels, and a homogeneous axonal population. Recent studies in the spinal cord 
suggest that the developing spinal cord is considerably more complex, in terms of 
gliogenesis, than the developing optic nerve. Finally, these structures are easily 
localized and dissected in mice at all ages which allows more accuracy in the work.
2. DEVELOPMENT IN THE CNS
a) Introduction
The nervous system is one of the most complex structures known to man, and 
certainly the most complex organ system in the body. This is due in part to its large 
number of cells (about 1012 neurons in m an and many more glial ce lls). and in 
part to the precise patterns of connections that neurons make onto other neurons. 
Not surprisingly, many features of the development of the nervous system are poorly 
understood. Although the gross embryological neural development has been 
accurately documented, the complexity of the massive increase in cell numbers and 
further cellular arrangements that take place as the structures develop are obscure and 
poorly defined. In fact, there is very little literature combining the embryological 
origin and cellular development of the different CNS structures.
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b) Embryology and myelination o f the CNS
The CNS is derived from the ectoderm. This structure begins as the neural 
plate closes to produce at tubular formation known as the central canal (Climent and 
Bascuas, 1982). The cranial portion of the canal, which is the broadest portion, 
develops three encephalic vesicles of which the prosencephalon is the most cranial. 
This dilatation of the neural tube generates the cerebral hemispheres and the 
diencephalon.
(I) Spinal cord embryogenesis
The caudal portion of the neural tube will develop the spinal cord. The 
neural tube shows a pseudostratified arrangement of neuroepithelial cells. The cells 
of the ependymal layer divide and accumulate giving rise to the neuroblast and 
spongioblasts, eventually developing into the grey matter of the spinal cord. The 
outer layer of the neural tube containing the elongated cell processes of the 
neuroblasts constitutes the future white matter (Climent and Bascuas, 1982). In the 
old animal the neuroepithelial cells will constitute the ependymal cells of the adult.
The cellular development of the spinal cord is very complex. The origin, 
migration patterns, division and differentiation of the progenitor cells are poorly 
documented in the spinal cord (Fok-Seang and Miller, 1992). Distinct hypotheses 
have been proposed to explain the spinal cord origin of the macroglia which 
comprises the oligodendrocytes and the astrocytes. It has been suggested that 
glioblasts, initially located in the region of the central canal, subsequently migrate to 
the peripheral white matter, proliferate and differentiate into astrocytes and 
oligodendrocytes (Gilmore, 1971). Another hypothesis contemplates the possibility 
of macroglial cells originating directly from the spinal cord radial glia (Hirano and 
Goldman, 1988). It has also been proposed that the precursors of the macroglia are 
produced locally by the division of the multipotential neuroepithelial cells after the 
production of the neuroblasts (Skoff, 1975; Skoff et a/., 1976a).
Recent investigations have shown that the migration and differentiation of 
oligodendrocyte precursors in the spinal cord follows a rostral-caudal and ventral- 
dorsal sequence of differentiation during embryonic development (Warf et al. , 1991). 
It is also known that there are oligodendrocyte-type-2 astrocyte (0-2A) progenitor 
cells, similar to those described for the optic nerve, but that these represent a small 
number of the A2B5 + cells (Fok-Seang and Miller, 1992) (see section 2.c) (figure 
1).
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(2) Myelination in the spinal cord
The spinal cord begins myelinating during the later stages of embryonic 
development. Before myelination commences, the histological appearance of the 
spinal cord reveals small unmyelinated axons, subdivided into bundles by radial glial 
processes which contain filaments and extend towards the pia (Remahl and 
Hildebrand, 1990). Among the axons, a few scattered undifferentiated glioblasts can 
be seen, but cells with ultrastructural features typical for the astroglial and 
oligodendroglial lineages are not yet present. At this stage microglial cells are not 
identifiable (Remahl and Hildebrand, 1990).
The ensheathment of the axons by oligodendrocytic processes, which was 
always thought to be a stereotyped process, has been recently re-described in the 
feline spinal cord white matter. Here, during the very early stages of myelination 
many oligodendrocytes appear to interact with axons in a manner similar to that 
adopted by Schwann cells in the peripheral nervous system (PNS) (Remahl and 
Hildebrand, 1990) (figure 2). These oligodendrocytes connected to a single axon, 
generally of large calibre, exhibited the most mature cytology. Glioblast-like cells 
co-exist with these mature forms of oligodendrocytes until later periods, which will 
subsequently differentiate and myelinate the remainder of the axons (Remahl and 
Hildebrand, 1990). Therefore, a two stage myelin sheath production by 
oligodendrocytes has been described. At stage one, only large fibres are myelinated 
in a Schwann cell-like fashion and in stage two all smaller calibre axons progressively 
acquire a myelin sheath. However, this finding has not been verified in other species 
so far. Hahn et al. (Hahn et al., 1987) have reported a similar sequence of events in 
the myelination of the PNS where larger fibres are myelinated prior to smaller ones. 
Del Rio Hortega's classification of oligodendrocytes also describes a similar type of 
Schwann-cell-like myelinating oligodendrocyte in various species (see section 3 .a.).
(3) Optic nerve embryogenesis
The optic vesicles are derived from the diencephalon and remain connected to 
this structure by the optic stalk which is composed of a small marginal zone 
containing the axons of retinal cells and a ventricular cell layer surrounding the optic 
canal (Skoff et al., 1976a). Morphological studies in the developing rat optic nerve 
suggest that the invasion of axons into the optic stalk induces the differentiation of the 
ventricular cells from the optic stalk into type-1 astrocytes at approximately 
embryonic day 16 (Skoff et a /., 1976b; Skoff et a l., 1976a; Miller et al., 1985). On 
the other hand, in vitro studies propose the neuroepithelial cells as possible type-1 
astrocyte precursors (Small et a/., 1987; Richardson et a /., 1990).
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(4) Myelination in the optic nerve
Myelination in the optic nerve has been described in detail in the rat. At birth
(embryonic day 21), the optic nerve is composed entirely of 200 to 400 nm non­
myelinated axons remaining so up until day two (Black et al., 1982; Meier and 
Bischoff, 1975). The axons contain microtubules, small mitochondria and small 
vesicles. In transverse section, groups of axons are separated by radially oriented 
astrocytic processes which often contain round homogeneous fat droplets and
glycogen granules. Between the axons, longitudinallyarranged glial cell processes
are frequently found which exhibit a granular matrix and, rarely mitochondria or 
dense bodies (Meier and Bischoff, 1975). Myelination starts around 6 days after 
birth, proceeding rapidly. By 8 days of age, most fibres are not yet associated with 
oligodendrocytic processes although axons in varying stages of wrapping are present 
(Black et al., 1982). The morphology of axons at 8 days of age is similar to those 
from the 2 day-old optic nerves, although at this stage the axonal diameters have 
increased by around 50% i.e. up to 500-600 nm in diameter (Meier and Bischoff, 
1975; Black et al., 1982). There is no critical axonal diameter for myelination 
although axons of >  1 diameter are preferably myelinated. However fibres of 
less of 0.5 /xm in diameter are also myelinated while much larger neighbouring axons 
remain unmyelinated. Axonal diameter parameter continuously increases during the 
ensheathment until the adult size is reached (Black et al., 1982). The association of 
the axon with oligodendrocytes seems to be an important factor for the axonal 
development as axons not associated with oligodendrocytic processes do not exceed 
0.2-0.3 pm diameter until intimate association is made (Black et al., 1982). 
Frequently, myelinated axons appear in clusters, often in relationship with an active 
oligodendrocyte (Meier and Bischoff, 1975). A representative field of a section of a 
16 day-old optic nerve shows profiles of fibres not yet associated with glial processes, 
fibres in which ensheathment has just begun, fibres in which the myelin sheath has not 
yet been compacted, and fibres with compact myelin. Glial proliferation is reported 
to slow dramatically after 19 days postnatal in the rat optic nerve (Skoff, 1990). 
Optic nerves at 28 days contain approximately 85 % of the axons ensheathed (Black et 
al., 1982) and by 30 days they are composed primarily of myelinated fibres with only 
a few unmyelinated axons that show oligodendroglial processes in their vicinity (Black 
et al., 1982). Once several wraps of myelin have been laid down, the g ratio 
remains fairly constant (around 0.75) throughout development (Black et al., 1982: g 
is defined as the ratio of axon diameter to that of the axon plus myelin sheath; an 
increased g ratio indicates that the sheath is disproportionately thin for the axonal 
size).
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Myelination of the optic pathway exhibits a general rostral-caudal gradient 
extending from the eye to the lateral geniculate nucleus (Skoff et al., 1976b; Skoff, 
1990).
c) Glial cell development
The cellular origin of the oligodendrocytes and astrocytes in the CNS remains 
controversial. There are two approaches to the study of glial cell development in the 
CNS: the histological approach, based on the study of the morphological and, to some 
degree, the antigenic characteristics of the macroglial cells in vivo, and the tissue 
culture approach, where the cells are dissociated, allowed to differentiate in vitro and 
are then immunologically identified.
While the traditional histological description of the developing CNS identified 
astroblasts, oligodendroblasts as well as very few undifferentiated glioblasts, tissue 
culture experiments have revealed several macroglial cell types (Skoff et al., 1976a). 
At present, the 0-2A progenitors identified in tissue culture have not been directly 
identified in vivo (section 2) (Skoff and Knapp, 1991). More than 80% of the 
dividing cells in the optic nerve can be classified histologicaly as either 
oligodendroblasts or astroblasts rather than undifferentiated glioblasts (Skoff et al., 
1976a). In fact, histological autoradiographic investigations demonstrate that 
oligodendrocytes attached to myelin sheaths can divide (Skoff, 1990; Arenella and 
Herndon, 1984; Skoff et al., 1976a). Thus, some authors (Skoff and Knapp, 1991; 
Skoff et al., 1976a) argue the possibility of differentiated macroglia cells to vacillate 
in their selection of a specific lineage demonstrating developmental plasticity and the 
ability of glia to adapt to an altered environment (Skoff and Knapp, 1991; Raff et al., 
1984b).
(1) Histological appearance o f  the developing glia
The development of the glial population has been precisely described in the 
optic nerve as it is a well defined structure with a relatively homogeneous fibre 
population where gliogenesis is unencumbered by neurons. It also myelinates 
postnatally, thus being particularly suitable to study this process.
The glial cell population in the premyelinated optic nerve (1-6 days of age) 
consists mainly of astrocytes in varying developmental stages (Skoff et al., 1976a). 
These are the first morphologically-identifiable macroglial cells. Ultrastructurally 
they present a moderately stained and loosely packed stellate cytoplasm which forms 
several processes radiating from the perikaryon to interdigitate with other astrocytic 
processes. Although these immature astrocytes have very few, if any, filaments they 
exhibit other features characteristic for astrocytes such as glycogen granules, puncta
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adhereruia and wide cistemae of endoplasmic reticulum which are always filled with a 
flocculent material. Polysomes, lipid droplets and mitochondria are also present. 
Their nucleus, which is often irregularly shaped, contains dispersed chromatin with a 
rim of condensed chromatin along the nuclear envelope and frequently a nucleolus 
(Skoff e ta l.,  1976a).
Later-proliferating astroblasts resemble mature fibrous astrocytes with a more 
electrolucent cytoplasm and nucleus with evenly dispersed chromatin, although still 
showing immature features like the larger number of organelles and fewer bundles of 
filaments (Skoff et al., 1976a). While the perikarya and processes of these 
developing astrocytes contain large numbers of filaments, they also have many more 
microtubules and other organelles than the fully differentiated fibrous astrocytes 
(Vaughn and Peters, 1967; Meier and Bischoff, 1975). The transition of early 
postnatal astrocytes to fully differentiated astrocytes is gradual. By 21 days after 
birth, there are many astrocytes which are almost identical in every respect with 
mature fibrous astrocytes, but alongside are other astrocytes whose cytoplasmic 
features are intermediate between those of mature and early postnatal astrocytes. 
Astrocytic processes are found beneath the meninges and around vessels, as well as 
grouping the axons in fascicular bundles throughout the optic nerve (Meier and 
Bischoff, 1975; Vaughn and Peters, 1967). This distribution of astrocytes
corresponds best to the in vitro type-1 astrocytes (Miller et al., 1989) which are the 
first to differentiate in situ, approximately at embryonic day 16, probably from the 
neuroepithelial cells from the optic stalk (Skoff et al., 1976a; Small et al., 1987; 
Richardson et al., 1990; Sturrock, 1976). The second type of astrocyte identified in 
vitro, termed type-2, begins to differentiate during the second postnatal week from a 
bipotential 0 -2 A progenitor cell after generating the oligodendrocytes (Raff et al., 
1983).
Some authors have also identified glioblasts in the newborn mouse optic nerve 
(Meier and Bischoff, 1975). These cells exhibited pronounced chromatin aggregates 
close to the nuclear envelope (Meier and Bischoff, 1975). The cytoplasm showed 
many free ribosomes which were often arranged as rosettes; the rough endoplasmic 
reticulum appeared as a sheet-like cistema or as few short cistemae and the Golgi 
apparatus was poorly developed and situated in a perinuclear position. Mitochondria 
contained both light and dense matrices. The cytoplasm was confined to a more or 
less narrow zone around the nucleus and processes were seldom encountered (Meier 
and Bischoff, 1975). Oligodendroblasts were also observed in newborn mouse optic 
nerve. These cells were intermediate forms of developed glioblasts (Meier and 
Bischoff, 1975; Skoff and Knapp, 1991) comprising postmitotic cells which were 
larger with a rounder nucleus containing more evenly dispersed chromatin, and some 
broad processes Skoff et al., 1976a; Skoff et al., 1976b). A characteristic of these
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cells was a well developed Golgi apparatus which often reached into the cytoplasmic 
extensions, and microtubules. Some cells contained lamellar inclusions and/or 
polymorphous fat droplets (Meier and Bischoff, 1975). The oligodendroblasts 
proliferated and differentiated into oligodendrocytes (Skoff et al., 1976a; Skoff and 
Knapp, 1991; Skoff, 1990; Skoff et al., 1976b) being very conspicuous at 
approximately five days postnatally, a day or two before the onset of myelination in 
the optic nerve (Skoff et al., 1976a). More mature oligodendroblasts presented a 
cytoplasm of moderate to high electron-density packed with clusters of ribosomes, 
many small mitochondria and microtubules, thin cistemae of Golgi apparatus and 
endoplasmic reticulum often not stacked (Skoff et al., 1976a; Skoff, 1990). The 
nucleus which was often larger than that of astrocytes (Skoff, 1990), was situated at 
one pole of the cell and showed small clumps of heterochromatin scattered 
throughout. Oligodendroblasts accounted for the majority of proliferating cells 
during the second postnatal week which is the period of myelin formation (Skoff et 
al., 1976a; Skoff and Knapp, 1991; Skoff, 1990; Skoff et al., 1976b). It has been 
suggested that occasional oligodendrocytes at various stages of development, 
including those of the "dark" variety described by Mori & Leblond (Mori and 
Leblond, 1970), can divide while connected to myelin sheaths (Skoff, 1990; Arenella 
and Herndon, 1984; Skoff et al., 1976a). The ultrastructural appearance of dividing 
oligodendrocytes at five days of age corresponded to the oligodendroblasts present in 
14 day-old nerves (Skoff et al., 1976a; Skoff et al., 1976b). Microglial cells are 
present at birth and increase progressively until the second and third postnatal week 
(Skoff et al., 1976a; Sturrock, 1976).
Occasional necrotic cells have also been described during gliogenesis (Meier 
and Bischoff, 1975) although according a recent investigations (Barres et al., 1992) 
more than 50% of the oligodendrocytes die in the optic nerve during development, 
mainly as a result of competition for survival factors such as platelet derived growth 
factor (PDGF) and insulin-like growth factor-1 (IGF-1) (figure 3). The growth 
factors appear to promote survival by suppressing an active death program in the glial 
cells (Barres et al., 1992). These cells suffer a programmed self destructive 
phenomenon termed "apoptosis" involving RNA synthesis (Raff, 1992). The nucleus 
of these cells exhibits a highly condensed and sometimes fragmented chromatin which 
stains intensely with propidium iodide and the cytoplasm frequently contains multiple 
vacuoles (Barres et al., 1992). Dead cells are rapidly removed from the tissue 
without inflammation (Raff, 1992).
(2) In vitro approach to glial cell development
Cell dissociations of rat optic nerve contain at least three different types of 
macroglial cells: oligodendrocytes and two types of astrocytes termed type-1 and type-
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2, which differ in their morphology, antigenic phenotype, and timing of 
differentiation (Miller et al., 1985; Raff, 1989) (table 1). These three types of 
macroglial cells in the optic nerve cultures develop from two different precursors. 
The type-1 astrocyte precursor cell has not been determined yet. Oligodendrocytes 
and type-2 astrocytes develop from highly motile (Small et al., 1987) progenitor cell 
that labels with A2B5 but not Ran-2 antibodies (Raff et al., 1983) (figure 1). This 
oligodendrocyte-type-2 astrocyte common precursor cell (0-2A) migrates, divides but 
differentiates into oligodendrocytes or type-2 astrocytes depending on different 
environmental signals (Small et al., 1987; Raff, 1989). When dissociated from a 
perinatal optic nerve and cultured in the absence of foetal calf serum (FCS) 0-2A 
progenitor cells give rise to oligodendrocytes, whereas cultured in 10% FCS they 
become type-2 astrocytes (Raff et al., 1983; Raff, 1989). Type-1 astrocytes secrete 
PDGF which keeps 0 -2A progenitors dividing (Raff, 1989; Noble and Murray, 1984; 
Richardson et al., 1990) preventing their premature differentiation into 
oligodendrocytes. It is believed that the 0-2A progenitor cells start their migration 
when type-1 astrocytes stabilize at birth. These migrate from the brain along the 
nerve towards the eye guided by the axons (Small et al., 1987).
Small numbers of proliferating 0-2A progenitor cells are present in the nerve 
at embryonic day 15 (Small et al., 1987). A week or so later, cells with the 
antigenic phenotype of type-2 astrocytes begin to appear. Some 0-2A progenitors 
seem to undergo yet another developmental transition, not differentiating immediately 
and dividing to give rise to a different type of 0-2A progenitor cell that persists in the 
adult nerve (Hardy and Reynolds, 1991) (see section 3). The 0 -2 A progenitors are 
characterized in culture by a bipolar morphology and an undifferentiated and 
uncommitted antigenic profile A2B54-/vimentin+/galactocerebroside (GalC)-/glial 
fibrillary acidic protein (GFAP)- (Miller et al., 1985; Berg and Schachner, 1982; 
Raff et al., 1984b). Further differentiation towards more mature forms is recognised 
by reactivity with the mouse monoclonal 04  antibody (Sommer and Schachner, 
1981), loss of A2B5 staining, as the GalC is acquired, and absence of vimentin (Raff 
et al., 1984b). GalC is a marker for commitment of such cells to the 
oligodendrocyte lineage (Raff et al., 1978) while GFAP is indicative of the astrocyte 
lineage (Bignami et al., 1972). However, cultured 0-2A progenitor cells are capable 
of reversing the differentiation process, even a couple of days after becoming 
GFAP-I- type-2 astrocytes, to become oligodendrocytes GalC-I-/GFAP- (Raff et al., 
1984b).
Although cells with the antigenic phenotypes corresponding to type-1 
astrocytes and 0-2A progenitor have been described in cultures from developing 
cerebellum (Levi et al., 1986b; Levi et al., 1986a) and cerebrum (Ingraham and 
McCarthy, 1989), this simple classification does not correspond to the findings in
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cultures from the newborn rat spinal cord as previously described or the olfactory 
bulb (Barnett et al., 1993). Again this raises the argument of the validity of the 
tissue culture models for the study of developing glia cells. In fact, retroviral tracers 
have failed to demonstrate a common progenitor cell for both oligodendrocytes and 
astrocytes (Vaysse and Goldman, 1990). Other studies have also demonstrated 
several significant alterations in the timing of antigen expression in both 0-2A 
progenitor cells and oligodendrocytes in vivo compared to the in vitro situation (Hardy 
and Reynolds, 1991). Therefore, there is no direct in situ evidence for the existence 
of a multipotential progenitor that is a major source of oligodendrocytes and some 
astrocytes (Skoff and Knapp, 1991). The developmental potential of cells may be 
altered when dissociated and cultured. Glial cell differentiation in culture may 
exhibit considerable plasticity, to the extent of actually switching lineages (Raff et al., 
1984b), although this plasticity should not be taken as their normal path of 
differentiation in situ (Skoff and Knapp, 1991).
d) Formation o f the CNS mvelin sheath
Myelinogenesis in the CNS is a complex process involving differentiated 
oligodendrocytes. The oligodendrocyte generally gives rise to thin processes, which 
associate with the surface of axons; then elongate and spirally wrap the axons in a 
clockwise or anti-clockwise direction (Skoff et al., 1980). The free edges of lips will 
form the mesaxon which will elongate by growing of one of the lips over the other. 
It is unknown why oligodendrocytes choose a particular fibre after avoiding 
association with other much closer axons. The major dense line (MDL) results from 
the extrusion of the cytoplasm from the myelinating process and the apposition of the 
cytoplasmic membranes and the intra period line (IPL) forms as the mesaxon 
compacts by the apposition of the extracellular membrane face. Consequently the 
most mature sheaths will only show cytoplasm within the outer and inner ends of the 
spiralling process. The subsequent growth of the sheath is achieved by the addition 
of more turns to the spiral (Peters et al., 1976). It has been postulated traditionally 
that the oligodendrocyte is situated some distance away from the sheath, the two being 
connected by a bridging process of cytoplasm. However, recent studies demonstrate 
that the oligodendrocyte/intemode ratio is a flexible parameter as some large fibres 
intemodes are ensheathed in a Schwann cell-like fashion, thus a 1:1 ratio (Remahl and 
Hildebrand, 1990). The myelin assembled and maintained by a single "Schwann- 
cell-like" oligodendrocyte is greater than that produced by an oligodendrocyte related 
to several sheaths (Remahl and Hildebrand, 1990). Other factors such as the CNS 
tract and the animal species also influence the number of intemodes produced by a 
single oligodendrocyte.
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The myelin deposition starts at several discrete sites along the entire length of 
an individual axon (Skoff et al., 1980). The appearance of the sheath is a series of 
cuffs that form around the axon and later extend toward each other, eventually leaving 
only short intervening gaps, the nodes of Ranvier.
3. REVIEW CNS STRUCTURE 
a) Cellular components o f the CNS 
(1) The oligodendrocyte
(a) Historical perspectives
The oligodendrocytes were first named and described by the Spanish 
histologist Del Rio Hortega (Del Rio Hortega, 1921; Del Rio Hortega, 1922; Del Rio 
Hortega, 1924). With Del Rio Hortega's silver carbonate stain, the cell was seen in 
profile, with little information regarding specific cytoplasmic components. It was 
named "the cell with few branches" the oligodendrocyte. In his extensive description 
of the oligodendrocyte, Del Rio Hortega classified these cells with regard to their 
position, as either perineuronal or interfascicular. A second classification derived 
from his analysis of the number and branching of the processes. Del Rio Hortega 
(Del Rio Hortega, 1922; Del Rio Hortega, 1924) found four patterns that he believed 
described the branching patterns of the processes of all oligodendrocytes whether 
perineuronal or interfascicular (figure 4). The first two types of oligodendrocytes 
had branches scattering in many directions; the other two forms dispatched processes 
parallel to adjacent myelin sheaths and therefore assumed a much more linear overall 
pattern. Type I oligodendrocytes possess a small soma with relatively numerous 
processes (5 to 10) which are long and very thin with periodic knot-like expansions of 
protoplasm and branching frequently occurring at obtuse angles. Type I is the most 
abundant of all the oligodendrocyte types. Type II are mostly found in the white 
matter, especially within fascicles of thinly myelinated axons, and in grey matter 
closely related to the cell bodies of neurons. Type II oligodendrocytes have a larger 
cell soma than type I but fewer primary processes (3 to 5). These are larger in 
diameter and divide at "T” or "Y" branches into smaller or secondary processes that 
are long and thin as in type I. This form is intermediate in frequency between type I 
and types III and IV. Types III and IV are more elongated than the other types and 
have only 1 or 2 processes. Both are prominent in the white matter in relation to the 
largest myelinated axons. They differ in that type III cells often have 2 processes, 
each reticulating over the surface of adjacent myelinated fibres. Type IV cells along 
with their processes, are flattened over the surface of a single large myelinated axon
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such as for Schwann cells myelinating the PNS (Del Rio Hortega, 1921; Del Rio 
Hortega, 1922; Del Rio Hortega, 1924).
This classification of oligodendrocytes was supported by electron 
microscopical observations of neuroglia in the amphibian spinal cord (Stensaas and 
Stensaas, 1968). The authors confirmed that four basic types of oligodendrocytes 
could be identified in this tissue and supplemented the analysis by three-dimensional 
reconstructions of several oligodendrocyte soma from serial sections. Recently, a 
similar investigation of the feline spinal cord has lead to similar findings, as discussed 
below (Remahl and Hildebrand, 1990). Del Rio Hortega's silver carbonate stain of 
the white matter from young animals frequently demonstrated extensions from the 
oligodendrocyte somal regions that provided a spiral process around a forming myelin 
sheath. There seems little doubt that these processes were, in fact, the cytoplasm 
directly related to the myelin sheath in either the internal or the external aspect.
(b) Histological features o f the developing oligodendrocyte
The oligodendroglial cells have been traditionally classified in three 
subpopulations according to their cytoplasmic density and state of differentiation 
(Mori and Leblond, 1970). The most immature form of oligodendrocyte is the light 
oligodendrocyte presenting a less organized arrangement of cytoplasmic organelles 
typical of actively proliferating oligodendroblasts (Mori and Leblond, 1970), these 
cells are characterised by a large pale cytoplasm which contains a light nucleus 6 to 
8.5 pm in diameter with the chromatin slightly more clumped than in astrocytes; a 
smooth and regular nuclear envelope and a large and centrally located nucleolus. 
The cytoplasm is packed with organelles such as free ribosomes arranged as 
polysomes; a rather scanty rough endoplasmic reticulum for the size of the cell with 
non-prominent cistemae, usually not stacked; numerous microtubules and a variable 
Golgi apparatus. Centrioles are occasionally present. Mitochondria usually do not 
contain small dark granules. The cell membrane is not well defined. Occasional 
fine processes of a uniform diameter, measuring from 0.06 to 0.3 pm  running fairly 
straight and unbranched, are characteristic of this variety of oligodendrocytes. While 
the processes include no ribosomes and only occasional mitochondria, they contain 1- 
20 microtubules which continue along their length (Mori and Leblond, 1970).
Medium oligodendrocytes are denser and smaller than light oligodendrocytes. 
They present an oval or irregularly rounded nucleus of 4-7pm in diameter with a few 
chromatin masses at the periphery and sometimes in the centre. Their cytoplasm is 
denser and usually less ample than those of light oligodendrocytes; the rough 
endoplasmic reticulum tends to have longer and more regularly stacked cistemae, and 
the free ribosomes, though still numerous are less abundant and less evenly
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distributed. Golgi saccules are more prominent and distended, and finally the 
protoplasm between organelles is darker than in light cells. Microtubules are also 
present. Occasionally there are some lamellar bodies although these structures are 
more frequent in the dark type. Medium oligodendrocytes have fine processes 
containing microtubules similar to, but less numerous, than those of the light cells 
(Mori and Leblond, 1970).
When myelination is complete and the cell has fully matured, the cytoplasmic 
volume decreases and the nuclear chromatin becomes much more clumped (Skoff et 
al., 1976a) constituting the typical dark oligodendrocytes whose dense cytoplasm 
and nucleus contrast strongly with nearby axons. Typically the nucleus is small and 
centrally located, more or less spherical with a diameter of 3.5 to 5.5 ^im, although it 
may be flattened or crescent-shaped with chromatin masses attached along the inner 
nuclear membrane. The nucleolus is rather small and paracentrally located, often 
next to a peripheral chromatin mass (Mori and Leblond, 1970). There are only four 
or five short saccules of the Golgi apparatus which are distended by a light material 
and stand out in the dark surroundings. The membranes of the Golgi saccules are 
indistinct. The cistemae of the rough endoplasmic reticulum are rather long and 
often regularly stacked containing luminal material of a lesser density than the 
cytoplasm. A peculiar feature is the presence of the lamellar bodies. These 
structures consist of membranes which may be closely apposed or loosely arranged. 
Dark oligodendrocytes have only few processes, usually presenting the same density 
as the cytoplasm. They resemble those seen in the other two types of cell although 
shorter and darker.
The beginning of myelination coincides very closely in time with the 
termination of cell division for some oligodendrocytes, but there is very little 
evidence that oligodendrocytes begin synthesizing myelin proteins prior to their final 
cell division. The relationship among light, medium and dark oligodendrocytes was 
further investigated by autoradiographic techniques in two more detailed studies of the 
rat corpus callosum reported by Paterson et al. (Paterson et al., 1973). The label 
appeared sequentially in the light, medium and dark oligodendrocytes, with kinetics 
that clearly supported the interpretation that the light oligodendrocytes were 
differentiating into the medium and subsequently into the dark form during variable 
lengths of time. The organelle content of either light or the medium 
oligodendrocytes could be said to be consistent with the myelinating activity. The 
profiles of oligodendrocytes during the peak period of myelination show an abundant 
cytoplasm containing numerous free ribosomes or polysomes, several moderate 
lengths of rough endoplasmic reticulum occasionally arranged in stacks, and several 
Golgi complexes. After myelination is completed, the morphology and the numbers 
of mature or dark oligodendrocytes change very little (Vaughn and Peters, 1974).
I
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Fully mature oligodendrocytes are reported not to divide (Skoff et al., 1976b) and to 
remain relatively indifferent to drastic changes in environment such as Wallerian 
degeneration as long as they themselves are not damaged (Skoff, 1975).
(c) In vitro morphology
The morphology of the oligodendrocyte in vitro represents a remarkable 
example of plasticity. My experiments in the mouse CNS (see chapter 3) 
demonstrate that freshly dissociated oligodendrocytes are capable of developing 
numerous processes in less than 2 hr after being plated on Poly-L-lysine-coated 
coverslips. These cells, when allowed to grow in culture, develop the various 
morphological forms previously described by Kuhlmann-Krieg et al. (Kuhlmann- 
Krieg et al., 1988). Some of the morphological and ultrastructural characteristics 
found in the three varieties are described. Type I oligodendrocytes present a round 
or triangular cell body (approximately 10 pm  in diameter) with few processes; an 
organelle-rich cytoplasm with scattered microtubules, narrow mitochondria, very 
prominent ribosomes and a nucleus with dispersed chromatin containing a small 
nucleolus. Type II oligodendrocytes usually display a larger cell body and a halo 
of highly branched processes which typically will develop large flattened membranous 
sheets containing myelin-specific antigens such as GalC, CNPase and MBP (Knapp et 
al., 1987; Dyer and Benjamins, 1989; Konola et al., 1991). Ultrastructurally they 
have a more homogeneous electrolucent cytoplasm with fewer organelles, 
mitochondria, numerous scattered microtubules and single ribosomes not organized in 
polysomes. A well developed Golgi apparatus; a smooth endoplasmic reticulum and 
a large number of coated vesicles are characteristic of these cells. The nucleus 
presents more condensed chromatin than in the previous category. Type HI 
oligodendrocytes are less abundant than the other two categories. They express 
antigens indicative of the more mature forms of oligodendrocytes (Kuhlmann-Krieg et 
al., 1988). These glial cells are usually very large and often display a bipolar shape 
with large extensions of flat membranes that can be connected to several processes. 
These oligodendrocytes are often characterised by numerous membranous whorls on 
cell bodies and processes. The main ultrastructural feature of type III is the more 
electron-dense matrix. Ribosomes and few polysomes are present as well as some 
dense lysosomal inclusions. The prominent rough endoplasmic reticulum often 
presents enlarged cistemae filled with an slightly electron-dense material. The 
nucleus is irregular in shape and often contains large amounts of condensed 
chromatin.
Oligodendrocytes maintained in culture for more than 3 weeks may exhibit the 
ultrastructural characteristics of the most mature cells corresponding with the dark- 
variety described in vivo by Mori and Leblond (Mori and Leblond, 1970; Kuhlmann-
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Krieg et al., 1988; Bradel and Prince, 1983). At this stage of differentiation, 
oligodendrocytes are capable of producing loose loops of myelin membranes, in the 
absence of neurones, which occasionally exhibit an ultrastructurally compacted 
appearance (Bradel and Prince, 1983).
(d) Immunological profile o f the developing oligodendrocyte
The oligodendrocytes go through a complex differentiation pathway from O- 
2A progenitor cells to fully mature cells (Raff, 1989). Detection of a particular 
antigen serves as a means to identify the stage of differentiation. Progressive 
differentiation can be recognized by the expression of new molecules which can be 
detected immunologically (table 1). The 0-2A progenitor cells have been 
traditionally identified by the A2B5 antibody (Raff et al., 1983). However, this 
antibody, crucial to the identification of this cell lineage in the rat optic nerve, reacts 
with a subset of gangliosides on the cell's surface (Einsenbarth et al., 1979). The 
study of other areas of the CNS has been confusing because these gangliosides are 
also expressed on neurons and astrocytes (Einsenbarth et al., 1979; Schnitzer and 
Schachner, 1982) (table 1). The 04 antibody (Sommer and Schachner, 1981) is 
known also to react with the 0-2A progenitor cells at a later stage of development 
before the expression of GalC, a marker for oligodendrocytes (see below) (Dubois- 
Dalcq, 1987). Very recently, the 04 immunoreactivity has been shown to coincide 
with a newly-described antibody A 0 0 7  which also recognizes the, as yet undefined, 
proligodendroblast antigen (POA) that appears during the stage of progenitor 
development prior to the expression of sulfatide and GalC (Bansal et al., 1992; Berry 
et al., 1992). When 04 stains mature oligodendrocytes it recognizes different 
antigens such as sulfatide and seminolipids (table 2).
GalC is the first antigen indicating commitment of 0-2A progenitor cells to the 
oligodendrocyte lineage (Raff et al., 1978). It is known that CNPase and MBP 
follow in the development of cultured oligodendrocytes (Bologa-Sandru et al., 1981; 
Konola et al., 1991) closely followed by MAG and 1 or 2 days later by PLP/DM-20 
(Dubois-Dalcq et al., 1986; Knapp et al., 1987; Konola et al., 1991). MBP can first 
bfr detected diffusely throughout the cytoplasm of GalC -I- cells (Dubois-Dalcq et a l., 
1986; Konola et al., 1991). Approximately a week later it is also detected as 
punctuate dots distributed along the edges of the processes (Dubois-Dalcq et al., 
1986; Konola et al., 1991). Coarse grains of MBP staining are also detectable in 
sheets surrounded by loops of processes. MAG immunostaining is also confined to 
the cytoplasm until postnatal day 9 in the rat, presenting a higher intensity close to the 
nucleus (Dubois-Dalcq et al., 1986). PLP and DM-20 are initially detectable only in 
the perinuclear region as granular shaped deposits (Dubois-Dalcq et al., 1986; Konola 
et al., 1991) and, as a result of the increase of the granules, it is detectable by 14
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days in the processes (Dubois-Dalcq et al., 1986; Konola et al., 1991). MBP and 
PLP are differentially located in mature cultured oligodendrocytes as membranous 
sheets immunostained for MBP while PLP/DM-20 is detected mainly along the course 
of the cell processes (Konola et al., 1991). CNPase is located mainly in the 
networks of processes and in the periphery of sheets (Knapp et al., 1987; Konola et 
al., 1991) (table 3).
The antigens defined by the 010 and O il  antibodies are the most mature 
antigens recognised by the "O" group of antibodies (Kuhlmann-Krieg et al., 1988) 
(table 2). 010 defines a protein on the oligodendroglial surface, which has been
detected in the mouse spinal cord at postnatal day 2 (Kuhlmann-Krieg et al., 1988) 
whereas O il  recognises a surface lipid detectable after postnatal day 4. Both are 
indicative of mature stages of differentiation of the oligodendrocytes (Kuhlmann- 
Krieg et al., 1988). Unfortunately, there is no evidence supporting the combined 
appearance of MBP, PLP and DM-20 with these two antigens. However our own 
studies suggest that 010 staining is expressed at about the same time as PLP/DM-20 
and that O il  staining may be present slightly later than PLP.
(2) Other CNS cells
(a) The mature astrocyte
Astrocytes are star-shaped cells with a pale cytoplasm and nucleus whose 
processes extend into the surrounding neuropil forming glial sheets between fascicles 
of axons. In 1909, Cajal defined two astrocytic types, fibrous and protoplasmic, in 
the mammalian CNS. The majority of fibrous astrocytes are located in the CNS 
white matter and have a small cell body with cylindrical processes containing many 
intermediate filaments. Some of these terminate at the glia limitans, while others 
reach the surface of capillaries located within the tissue (Vaughn and Peters, 1967). 
By contrast, protoplasmic astrocytes are found mainly in grey matter and have 
broader processes containing fewer intermediate filaments. Fibrous astrocytes have 
numerous fibrils within their cytoplasm whereas protoplasmic astrocytes contain fewer 
glial filaments.
Ultrastructurally, the most distinctive feature of a mature astrocyte is the mass 
of glial filaments packing their cytoplasm. These are large polymers of GFAP (Raff 
et al., 1983; Bignami et al., 1972) arranged parallel to the long axis within the 
processes and forming bundles that extend through the perikaryon between the bases 
of the processes. This protein immunologically identifies astrocytes in tissue sections 
and cultures from the CNS. The external diameter of each filament is between 80 A 
and 90 A, and in cross sections they appear as electron-dense circles with clear 
centres (Vaughn and Peters, 1967). The astrocyte nucleus presents a homogeneous
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distribution of the chromatin. In comparison with most other types of cells, the 
mitochondria, endoplasmic reticulum and Golgi apparatus are sparse within the 
cytoplasm of mature fibrous astrocytes. Microtubules are seldom observed within 
mature astrocytes but these cells contain glycogen particles, dense inclusion bodies 
and droplets that are probably of fatty nature (Meier and Bischoff, 1975; Vaughn and 
Peters, 1967).
The classification of astrocytes into fibrous and protoplasmic astrocytes 
according to their location in the CNS and morphological appearance may not be an 
accurate reflection of the extent of diversity within this family of cells. Two 
different types of GFAP+ cells have been detected in cultures of optic nerve of rats, 
on the basis of their morphology, growth characteristics and labelling with the 
monoclonal antibody A2B5 (Raff, 1989; Raff et al., 1983). These may correspond 
to protoplasmic and fibrous astrocytes, respectively (Miller and Raff, 1984). Type-1 
astrocytes have a flat, fibroblast-like morphology, proliferate in culture in the 
presence of FCS and do not bind detectable amounts of tetanus toxin or A2B5 
antibody (Einsenbarth et al., 1979; Raff et al., 1983) although they bind Ran-2 (Raff 
et al., 1984a; Bartlett et al., 1981) (table 1). Type-2 astrocytes have a process- 
bearing morphology resembling neurons or oligodendrocytes and bind tetanus toxin 
and A2B5 antibody but not Ran-2 (Raff et al., 1984a). These two phenotypes of 
astrocytes develop at different times and from different lineages, at least in vitro 
(Raff, 1989) (figure 1). It is believed that type-1 astrocytes develop before birth and 
are located at the periphery of the adult optic nerve where they form the glial limiting 
membrane, while type-2 astrocyte develop after the first week of postnatal life and are 
allocated in the interior of the adult optic nerve (Miller and Raff, 1984; Miller et al., 
1985). It has also been demonstrated that both type of astrocytes derive from 
different progenitors (Raff et al., 1984a; Miller et al., 1985; Miller and Raff, 1984; 
Raff et al., 1983; Raff, 1989). Cells with characteristics similar to optic nerve type- 
1 and type-2 astrocytes have been described in cultures from other regions of the CNS 
including the cerebellum (Levi et al., 1986b; Levi et a l., 1986a) and cerebral cortex 
(Ingraham and McCarthy, 1989), suggesting that they may be a common feature of 
the mammalian CNS. However, recent studies of neonatal spinal cord revealed at 
least five morphologically distinct classes of astrocytes (Miller and Szigeti, 1991) 
exhibiting different proliferative capacity as well as different Ran-2 and A2B5 
immunoreactivity, suggesting that the spinal cord contains multiple classes of 
astrocytes which develop from distinct precursor cells (Miller and Szigeti, 1991).
(b) Microglial cells
Microglial cells have an electron-dense nucleus with large clumps of 
chromatin. Their cytoplasm is light to moderately stained containing long and
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branching cistemae of granular endoplasmic reticulum (Skoff, 1990; Vaughn and 
Peters, 1967). Other distinguishing features include the dense core vesicles, no 
microtubules or filaments (Skoff et al., 1976a) and large amounts of closely packed 
cistemae of the Golgi apparatus (Skoff, 1990). Microglial cells assume a variety of 
shapes. Like astrocytes, many have irregular outlines that conform to the contours of 
the surrounding neuropil. These cells have an ovoid appearance, with eccentrically 
located nuclei. Short stout protrusions sometimes extend from the perikarya. 
Nuclear profiles are rounded or elongated and contain clumps of chromatin which 
usually form broad irregular bands adjacent to the nuclear membranes.
The cytoplasmic density of these cells is greater than that of astrocytes, but 
less than the density shown by oligodendrocytes. Neither filaments, glycogen 
particles or microtubules occur in microglia. The rough endoplasmic reticulum of 
microglial cells is the most useful feature for distinguishing microglia from 
oligodendrocytes. It is generally absent in the narrow rim of cytoplasm that 
surrounds the nucleus, but is prominent where the cytoplasm is more voluminous at 
one pole of the perikarya and within the microglial processes. It consists of long 
narrow cistemae which characteristically have few ribosomes, and have a lumen of 
similar electron-density as the surrounding cytoplasm. Conversely, the Golgi 
apparatus has slender tightly-packed saccules and associated vesicles which frequently 
reveal electron-lucent contents. Dense lamellar bodies and homogeneous droplets, 
probably containing fat are frequent (Vaughn et al., 1970; Vaughn and Peters, 1967).
(c) 0-2A progenitor cells in the mature CNS
Recent studies based on tissue culture of the optic nerve of the rat have 
identified an adult progenitor cell (0 -2 A ^ w^ ) different from the one in perinatal 
animals (Wolswijk and Noble, 1989; Wren et al., 1992) (figure 1). The 0 -2 A ^ w^  
progenitors can be distinguished from the 0-2AJ,er n^ata  ^ progenitors by its 
morphology and antigenic phenotype. In contrast to the bipolar morphology of the 
A2B5+/04- O-'lp^pcrinatal progenitor cells (see section A.2.), most 0 -2 A ^ w^  
progenitors isolated from the optic nerves of adult animals have one major branched 
process plus several smaller thinner processes (Wolswijk and Noble, 1989; 
Richardson et al., 1990) (table 1). 0 - 2 A ^ w^  progenitors are also labelled with
A2B5, although not so heavily as the perinatal progenitors and they rapidly express 
the next antigen (Wolswijk and Noble, 1989). Furthermore, 0 - 2 A ^ w^  progenitor 
cells do not label with antibodies to Vimentin, whereas 0 -2Aperinatal progenitors do 
(Wolswijk and Noble, 1989). In addition, 0 -2 A ^ w^  progenitors have a longer 
average cell-cycle time in vitro than 0-2APer n^ata  ^ progenitors (65 hr versus 15 hr) 
(Small et al., 1987; Wolswijk and Noble, 1989; Richardson et al., 1990; ffrench- 
Constant et al., 1988), migrate more slowly in vitro (Wolswijk and Noble, 1989;
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Richardson et al., 1990) and take longer to differentiate (5 days versus 2 days for 
50% differentiation) (Wolswijk and Noble, 1989).
0 - 2 A p r o g e n i t o r s  first appear in the optic nerve in small numbers during 
the second postnatal week and replace the O-lhperinatal progenitors as the dominant 
precursor population during the first postnatal month (Richardson et al., 1990). 
Thus the 0 - 2 A ^ M^  and the 0-2Aperinatal progenitors seem to co-exist in vivo for 
several weeks. These cells are found in the adult rat optic nerve (ffrench-Constant 
and Raff, 1986; Wolswijk and Noble, 1989; Richardson et al., 1990) and presumably 
provide a continuous source of new oligodendrocytes and type-2 astrocytes to replace 
those that die as a result of injury or normal cell turnover. It is not obvious, 
however, how these 0 - 2 A ^ w^  progenitors manage to persist in the nerve beyond 
early postnatal development. 0 - 2 A ^ M^  progenitors also differ from 0-2Aperinatal 
progenitors in the rat optic nerve in the manner in which dividing cells generate 
oligodendrocytes (Wren et al., 1992). 0 -2 Aperinatal progenitors generally divide a 
limited number of times before all their daughter cells differentiate more or less 
synchronously into oligodendrocytes (Temple and Raff, 1986). In contrast, O- 
2Aadult progenitors appear to divide and differentiate asymmetrically, giving rise to 
mixed clones of cells containing both 0 - 2 A ^ w^  progenitors and oligodendrocytes 
(Richardson et al., 1990). Thus 0-2A <2^ M^  progenitors may be capable of self 
renewal and their presence in the adult optic nerve may not require that they be 
continuously generated from a precursor cell (Richardson et al., 1990). Recent 
investigations have reported that 0 -2 A °^u^  progenitors modify their dividing 
characteristics towards a Q-2APerinatal progenitors fashion when cultured in the 
presence of PDGF and fibroblast growth factor (FGF) (Wolswijk and Noble, 1992). 
The characteristics of adult progenitor cells make these cells ideally suitable for the 
needs of the adult CNS (Wolswijk and Noble, 1989; ffrench-Constant et al., 1988).
b) Biochemical composition o f  the CNS mvelin sheath
(1) Introduction
Mature CNS myelin closely resembles PNS myelin by virtue of it having been 
formed by a cell process from a myelin-forming cell becoming wrapped spirally 
around the axon. However, several differences exist. The CNS myelin periodicity 
is somewhat smaller but the manner in which the myelin lamellae arise is identical 
(Peters et al., 1976). CNS myelin is rarely directly attached to the soma of the 
myelin-forming cell although some Schwann cell-like oligodendrocytes occur in the 
developing spinal cord (Remahl and Hildebrand, 1990; Del Rio Hortega, 1922; 
Stensaas and Stensaas, 1968). In general, the cytoplasm of the oligodendrocyte in
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the mature sheath is restricted to the inner and outer tongues. No basal lamina 
surrounds the CNS myelin sheath whose matrix is non-collagenated. The sheaths in 
the CNS never attain the same thickness as those around axons of similar diameter in 
the PNS, as has been demonstrated by studying the transition zone between CNS and 
PNS (Fraher, 1992).
Some morphological differences between mature CNS and PNS myelin reflect 
immunochemical and biochemical differences between the two. The PNS myelin, 
which is produced by Schwann cells which have a different embryological origin (see 
section A), has also evolved a quantitatively similar lipid composition and comparable 
protein content (Norton and Cammer, 1984). The CNS myelin composition is very 
similar for all the vertebrates. This biochemical composition of myelin reflects a 
precise evolution of the most appropriate membrane that would spiral wrap around the 
axon, thereby permitting fast saltatory conduction of nerve impulses. In the present 
review I describe only the characteristic of the CNS myelin (for a PNS review see: 
Norton and Cammer, 1984)).
(2) Lipids in myelin
Even though there are no lipids specific to myelin the high content of 
galactosphingolipids, cerebroside (galactosylceramide) and sulphatide are the 
distinguishing feature of myelin lipids (table 4). Cerebroside is the most "myelin 
typical" lipid and it is also an specific marker for oligodendrocytes (Raff et al., 1978) 
as within the CNS it is restricted to those cells and myelin. The specificity of 
sulphatide for the myelin-oligodendroglial unit is less certain. In addition to 
cerebroside, myelin lipids are also enriched in cholesterol and ethanolamine 
phosphoglycerides relative to other membranes. These three lipids together comprise 
about 65% of the total lipid accounting for 45 to 50% of the total dry weight of 
myelin (Norton and Cammer, 1984).
Other lipids in myelin usually not included in routine analytical studies include 
di- and tri-phosphoinositide, a series of fatty acid esters of cerebroside, at least three 
galactosyldiglyceride derivatives, a series of gangliosides and some alkanes. Myelin 
contains only small amounts of phosphatidylinositol remaining tightly bound to myelin 
proteins. Beside the two main galactolipids, cerebroside and sulphatide, myelin has 
several minor galactolipids, half of which consists of several fatty acids esters of 
cerebroside, and the other half of two glycerol-based lipids, diacylglycerylgalactoside 
and monoacylmonoalkylglyceryl-galactoside, called collectively galactosyldiglyceride. 
A sulphate ester of these latter compounds also exists. The biosynthesis of these
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glycerol derivatives appears to be closely associated with myelination (Norton and 
Cammer, 1984) (table 4).
(3) Myelin proteins
The most striking feature of CNS myelin proteins is their simplicity on SDS- 
PAGE as, in most species, they separate into only six prominent bands (Norton and 
Cammer, 1984).
(a) Myelin-associated Glycoprotein (MAG)
In the high-molecular-weight region of a typical SDS-polyacrylamide gel 
(>60,000), a number of minor, uncharacterised protein bands can be seen. These 
vary in amount, depending in the species and the degree of maturity. Although 
MAG is probably the major myelin glycoprotein characterised in this region, many 
other glycoproteins can be detected in most species (Norton and Cammer, 1984). 
MAG constitutes approximately 1% of the total CNS myelin protein and is also 
present in the PNS (Campagnoni and Macklin, 1988). It has an apparent molecular 
weight of 100 kDa, 30% of which is carbohydrate (Campagnoni and Macklin, 1988). 
This protein can exist in two isoforms with apparent molecular masses of 72 and 67 
kDa. which are encoded by separate mRNAs (Lai et al., 1987; Pedraza et al., 1991) 
(table 3). Biochemical and immunological studies have demonstrated that it is most 
prominent in oligodendrocyte membranes in the periaxonal regions of the CNS myelin 
intemodes but is absent from compact myelin (Stemberger et al., 1979; Trapp et al., 
1989) Its presence has also been demonstrated in oligodendrocyte processes during 
initial ensheathment of CNS axons (Trapp et al., 1989). The periaxonal localization 
together with the significant amino-acid sequence identity between the extracellular 
domain of MAG and other cell adhesion and ligand binding molecules supports a role 
for MAG in oligodendrocyte-axon interactions (Campagnoni and Macklin, 1988; 
Quarles et al., 1984; Trapp et al., 1989; Norton and Cammer, 1984).
MAG is a monotopic membrane protein and a large extracellular domain that 
contains five Ig-like regions, eight potential N-linked glycosylation sites and one of 
two possible cytoplasmic domains that contain putative phosphorylation sites (Arquint 
et al., 1987; Campagnoni and Macklin, 1988). MAG mRNA has been detected at 
about a week after birth in rodents and increases until about 25-27 days postnatally 
after which it decreases (Campagnoni and Macklin, 1988). Thus, in spite of the 
popular notion that MAG may play an important role in the early interaction between 
the growing myelin sheath and the axon, the developmental data suggest that the 
protein is not expressed earlier than the major myelin proteins (MBP and PLP), and 
that the developmental peak of its synthesis is somewhat later than MBP (Campagnoni 
and Macklin, 1988).
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(b) Wolfgram proteins
Three prominent bands are observed in stained gels in the molecular weight 
region of 43,000-60,000. These are the Wolfgram proteins Wj & W2 (Norton and 
Cammer, 1984). The amount of these proteins as well as their molecular weight 
varies among species and giving rise to some confusion in the literature. Recently, 
Wj (molecular weight 42,000-50,000) has been shown to correspond in molecular 
weight, amino-acid composition and immunological properties to the previously 
purified myelin-specific enzyme CNPase (Campagnoni and Macklin, 1988; Norton 
and Cammer, 1984). Both W la and W lb react with antiserum to CNPase, but the 
band at molecular weight 55,000 (W2) does not.
(c) 2 ',3 '-Cyclic Nucleotide 3 '-Phosphodiesterase (CNPase)
The purified enzyme consists of two polypeptides (46 kDa and 48 kDa) that 
represent about 5% of the total protein in purified CNS myelin (Kurihara et al., 1992; 
Sprinkle et al., 1978; Sprinkle et al., 1978). The two polypeptide forms of CNPase 
are encoded by separate mRNA (Bernier et al., 1987) which are concentrated around 
oligodendrocyte perinuclear regions during active stages of myelination (Trapp et al. , 
1987; Jordan et al., 1989) (table 3). CNPase mRNA is translated on free polysomes 
and is actively retained within the perinuclear region of the oligodendrocytes 
becoming tightly associated with membrane shortly after synthesis (Bernier et al., 
1987).
CNPase has been detected immunologically within specific regions of the 
oligodendrocyte and myelin intemode. These include the plasma membranes of 
oligodendrocytes and their processes, the paranodal loops, the periaxonal membrane 
and inner mesaxon, the outer tongue process and incisure-like membranes found in 
many larger CNS sheaths (Trapp et al., 1988; Braun et al., 1988). This wide 
distribution suggests that CNPase has a general function related to the maintenance of 
membranes that demarcate cytoplasmic channels within the myelin intemode and 
plasma membranes of the oligodendrocytes. In vitro CNPase catalyses the 
hydrolysis of 2 ',3 '-nucleotides into the corresponding 2 '-nucleotide (Norton and 
Cammer, 1984). The in vivo function of CNPase is unknown as natural substrates 
for these enzymatic activities have not yet been found in brain. Since CNPase 
appears to be the first myelin-related protein detected during development, it may 
have a crucial role in early stages of myelination (Trapp, 1990).
(d) Proteolipid proteins (PLP/DM-20)
The proteolipid fraction comprises two proteins in the SDS gel with molecular 
weights of 25,000 and 20,500. These are PLP and its isoform DM-20, respectively.
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The proteolipid proteins are highly hydrophobic intrinsic membrane proteins that 
represent about 50% of the total protein mass in isolated human CNS myelin (Nave 
and Milner, 1989). There is a controversy about the individual proportions of both 
of the proteolipid proteins (see below).
(a) Synthesis and trafficking o f PLP and DM-20
Membrane-bound ribosomes are the main location for PLP synthesis (Hartman 
et al., 1982; Colman et al., 1982). The PLP polypeptide is synthesized and 
integrated into membranes of the rough endoplasmic reticulum (Colman et al., 1982). 
The protein is acylated at a step following passage through the Golgi complex prior to 
its transport and insertion into compact myelin (Colman et al., 1982; Trapp, 1990). 
Similar DM-20 protein trafficking has been observed in Hella cells transfected with 
DM-20 cDNA (Timsit et al., 1992) (table 3). Antiserum directed against PLP/DM- 
20 stains compact CNS myelin intensely and produce particulate staining of 
perinuclear regions of actively myelinating oligodendrocytes (Hartman et al., 1982; 
Colman et al., 1982; Trapp, 1990). There is a substantial delay (30 minutes 
approximately) between synthesis of the polypeptide and its insertion into compact 
myelin (Colman et al., 1982; Benjamins et al., 1978).
(b) Protein structure and topological orientation
PLP is 276 amino acids long and has a molecular weight of exactly 30,000, 
which is considerably higher than the apparent molecular weight (approximately of 
24,000-25,000) of the active protein on SDS polyacrylamide gel electrophoresis 
(Nave and Milner, 1989). It is highly hydrophobic and 75% of its amino acids 
appear to exist in an a-helical conformation (Stoffel et al., 1984; Laursen et al., 
1984; Hudson et al., 1989). SDS gel electrophoresis separates the major PLP from a 
related myelin protein with higher electrophoretic mobility (Nave and Milner, 1989). 
This protein, which co-purifies with PLP, was termed DM-20 from its apparent 
weight of approximately 20,000 on gels (molecular weight of 26,500). A close 
biochemical relatedness between DM-20 protein and PLP was revealed, including 
identical of amino-terminal and carboxy-terminal amino acid residues. The primary 
structure of DM-20 and its relationship to PLP was deduced from cloned cDNA 
sequences (Nave et al., 1986) (figure 5.e). DM-20 differed from all known PLP
cDNAs by lacking 105 nucleotides from the protein coding region (Nave and Milner, 
1989) corresponding to a loss of amino acid residues 116 to 150 (Nave and Milner, 
1989). Thus PLP and DM-20 differ by the internal deletion of 35 amino acid 
residues (from 116 to 150) (Nave et al., 1987; Nave and Milner, 1989; Stoffel et al., 
1984; Trapp, 1990). DM-20 is present in almost the same quantity as PLP in adult
bovine (Trapp et al., 1983; Schindler et al., 1990) and rat brains (Van Dorsselaer et
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al., 1987) although it was previously believed that DM-20 was a minor component 
compared to PLP (Hudson et al., 1987). DM-20 is detected earlier and in larger
amounts than PLP at the beginning of myelination in the foetal bovine brain (Van 
Dorsselaer et al., 1987; Schindler et al., 1990). Just before birth PLP is less 
abundant than DM-20 in bovine brain (Schindler et al., 1990). Similar results have 
been obtained in human spinal cord (Kronquist et al., 1987) and mouse CNS 
(Gardinier and Macklin, 1988).
Rat, mouse, bovine and human PLP amino acid sequences are 99% identical, 
suggesting that their general three-dimensional structures are also virtually identical 
(Nave and Milner, 1989). PLP spans the lipid bilayer of myelin membranes; 
however, the precise orientation of the polypeptide within the membrane bilayer is 
unclear at present. PLP contains four stretches of hydrophobic amino acids, each of 
which is long enough to fully transverse the membrane bilayer (Milner et al., 1985; 
Nave and Milner, 1989), hence the different models of insertion in the membrane 
proposed by different authors (figure 5.e). Hudson and co-workers suggest that PLP 
has only two transmembrane domains and that the great majority of the protein is 
located on the extracellular face of the oligodendrocyte plasma membrane (Hudson et 
al., 1989). Laursen and co-workers, on the other hand, propose a model which has 
three putative transmembrane domains and some domains that may be exposed to each 
side of the bilayer (Laursen et al., 1984). Finally, Stoffel's (Stoffel et al., 1984; 
Trapp, 1990) model proposed that the major hydrophilic and positively charged 
domain of the protein is exposed at the extracellular surface of the myelin membrane. 
Most authors locate the orientation of the C-terminus at the cytoplasmic face of the 
oligodendrocyte membranes (Stoffel et al., 1984; Laursen et al., 1984; Konola et al., 
1992). However, the only established fact at present is that PLP is a polytopic 
membrane protein.
The region of PLP that is absent in DM-20 (residues 116-150) corresponds to 
the major hydrophilic and positively charged domain of the protein. This part of the 
sequence exactly precedes the putative third membrane embedded domain (Nave et 
al., 1987; Houbre et al., 1990) which is exposed at the extracellular surface of the 
myelin membrane in the model of Stoffel et al. (Stoffel et al., 1984; Trapp, 1990) 
(figure 5). As DM-20 lacks most of these charged residues, it presumably contains 
its functional site in the second extracellular domain of the molecule as proposed by 
Laursen (Laursen et al., 1984). This part of the molecule, which is identical in PLP 
and DM-20 is exposed to the cell surface and is acylated (Nave et al., 1987).
Some other lower molecular weight proteolipid proteins, apparently related to 
the major myelin PLP, have been observed in proteolipid preparations isolated from 
brain (Chan and Lees, 1974; Macklin and Pfeiffer, 1983; Lepage et al., 1986;
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Schindler et al., 1990) and translated in vitro from brain RNA (Sorg et al., 1986). 
PUB, an adult brain proteolipid (apparent Mr 24,000) (Helynck et al., 1983) shares an 
identical N-terminal tripeptide (Mr24,000) with that of PLP as well as its amino acid 
composition (Schindler et al., 1990). It reacts in immunoblot with the anti- 
tridecapeptide 117-129 antiserum. This proteolipid was never detected in foetal 
bovine cerebral hemispheres (Schindler et al., 1990). Another uncharacterised 
proteolipid named PUB', of approximately the same size as DM-20 (Mr 20,000) but 
different from PUB (Schindler et al., 1990), has also been described. Its amino acid 
composition differs from PUB and DM-20 and in immunoblots did not react with the 
anti-tridecapeptide or anti-C-terminal PLP antibodies (Schindler et al., 1990). PUB' 
has been found to be the major proteolipid in foetal hemispheres before the 
appearance of white matter but was not detected in adult bovine brain (Schindler et 
al., 1990).
(c) PLP gene localization and structure
The PLP gene locus has been located on the q-22 band of the X-chromosome 
(Mattei et al., 1986) which is significant in the implication of this gene in a group of 
sex-linked myelin-deficiency disorders (see section B). The PLP gene was first 
isolated from a human genomic library (Diehl et al., 1986) and further characterised 
in the mouse (Macklin et al., 1987) and the rat (Boison and Stoffel, 1989). Its 
overall structure suggested a high degree of sequence similarities between the mouse 
and human gene and remarkably little change during evolution. The PLP gene in 
both species is approximately 17,000 base pairs in length and contains seven exons. 
Alternative RNA splicing of the primary PLP gene transcript generates either PLP or 
the 105-nucleotide shorter DM-20 mRNA.
(d) Transcription o f the PLP gene
PLP specific mRNAs are highly abundant in the adult rodent brain 
(approximately 2% total mRNA) (Nave and Milner, 1989). The two major PLP 
mRNAs in rat brain are 3200 and 1600 nucleotides long, as shown by northern blot 
analysis (Nave and Milner, 1989; Campagnoni and Macklin, 1988). A third mRNA 
species of 2400 nucleotides is much less abundant (Nave and Milner, 1989). In 
mouse (Gardinier et al., 1986; Nave et al., 1986) and man (Kronquist et al., 1987) 
the 3200-nucleotide PLP mRNA is the predominant form. The relative abundance of 
the family of mRNAs appears to be different from different species (Campagnoni and 
Macklin, 1988). The PLP gene expresses two families of mRNAs through 
alternative splicing (Nave et al., 1987; Sorg et al., 1986; Campagnoni et al., 1992). 
The splicing of the PLP gene primary transcript in the brain appears to be 
developmentally regulated (Campagnoni et al., 1992). During the early stages of
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myelination the DM-20 mRNA is the predominant form and gradually declines with 
development (Schindler et al., 1990; Campagnoni et al., 1992). At later stages the 
PLP is the major form (Kronquist et al., 1987; Gardinier and Macklin, 1988; 
Schindler et al., 1990). PLP RNA levels are maximal at 18 days postnatally in brain 
(Campagnoni and Macklin, 1988). Recent application of polymerase chain reaction 
(PCR) technique demonstrated that DM-20 mRNA is detectable in embryonic mouse 
brain as early as embryonic day 11, showing a peak of expression at embryonic day
14, while PLP mRNA became detectable only at postnatal day 2 (Timsit et al., 1992; 
Ikenaka et al., 1992). Therefore, DM-20 mRNA is selectively spliced in a small 
amount from the very beginning of neural development (Ikenaka et al., 1992). The 
formation of DM-20 mRNA involves the excision of intron III and a 105-nucleotides 
of the PLP gene (exon IIIB) (Nave et al., 1987). The 5' end of the deleted sequence 
therefore constitutes an alternative 5' donor splice site, which is located within the 
open reading frame (exon IIIA) and is utilized with approximately 50% relative 
efficiency (Nave et al., 1987). By standard SDS gel electrophoresis of the myelin 
proteolipid fraction, PLP appears two to ten-fold more abundant than DM-20. 
However, at the RNA level, PLP mRNA is only twice as abundant as DM-20 mRNA 
in rat brain indicating a slightly higher efficiency of PLP specific RNA translation 
(Nave et al., 1986). Assuming that both mRNA forms are equally stable in vivo, 
PLP mRNA results from an about 2-fold higher splicing efficiency of the downstream 
splice site (Nave et al., 1987).
Recent investigations have demonstrated that DM-20 expression is not 
restricted to oligodendrocytes. Astrocytes (Macklin, 1988; Ikenaka et al., 1992), 
Schwann cells (Jordan et al., 1990; McPhilemy et al., 1989; Griffiths et al., 1989; 
Kamholz et al., 1992; Ikenaka et al., 1992) and various other cell lines of neuronal 
and glial origin including C6 glioma, oligodendroglioma G-26, B104, PC12, NG108-
15, N18-TG and Neuro 2A cells also produce DM-20 mRNA (Ikenaka et al., 1992). 
DM-20 mRNA has also been detected in newborn mouse heart and, to a lesser 
degree, in spleen (Campagnoni et al., 1992). The labelling was concentrated over 
the myocardial nuclei suggesting that substantial amounts of label were associated 
with the perinuclear, cytoplasmic regions of myocardial cells (Campagnoni et al., 
1992). Very recently I have also detected PLP mRNA expression in rat optic nerve 
A2B5 +  cells.
(e) Function o f  the proteolipid proteins
The remarkable degree of evolutionary conservation of PLP among mammals 
(Nave and Milner, 1989) and the extraordinary susceptibility of this protein to 
mutations suggests that some functions of this protein are not yet known. PLP 
mutants display two seemingly unrelated phenotypic features associated with the loss
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of function of PLP and DM-20. Firstly, the severe hypomyelination (see review in 
section B) together with an abnormally condensed IPL indicated that PLP/DM-20 
must predominate in the IPL as predicted by studies of the topology of PLP/DM-20 in 
the oligodendrocyte plasma membrane (see below) (Hudson et al., 1989). 
Secondly, striking phenotypic feature is the profound loss of oligodendrocytes in the 
CNS resulting in lethal mutations (see review in section B.3.). These features 
delineate two distinct roles for PLP and DM-20 in myelinating cells; one promoting 
oligodendrocyte survival and the other in providing stability at the IPL as a result of 
the homophilic interactions between PLP and/or the adjacent membrane (Schindler et 
al., 1990). Some authors consider DM-20 as a more complex proteolipid which 
developed later in proteolipid evolution (Nave et al., 1987). If DM-20 was inserted 
in the membrane following the PLP model, the major hydrophilic loop of PLP, which 
plays a key role in stabilization of the IPL, is almost entirely missing in DM-20 
(Schindler et al., 1990); thus, the homophilic interactions occurring between PLP 
molecules would not take place. However, as DM-20 is the only proteolipid detected 
in large amounts at the beginning of myelination, it is tempting to assume a particular 
role for DM-20 in the very early stages of the formation of the myelin sheath. 
Schindler et al. (Schindler et al., 1990) proposed a two step myelination model where 
by the flattened oligodendrocyte process can spirally wrap around the enlarging axon 
as the different layers slip over one another. This can occur since the hydrophobic 
loop is missing in DM-20, which is the major proteolipid in early myelination. 
During the second step, PLP stabilizes the arrangement of the myelin sheath with its 
hydrophobic loop anchoring adjacent layers. This hypothesis is compatible with the 
fact that the IPL may be formed at later stages (Schindler et al., 1990).
Recently, interest in the alternative roles for DM-20 in nervous tissue has 
increased. DM-20 mRNA has been detected in the embryonic mouse brain long 
before myelination occurs (Timsit et al., 1992; Ikenaka et al., 1992) and before PLP 
message is present (Van Dorsselaer et al., 1987). DM-20 mRNA and protein
production have also been described in astrocytes (Macklin, 1988; Ikenaka et al., 
1992) and Schwann cells (Jordan et al., 1990; McPhilemy et al., 1989; Griffiths et 
al., 1989; Kamholz et al., 1992; Ikenaka et al., 1992; Puckett et al., 1987). 
Additionally DM-20 mRNA has been found in various cell lines of neuronal and glial 
origin (Ikenaka et al., 1992), as well as in non-related tissues such as cardiac muscle 
(Campagnoni et al., 1992). Secondly, mutations within the PLP gene result in 
abnormal glial differentiation, such as degeneration of oligodendrocytes (Knapp et al., 
1986; Meier and Bischoff, 1975; Privat et al., 1982; Skoff and Knapp, 1990; Boison 
and Stoffel, 1989; Jackson et al., 1988; Jackson and Duncan, 1988; Nadon et al., 
1990; Fanarraga et al., 1992b) and hypertrophy of astrocytes (Skoff, 1976). These 
findings strongly suggest that DM-20 plays additional roles beyond that of a structural
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protein of myelin sheaths (Campagnoni et al., 1992). These roles may include the 
compartmentalization and differentiation of the neural tube (Timsit et al., 1992; 
Ikenaka et al., 1992; Schindler et al., 1990) or may even be involved in embryonic 
cell differentiation at all levels (Campagnoni et al., 1992). A reduction in DM-20 
mRNA occurred when PC 12 cells were induced to differentiate into neuron-like cells 
by nerve growth factor (NGF) addition (Ikenaka et al., 1992) which again supports 
the idea of DM-20 being necessary during the very early stages of cell differentiation.
Recently, the PMP-22 protein, in the PNS, has been found to be involved in 
Schwann cell growth-regulation (Snipes et al., 1992) (see section B.2.b.). DM-20
could represent the CNS equivalent to this protein as the structural role of DM-20 has 
yet to be demonstrated.
(e) Myelin Basic Proteins (MBP)
The prominent band at 18,5000 kDa on SDS PAGE is MBP accounting for 
30-35% of the total protein in purified CNS myelin. The myelin basic proteins 
consist of a family of low molecular weight product isoforms of a single gene by 
differential splicing (Ferra et al., 1985; Campagnoni, 1988; Norton and Cammer,
1984). The complete amino-acid sequence of bovine and human MBP was published 
in 1971 (Norton and Cammer, 1984). Four major forms of MBP (21.5 kDa, 18.5 
kDa, 17 kDa, 14 kDa) exist in rodents (Barbarese et al., 1978). However, the basic 
proteins of all mammals are very similar (Norton and Cammer, 1984). They have 
isoelectric points greater than 10, are highly denatured in solution, and are very 
susceptible to proteolysis. They contain more than 50% polar amino-acids, have one 
tryptophan residue per molecule, and contain no cysteine. This is in contrast to 
PLP, which is rich in cysteine and tryptophan. The MBPs can be extracted from 
myelin by acid or salt solutions, but are also soluble in chloroform-methanol when 
myelin is treated with this mixture. When extracted from the membrane, they are 
very soluble in water (Norton and Cammer, 1984).
The basic proteins are extrinsic membrane proteins and located on the 
cytoplasmic side of myelin membranes (Omlin et al., 1982) playing a structural role 
in maintaining the close apposition of the cytoplasmic leaflets of the MDL (Dupouey 
et al., 1979; Privat et al., 1979; Omlin et al., 1982) as demonstrated 
immunocytochemically (table 3). Antibodies specific for MBP stain compact CNS 
myelin (Stemberger et al., 1978a; Hartman et al., 1982). Mutations in the MBP 
gene, such as shiverer (shi), correlate the absence of MBP with ultrastructural 
alterations in the MDL of the myelin membrane.
MBP mRNA is distributed diffusely over myelinated fibres within the adult 
CNS indicating that it is translated on free polysomes and transported to sites near
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compact myelin during active stages of myelination (Trapp, 1990). MBP enters 
myelin within a few minutes after synthesis which may indicate that most of MBP 
synthesis occurs along the myelin intemode on polysomes that are present in the outer 
tongue process. This site of MBP synthesis also explains the dramatic reduction of 
MBP immunoreactivity in perinuclear regions of oligodendrocytes during peak 
periods of myelination (Stemberger et al., 1978b). Primary cultures of mouse brain 
oligodendrocytes show that MBP mRNAs activity is asymmetrical within the 
oligodendrocyte cell body, and then progressively label the cell processes (Amur- 
Umarjee et al., 1990). Older cells have clumps of MBP mRNA at significant 
distances from the cell body (Amur-Umaijee et al., 1990).
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B. CNS MUTANTS
1. INTRODUCTION AND AIMS OF THE STUDY
Myelin mutants have significantly contributed towards our understanding of 
assembly and maintenance of myelin and its functional importance in the nervous 
system. The largest group of myelin mutations involve the PLP gene and are 
inherited in an X-linked recessive manner. The normal myelination process is 
impaired in these mutants leading to severe neurological dysfunctions such as tremor, 
ataxia and seizures, and, in most cases, the early death of the animal. Mutations of 
the PLP gene occur in several species including man, dog, pig, rat and mouse (table 
5). In its most severe forms, dysmyelination results in only a few poorly compacted 
myelin sheaths, such as in the md rat (Duncan et al., 1987b).
2. DYSMYELINATING MUTANTS
The dysmyelinating mutants are useful models for investigating the normal 
process of myelination. These animals provide a uniform system in which to study a 
specific defect in myelination and secondary effects resulting from that defect. 
Several of the mutant mice have been extensively characterised.
a) Shiverer mutant
The shiverer (shi) and its allele myelin deficient (shim exhibit tremors 
beginning approximately at postnatal day 12, becoming progressively worse until 
convulsions appear. These mice do no survive past 90-150 days (Chemoff, 1981; 
Hogan and Greenfield, 1984). Morphological analyses indicate that many axons are 
unmyelinated, and those that are myelinated have only low amounts of myelin. 
Immunological and ultrastructural observations of shi and shimM tissue indicates the 
total absence of MBP (Bourre et al., 1980; Barbarese et al., 1983; Hogan and 
Greenfield, 1984) reflected in the lack of the MDL of the myelin sheaths (Privat et 
al., 1979; Dupouey et al., 1979; Mikoshiba et al., 1987). Recently, it has been 
established that the sh and shimM mutations map to the distal end of mouse 
chromosome 18 which contains the MBP gene (Okano et al., 1988; Roach et al.,
1985). The shi mutation results from a deletion of exons 3-7 of the MBP gene 
(Roach et al., 1985). In contrast, in shimM mice, there appears to be a duplication
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of the MBP gene with the downstream gene inverted (Okano et al., 1988; Popko et 
al., 1987).
When shi oligodendrocytes are immunostained for carbonic anhydrase II 
(CAII) an early oligodendrocyte marker, there is elevated staining relative to normal 
animals (Cammer et al., 1985). However, levels for both PLP and MAG are 
reduced, although significantly above MBP levels (Mikoshiba et al., 1980). PLP 
mRNA levels in 21 day-old shi brain were at approximately 50% of normal, although 
the amount of PLP that accumulated in these brains was relatively less (Sorg et al.,
1986).
b) Trembler mutant
The autosomal dominant trembler mutation (tr) maps to the mouse 
chromosome 11 and manifests as a Schwann cell defect characterised by severe 
hypomyelination and continuing Schwann cell proliferation throughout life (Ayers and 
Anderson, 1973). Affected animals move clumsily and develop tremor and transient 
seizures at young age. Recently, the tr mutation has been identified in the peripheral 
myelin protein-22 (PMP-22) gene which encodes for a potentially growth-regulating 
myelin protein (Suter et al., 1992).
c) Ouakins mutant
The quaking (qk) mutation is autosomal recessively-inherited, and maps to the 
mouse chromosome 17 causing a disorder in both the CNS and PNS (Guenet, 1980). 
These mice exhibit tremors, which begins approximately at postnatal day 12 and 
continue throughout their lifetime. Tonic seizures occur in these animals, although 
they have a normal life-span. Affected females are fertile but affected males are 
sterile. Histological examination indicated grey translucent areas in the optic nerve 
and the myelinated tracts of the spinal cord and brain stem. There was a significant 
loss of CNS myelin, although PNS myelination was not severely defective at the light 
microscopic level. The density of oligodendrocyte cells was increased along fibre 
tracts (Friedrich, 1975), often with vacuoles in the cytoplasm suggesting a defective 
incorporation (Greenfield et al., 1977) and a lysosomal degradation of myelin 
proteins (Watanabe and Bingle, 1972; Wisniewski and Morell, 1971).
No oligodendrocyte/myelin gene product has been clearly implicated as the 
primary site of the genetic lesion in qk mice. At present no myelin-specific gene has 
been mapped to the chromosome 17 in qk. It has been suggested that the defect in qk
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is a maturation defect that results in an arrest in myelinogenesis (Wisniewski and 
Morell, 1971) due to the inability of the myelin membranes to assemble correctly, 
rather than in an inability of the cell to synthesize the proteins (Greenfield et al., 
1977).
3. REVIEW OF THE PHENOTYPE OF THE PLP MUTANTS
This group of myelin mutants comprises animals from different species such as 
jimpy (jp) mice and its alleles jimpy synthesis deficient (jpwsd) (Meier and MacPike, 
1970) and jp rsh (Cattanach and Beechey, 1991); the md rats (Boison and Stoffel,
1989) the shaking pup (sh pup) (Nadon et al., 1990), the Type AIII pig (Harding et 
al., 1973) and Pelizaeus Merzbacher Disease (PMD) in humans (table 5).
a) Clinical presentation
The first neurological abnormality seen in these mutants is usually a tremor, 
which is noted when they begin to ambulate at 10 to 12 days of age; however, a fine 
tremor may be seen in the sh pup as early as 7 days (Duncan, 1990). The tremor 
worsens with attempts to perform volitional movements and disappears when the 
animal rests or sleeps. In the md rat and jp  mouse, seizures begin at 20 days of age 
and increasing in frequency and severity, resulting in death at about 25 to 30 days. 
A long lived "strain" of md rats has been noted in two different colonies with affected 
males living up to 85 days of age despite continued tremoring and seizure activity 
(Jackson et al., 1988). In contrast to the murine mutants, sh pup hemizygotes can 
live for prolonged periods if hand-reared, but they have persistent neurologic deficits 
and may develop seizures after 3 to 4 months. The genetic heterogeneity of human 
PMD, with at least six known forms of the disease, results in a variable phenotype. 
The connatal form of PMD is the most severe, with affected children showing tremor, 
ataxia and athetosis; death occurs early in life, usually before the age of 10. Type 
AIII hypomyelinogenesis congenita described in the Landrace pig results in tremor 
and ataxia (Blakemore et al., 1974).
h) MorpholoQical characteristics
(1) Amount o f myelin
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Light microscopy of mutant CNS reveals a variable severity of 
hypomyelination for the different mutations. Later-myelinating structures in the 
brain, such as the corpus callosum, compared to the spinal cord (an earlier 
myelinating structure) seemed to be more affected (Duncan, 1990). Within one type 
of mutation some animals are more affected than others. In jp , clumps of myelinated 
fibres and occasional scattered myelinated fibres are seen. However, quantitation of 
the amount of myelin in the spinal cord of jp  demonstrated only 1.6% of the amount 
in control animals (Duncan et al., 1989). The allele of jp , the j p ^ d  (Billings- 
Gagliardi et al., 1983) mouse has, in comparison, twice the amount of myelin as jp  
(Duncan et al., 1989). Those mutants with the greatest amounts of myelin, that is 
the sh pup , Type AIII pig and jp rs^  live longer than those with little myelin. One 
exception, however, is the "older strain" of md rats which can live up to three times 
longer than the original mutant (Jackson et al., 1988). As the increase in the amount 
of myelin in these older md rats is small, it is unlikely to be responsible for their 
longer survival.
(2) Myelin structure
There is also a great variation in the structure of the myelin formed in the X- 
linked mutants. In the md rat most of the myelin that is formed consists of loosely 
whorled layers of membrane. Similar, poorly compacted myelin is frequently seen in 
the other mutants. However, in both the md rat and jp  mouse, occasional 
surprisingly thick and apparently well-compacted myelin sheaths with up to 20 
lamellae can be seen (Duncan et al., 1989; Duncan et al., 1987b). In those mutants 
with more myelin the majority of myelin sheaths are thin (hypomyelination), even in 
mature sh pups at 2 years of age (Duncan, 1990). Certain smaller axons have thicker 
myelin sheaths, but examination of longitudinal sections of the spinal cord suggests 
that these are likely to have shorter intemodes (Duncan, 1990). High power 
resolution of the myelin sheath of the md rat has shown an abnormality in the 
compacted myelin sheaths with fusion of the intraperiod line (Hudson, 1990a; Duncan 
et al., 1989; Duncan et al., 1987b; Rosenbluth, 1987). A similar abnormality can 
be seen in certain parts of the myelin sheaths found in jp  (Duncan et al., 1989). As 
PLP is thought to be localized predominantly at the intraperiod line (Hudson et al.,
1989), the previously noted lack of PLP in these mutants could result in this structural 
abnormality. Immunocytochemical staining of the myelin sheaths in the X-linked 
mutants has produced interesting but variable results. Myelin sheaths of the md rat 
and jp  mice do not immunostain with the anti-C-terminal antibody (common for PLP 
and DM-20), which stains the myelin found in the sh pup and type AIII pig (Duncan,
1990). In PMD, PLP is not detectable by immunostaining. In each mutant in 
which there is a lack of PLP staining, the myelin present is positive for MBP. 
Immunostaining of the same sheaths in serial sections of md and jp  demonstrates that
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they are MBP positive, yet PLP negative (Duncan et al., 1989; Duncan et al., 
1987b). In the sh pup, although the myelin is PLP and MBP positive, the staining of 
myelin is poor when compared to controls (Yanagisawa et al., 1987).
(3) Oligodendroglia in PLP mutants
The number of mature oligodendrocytes is reduced in the X-linked mutants as 
evaluated by both quantitative and qualitative microscopic studies of certain areas of 
the CNS (Duncan, 1990). Tissue culture studies of the optic nerve or brain of both 
jp  and md rat confirm that fewer viable cells of the oligodendrocyte lineage are found 
in the mutants compared to controls (Zeller et al., 1989). However, using anti-GalC 
antibodies as an oligodendrocyte-specific marker, jp  oligodendrocytes have been seen 
to reach the GalC-f- state of development (Ghandour and Skoff, 1988) and even to 
synthesize a fairly thick, though abnormally compacted, myelin sheath. These may 
represent the few oligodendrocytes capable of forming myelin (Duncan, 1990). 
Despite the apparent paucity of mature oligodendrocytes in these mutants cell kinetic 
studies in jp , md rat and sh pup (Jackson and Duncan, 1988; Knapp et al., 1986; 
Duncan, 1990) have shown an increased glial cell proliferation, most probably of 
oligodendrocytes. However it has also been documented that the premature death of 
these cells occurred especially in jp  (Meier and Bischoff, 1975; Knapp et al., 1986; 
Knapp et al., 1990; Privat et al., 1982; Skoff and Knapp, 1990; Vermeesch et al.,
1990), and md rat (Boison and Stoffel, 1989; Jackson and Duncan, 1988).
A unique cellular abnormality of oligodendrocytes noted in the md rat and sh 
pup is distension of the rough endoplasmic reticulum and nuclear envelope (Jackson 
and Duncan, 1988;Dentinger et al., 1982; Duncan et al., 1983). In the sh pup these 
distensions contain a floccular material, whereas in the md rat the rough endoplasmic 
reticulum swellings are often larger in size but appear more vacuolar. A mild 
swelling of the rough endoplasmic reticulum in oligodendrocytes has been reported in 
jpmsd (Billings-Gagliardi et al., 1983) whereas in jp , dying oligodendrocytes are 
present but the only consistent cytoplasmic abnormality is the presence of abnormal 
membranous profiles (Meier and Bischoff, 1975). Distension of the rough 
endoplasmic reticulum in the sh pup and the md rat may be the key to the underlying 
biochemical defect in these mutants. These two mutations are located in exons 2 and 
3 respectively resulting in the insertion of a proline residue (Nadon et al., 1990; 
Boison and Stoffel, 1989) (see below). The abnormal proteins may not be 
transported from the rough endoplasmic reticulum to the Golgi or if they are 
transported it is in an abnormal fashion resulting in their accumulation within the 
lumen or on the external luminal surface of the rough endoplasmic reticulum. In jp, 
distension of the rough endoplasmic reticulum does not occur. Immunocytochemical 
labelling of PLP in the rough endoplasmic reticulum, but not the Golgi apparatus
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(Roussel et al., 1987) of oligodendrocytes, suggests that PLP transport from rough 
endoplasmic reticulum to Golgi is blocked. In jp  this protein may be so abnormal that 
it is rapidly degraded and hence distension of the rough endoplasmic reticulum does 
not occur.
c) Molecular genetics o f  the PLP mutations
The PLP protein has demonstrated to be intolerant to structural changes. 
Some of the described PLP mutations involve a proline introduction in the primary 
structure which is known to markedly affect protein structure (Hogan and Greenfield, 
1984) (figure 5.e). However, other more conservative changes in the hydrophilic 
domains of the protein also provoke similar phenotypes, thus this demonstrates that it 
is not a proline phenomenon. Newly substituted residues may interfere with the 
pairing of hydrophobic regions, possibly in the formation of a functional oligomeric 
structure, thereby disrupting the normal folding of the molecule and subsequent 
transport to the sites of myelin assembly (Hudson, 1990a). The unusually high 
conservation of the PLP protein (100% between mouse, rat (Milner et al., 1985) and 
human (Diehl et al., 1986)) suggests multiple protein-protein interaction which do not 
take place in most PLP mutants (Schneider et al., 1992).
4. AIM OF THE STUDY OF THE k  lphMUTATION
Previously-described mutations involving the PLP gene are lethal (Nave and 
Milner, 1989). The phenotype of these mutants includes degeneration and premature 
death of oligodendrocytes with associated hypomyelination. However, the recent 
discovery of jp rsh reopened the discussion for the direct involvement of PLP 
mutations in the early death of these mutants. Even though jp rs^ is myelin-deficient 
it has normal longevity and a full complement of morphologically normal 
oligodendrocytes. Hypomyelination can thus be genetically separated from the PLP- 
dependent oligodendrocytic degeneration. Study of the jp rs^  mutation should 
hopefully contribute to our understanding of the complex role of proteolipid proteins, 
particularly DM-20 which is relatively abundant in jp rsh CNS.
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CHAPTER 2: MATERIALS AND METHODS
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A. FIXATION
1. FIXATIVES
a) Paraformaldehyde (4% )
This fixative was used for tissues destined for in situ hybridization and 
immunocytochemistry on paraffin-embedded tissue sections. Each mouse required 
approximately 200 ml.
For 500 ml of fixative:
Add 20 g of paraformaldehyde to 500 ml of 0.1 M phosphate buffer.
Heat solution to 70° C;
Add 1 M NaOH until solution clears;
Cool solution to 4° C.
b) Kamovskv's modified fixative (Paraformaldehyde/Glutaraldehvde 2%/5%)
This fixative was used for tissues destined for light and electron microscopy as 
well as for immunocytochemistry on resin-embedded sections. The total volume 
required was calculated as before.
For 500 ml of fixative:
Prepare an 8% paraformaldehyde solution in ddH20  as above;
(20 g of paraformaldehyde to 250 ml ddH20);
Add 100 ml of 25% glutaraldehyde;
Make up to 500 ml with 0.08 M caccodylate buffer;
Add 250 mg of CaC^;
Filter solution in a fume cupboard;
Adjust final pH to 7.2.
2. TECHNIQUES
a) lntra-cardiac perfusions.
(1) Technique
All perfusions took place in a fume cupboard.
Mice were killed by an overdose of halothane anaesthetic and immediately 
after death were pinned out in dorsal recumbency over a piece of cork, the skin of the 
thorax was removed; the sternum cut and the heart exposed. The perfusion was 
initiated through the left ventricle using a 21 x 1 or 25 x 5/8 gauge needle after a 
small cut had been made in the right atrium. The initial perfusate was 0.85% NaCl 
until most of the blood was flushed from the body (60 ml approximately), when it 
was changed to fixative. After the injection of about 60 ml, given over a period of
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approximately 3 min, the degree of fixation was assessed by the rigidity of the 
animal. Some animals required up to 300 ml to achieve a good tissue fixation.
Fixed mice were kept in a moisturized container until the tissue dissection. 
After 1 hr at 4° C the desired tissue was removed and stored in the appropriate 
fixative.
(2) Dissection and storage o f the samples
Microsurgical instruments and a low power microscope were used for the 
procedure.
The skin of the head and back was cut and the muscles were dissected 
longitudinally until the exposure of the skull and the spine. The removal of the bone 
started at the rostral end and continued with forceps until the brain and cerebellum 
were exposed. The vertebral arches were individually separated from the spine; the 
meninges and nerve roots were cut and spinal cord was then lifted from the canal by 
pulling from the caudal end. The brain and cerebellum were liberated from the skull 
by sectioning all the cranial nerves except the optic nerves, which were sectioned only 
for samples to be resin-embedded. Samples were stored at 4° C in universals with 
the same fixative used for the perfusion.
b) Tissue culture fixation.
Tissue culture coverslips were fixed by immersion in either 4% 
paraformaldehyde (cells destined for in situ hybridization), or methanol at -20° C 
(fixation and permeabilization for internal antigen staining) for 10 min.
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B. PROCESSING OF THE TISSUE SPECIMENS
1. PARAFFIN ROUTINE PROCESSING
The following procedure is for processing tissue for embedding in paraffin
wax:
Large tissue blocks (whole brains and, at least, 1 cm of length for the spinal
cord) obtained from the perfused mice were placed in processing biopsy cassettes
which were loaded in a basket of the Shandon Elliot automatic tissue processor
(Histokinette) and processed through the following dehydrating solutions:
70% methylated spirit for 2 hr;
70% methylated spirit/5 % phenol for hr;
90% methylated spirit/5 % phenol for 2 hr;
Methylated spirit 2 hr;
Ethanol & 5 % phenol for 1 hr;
1 % celloidin in methyl benzoate for 4 hr;
3 x 1 hr Xylene;
Paraffin wax for 4 to 6 hr;
Tissues were blocked out in 60° C fresh paraffin wax.
NB: Celloidin was obtained from Merk "Necoloidine" W  as a 8% solution, treated 
as a 100% solution when made up with methyl benzoate.
2. RESIN ROUTINE PROCESSING
The following procedure is for processing tissue for embedding in Araldite
resin:
(Day 1)
Samples were placed inside glass bottles that fitted on a Taab rotator (2 rpm.) 
inside a fume cupboard and were rinsed with isotonic caccodylate buffer for 10-20 
min.
The buffer was then replaced for a 1 % osmium tetroxide in 0.1 M caccodylate 
buffer solution or 1% osmium tetroxide/1.5% potassium ferricyanide in 0.1 M 
caccodylate buffer (modified Kamovsky's fixation for myelin studies (Langford and 
Coggeshall, 1980)) for 2 hr and washed in the same buffer for 1 hr.
The tissue was dehydrated for 15 minutes in each of the following alcohols of 
increasing concentrations: 50%, 70%, 80% and 90% and rinsed twice in 100% 
ethanol for 20 min each.
The tissue samples were immersed twice in propylene oxide (1,2- 
epoxypropane) for 15 min and left overnight in the rotors immersed a 1:1 mixture of 
propylene oxide and resin mix.
(Day 2)
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The 1:1 mixture of propylene oxide and resin was substituted for a 1:3 mixture 
of propylene oxide and resin and was left for 24 hr.
(Day 3)
The tops of the bijoux were removed to allow the propylene oxide to evaporate 
for 3 to 5 hr.
Processed samples were then embedded in rubber moulds filled with resin mix 
and were left to polymerize in a 60° C oven overnight.
NB: Resin composition: 30 g Araldite CY212 (resin), 25.2 g of D.D.S.A.
(dodecenyl succinic anhydride) (hardener), 1.2 ml of D.M.P. 30 (2,4,6-tri- 
dimethylaminomethyl-phenol) (accelerator) and 1 ml of Di-butyl phthalate 
(plasticizer).
3. SECTIONS
a) Paraffin-embedded tissue sections
Paraffin-embedded tissue sections varied from 5 to 6 ^m thick. The sections 
for immunocytochemistry were placed on Poly-L-lysine coated slides and then left 
overnight in a 60°C oven.
b) Resin sections
The resin blocks were loaded on a Reichert-Jung Ultracut E ultratome and cut 
at two different thickness 1 i^m (thick sections) for light microscopy and 70 nm (ultra- 
thin sections) for electron microscopy (see below). The 1 pm  sections were placed on 
either plain or gelatine coated slides (see section J.).
c) Ultra-thin sections
70 nm sections were cut with a diamond knife and mounted on 200 mesh-3.06 
mm diameter copper grids. Occasionally, small sections were mounted on 50 or 100 
mesh copper grids coated with 0.6% parlodion made up in amyl acetate.
4. STAINING TECHNIQUES
a ) Light microscopy
(1) Haematoxylin and eosin stain fo r  paraffin sections
The slides were dipped in fresh water; transferred to Mayer's haematoxylin for 
30 sec; washed gently in running tap water for 2 min; transferred to Scott's tap water 
for 15 sec and washed in running tap water for 2 min.
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The slides were counterstained by immersion in methylated spirits for 10 sec 
and then in a saturated alcoholic eosin solution for 25 sec.
The sections were dehydrated through methylated spirits and 2 x absolute 
ethanol, and then cleared in 2 x Xylene before mounting in DPX mountant.
NB: Mayer's haematoxylin was made up as follows: 1.0 g haematoxylin, 50.0 g
potassium alum, and 0.2 g sodium iodate in 1 litre of water, brought to boiling point 
and left overnight before adding 1.0 g citric acid and 50.0 g chloral hydrate.
Scott's tap water substitute: 3.5 g sodium bicarbonate and 20.0 g magnesium 
sulphate in 1 litre of water.
(2) Methylene blue/azure II fo r  resin sections
Methylene blue/azure 11= 1.0% methylene blue, 1.0% azure II, 1.0% borax 
in distilled water.
The slides were placed on a 60°C hot plate flooded with stain for 10-30 sec 
and rinsed in running tap water.
b) Electron microscopy
Ultra-thin sections were stained by covering the grids with a saturated solution 
of uranyl acetate in 50% ethanol for 5 to 15 min at room temperature. The grids 
were then rinsed in 50% and 75% ethanol; twice in distilled water and air-dried.
Subsequently the grids were stained with Reynold's lead citrate for 5-10 min 
inside a NaOH moisturised chamber and washed in 1 M NaOH solution x 3 and in 
ddH20  x 5.
NB: Reynold's lead citrate: 1.33 g Pb(N03)2 (lead nitrate), 1.76 g
Na3(C6H50 7)2H20  (sodium citrate) each dissolved in 15 ml H20 ; mixed together and 
shaken vigorously for 1 min and then occasionally over a 30 min period. 8.0 ml 1.0 
M NaOH was added to clear the solution and the volume made up to 50 ml with 
water; final pH 12.
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C. MORPHOLOGICAL STUDIES
1. QUANTIFICATION OF GLIA AND CELL COUNTS
Quantification of glia and cell counts were performed on 1 Araldite 
sections of tissue post-fixed in osmic acid and stained with methylene blue/azure II. 
The area selected in the spinal cord was immediately adjacent to the ventromedian 
fissure and its continuation onto the ventral surface of the cord. With the aid of an 
eyepiece graticule and using a x 100 oil immersion objective, six fields were 
examined in each transverse section (three each side of the ventromedian fissure) and 
the glial nuclei counted. Endothelial nuclei were not counted. Whole sections of 
the mid-position optic nerve sections were counted because of the smaller size. A 
further section cut at least 10 ^m from the first was treated in a similar manner for 
both spinal cord and optic nerve. Cells were categorized using their morphological 
characteristics (see chapter 1).
The diameter of glial cell nuclei was measured in longitudinal sections of the 
caudal segments of cervical cord using a calibrated eyepiece. The mean length of 50 
nuclei (oligodendrocytes and astrocytes) was calculated.
Using a digitizer pad, Apple II computer and a computer pen, the areas of the 
optic nerve and spinal cord on light microscopy negatives were calculated and then 
incorporated in the correction of the total glial cell count using Abercrombie's 
formula as discussed by Sturrock (Sturrock, 1983).
2. MORPHOMETRIC STUDIES
Random fields of 70 nm sections of spinal cord and optic nerve post fixed in 
osmium ferricyanide, embedded in Araldite, placed onto parlodion-coated grids and 
double stained by lead citrate and uranyl acetate were photographed at an initial 
magnification of approximately 5000 for adult spinal cords and 7500 for optic nerves 
and young spinal cords and printed at approximately two times magnification. 
Calibration was achieved using a diffraction grating (2160 lines per mm) which was 
photographed and printed for each cord and optic nerve sample.
Fibres were classified as myelinated (when some turns of compacted myelin 
were present), ensheathed (when an uncompacted oligodendrocytic process 
surrounded the axon) or unmyelinated (naked fibres).
Using a digitizer pad, Apple II computer and a computer pen, 100 to 250 
fibres were analysed by tracing around the axolemma and where appropriate the outer 
edge of the myelin sheath so allowing calculation of axonal and total area.
From this data the diameters of circles with equivalent areas were calculated 
allowing myelin thickness and g ratio to be derived: g is defined as the ratio of axon
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diameter to that of the axon plus myelin sheath; an increased g ratio indicates that 
the sheath is disproportionately thin for the axonal size).
3. MYELIN DENSITY
These measurements were performed over the previously described 
electron-micrographs using the point counting method described by Williams 
(Williams, 1977).
Two different transparent ruled squares were used for this purpose due to 
the two different magnifications and axonal diameters. Areas of 2 and 5 cm2 
areas were chosen for the spinal cord and optic nerve electronmicrographs 
respectively. The total volume of myelin and cell cytoplasm was calculated by 
counting the number of intercepts (16 possible for the spinal cord and 36 for the 
optic nerve) making contact with the myelin or cell cytoplasm in each micrograph. 
Results are expressed as the ratio of actual contacts to possible contacts.
STATISTICAL METHODS:
Three animals of each type were analysed for all the studies unless 
otherwise stated. The t test (student t distribution) was applied and a q value of
0.995 was chosen.
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D. IMMUNOCYTOCHEMISTRY
1. PEROXIDASE-ANTI-PEROXIDASE (PAP1
(Day 1)
Paraffin-embedded tissue sections:
Section were hydrated as follows:
Xylene 2 min;
Absolute alcohol 2 min;
Methylene 2 min;
Water 2 min;
Iodine 1 min;
Water 2 min;
5 % Sodium Thiosulphate 1 min;
Water 2 min.
Resin-embedded tissue sections:
The resin of the sections was removed by submerging the slides in sodium 
ethoxide solution using a basket rotor. After 30 min the removal was checked 
microscopically; the slides were washed 6 times in absolute alcohol and submerged in 
running water for 30 min.
The endogenous peroxidase activity of the tissue was then blocked by 
immersing the slides in a 3% hydrogen peroxide solution for 30 min (made up in 
absolute alcohol for the paraffin sections and in water for the plastic sections). The 
sections were washed in running water for 30 min
Non-specific binding sites were blocked with a 1:10 normal goat serum/PBS 
solution for 2 hr. The normal goat serum was then tapped off but the slides were 
not rinsed.
The sections were incubated at 4° C with the primary antibody solution (made 
up in 1% normal goat serum/PBS) inside a moisture chamber overnight (antibody 
sources and dilutions see Table 6). The control sections had normal mouse or normal 
rabbit serum applied at the same dilutions as the control sections.
(Day 2)
The sections were allowed to warm to room temperature for over a 30 minute
period.
The slides were then washed 6 times with PBS and the excess of liquid from 
around the specimen was wiped off. The link (secondary) antiserum was diluted to 
1:10 with 1% normal goat serum/PBS was added to the sections and incubated for 1 
hr.
The slides were then washed 6 times with PBS and the excess liquid was 
removed from around the specimen.
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The sections were covered with PAP complex diluted with 1% normal goat 
serum/PBS for 30 min. The mouse complex was diluted 1:1000 and the rabbit 
complex 1:40.
The slides were washed with 6 changes of PBS and then with 0.2 M phosphate 
buffer (pH 7.3) for 2 min and then transferred for 20 min to filtered solution of 50 
mg 3,4,3',4',-tetramino-biphenyl hydrochloride (DAB) in 50 ml distilled water which 
was then made up to 100 ml with the 0.1 M phosphate buffer.
330 /d of 30% aqueous hydrogen peroxide was added to the DAB solution and 
the colour allowed to develop for 5 min.
The sections were then washed in 0.2 M phosphate buffer for 2 min and 
running water for 5 min.
The sections were counterstained and mounted as follows.
Paraffin sections:
Haemalum 30 sec; running water 2 min and Scotts water 15 sec.
Sections were then dehydrated, cleared and mounted in DPX.
Resin sections:
1% osmium/caccodylate buffer 2 min and running water 15 min.
Sections were then cleared and mounted in DPX.
NB: Sodium ethoxide solution was made up from a 50% ripened sodium ethoxide
solution in absolute alcohol. All incubations are carried out at room temperature in a 
moisture chamber unless otherwise indicated.
2. IMMUNOFLUORESCENCE
Immunofluorescence was performed only on cells cultured on coverslips.
40 jul of the primary antibodies diluted to the appropriate concentration in 
buffered staining solution (see below) were applied over the coverslips and incubated 
for 20 min (antibody sources and dilutions see Table 7).
The coverslips were then washed three times with staining solution before 40 
/d of the secondary antibody were added and also incubated for 20 min.
The coverslips were washed three times with staining solution.
Cell permeabilization and internal immunostaining:
Cytoplasmic markers (MBP, PLP/DM-20, PLP and GFAP) required 
permeabilized cells prior to immunostaining. The cultures were permeabilized with 
methanol at -20° C for 10 min.
The coverslips were washed with fresh staining solution and had the second 
primary antibody applied for the cytoplasmic antigen for 20 min. After incubation 
the cells were washed three times as before and 40 jd of the secondary antibody was
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added for another 20 min before they were washed three times with staining solution 
and placed back onto the staining trays ready to be fixed.
NB: The coverslips where kept covered in fluid continuously. Buffered staining
solution contained: 4% donor calf serum, 0.05% azide in HEPES buffer made up in 
Hanks buffered salt solution, C a + +  and M g + +  free (HBSS). All antibodies were 
diluted in this staining solution. All incubations were carried out at room temperature 
on closed staining trays.
Fixation:
Cells were fixed in cold methanol at -20° C for 10 min.
The coverslips were washed in ddH20 ; dried on a tissue; had their back 
cleaned; mounted in Cytifluor and were sealed with glyceel.
The slides were stored at 4° C.
NB: Cytifluor (glycerol/PBS mounting media containing an antifade agent).
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E. IN SITU HYBRIDIZATION
1. PROBE DESCRIPTION
An 35S-labelled cRNA probe for PLP (PLP1) which recognised the majority 
of the coding region and part of the 5' non-coding region (nucleotide 48-Bam-Hl site 
up to the Pst-1 site at nucleotide 867) was transcribed. The probe was made by Ms 
K. McPhilemy, Dr. L. Mitchell and Dr. C. Thomsom.
2. TECHNIQUE
The basic procedure was as described by Cox et al. (Cox et al., 1984) and 
modified by Wilkinson et al. (Wilkinson et al., 1987).
The in situ hybridization was performed on 6 pm paraffin-embedded tissue 
sections as well as on 4 % paraformaldehyde-fixed oligodendrocyte cultures from wild 
type and jp rs^  mice at different ages.
The schedule for in situ hybridization has three phases. The first is a pre­
treatment that renders the target (mRNA) accessible to the probe which preserving the 
morphology of the tissue. This stage included a proteinase K treatment of the 
sections and also an acetylation stage (Hayashi, 1978) aimed at decreasing non­
specific binding by blocking basic groups of the proteins. The second phase is the 
hybridization of the riboprobe (0.1 ng/^l/kb) to the cellular mRNA which is 
performed under low stringency conditions that favour nucleic acid hybrid formation. 
The third phase consists of washing to remove unbound probe and produce an 
acceptable background. The sections are also treated with RNase to remove non-base- 
paired RNA from the tissue.
The technique was performed as follows:
(Day 1)
a) Tissue preparation
The sections were transferred through the following spirits and solutions:
Xylene for 10 min (paraffin-embedded sections only);
100% Ethanol for 5 min (paraffin-embedded sections only);
Methylated spirit for 5 min (paraffin-embedded sections only);
Saline for 5 min;
PBS for 5 min;
Fix with 4% paraformaldehyde for 20 min;
Fresh PBS for 5 min x 2.
hi Permeabilization
The sections were covered with freshly made proteinase K for 7 1/2 min at 
room temperature; then washed in PBS for 5 min and the proteinase K was inactivated 
by fixation in 4% paraformaldehyde for 5 min.
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c) Prehybridization
The slide rack was taken to a fume cupboard were the sections were washed in 
a 11.1% triethanolamine solution for 10 min where 625 jul acetic anhydride were 
added twice (the second dose of 625 /x1 of acetic anhydride added 5 min after the 
initiation of the wash).
The slides were then transferred to PBS for 5 min; saline for 5 min; 
methylated spirit for 5 min; 100% ethanol for 5 min x 2 and were air dried at room 
temperature for 1 hr.
d) Hybridization
The total volume of the probe was calculated (brain sections x 6 /tl; spinal 
cord sections x 3 /xl) and adequately diluted with hybridization buffer (approximately 
1:10 depending on the probe activity) having a 1:100 concentration of RNase free 
dithiothreitol (DTT) added to each vial. The vials had their lids perforated with a 
needle; were transferred to a 80°C water bath for 2 min and were cooled down on ice 
immediately after.
The probe was then applied to the sections and covered with a silicone-treated 
coverslip. The slides were placed horizontally inside a slide holding box which was 
sealed with tape, placed inside three vacuum sealed bags; immersed in a 50° C 
preheated water bath and left to hybridize at 50° C overnight.
NB: To produce an ideal moisturized environment for hybridization a tissue soaked
in 2.5 ml formamide and 1.25 ml 20 x SSC in 1.25 ml ddH20 was placed inside the 
slide box.
(Day 2)
e) Post hybridization treatments
Solutions W l, W2, W3, W4 and W5 were degassed and preheated (see 
temperatures below) for at least 30 min.
Plastic bags were cut; the slide box opened and the slides were transferred 
through to the following washes:
W l solution at 50° C for 30 min;
W2 at 65° C for 20 min;
W3 at 37° C for 10 min x 3;
Treat with 0.02 mg/ml RNase at 37° C for 30 min;
W3 at 37° C for 15 min;
W2 at 65° C for 20 min;
W4 at room temperature for 15 min;
W5 at room temperature for 15 min.
The sections were dehydrated through these solutions:
D l: 75 ml ethanol, 162.5 ml water, 12.5 ml 6 M ammonium acetate for 1 min;
D2: 150 ml ethanol, 87.5 ml water, 12.5 ml 6 M ammonium acetate for 1 min;
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D3: 200 ml ethanol, 37.5 ml water, 12.5 ml 6 M ammonium acetate for 1 min;
D4: 237.5 ml ethanol, 12.5 ml 6 M ammonium acetate for 1 min; 100% ethanol for 
2 min x 2.
Sections were then air dried at room temperature for at least 1 hr.
f) X  Ray
The slides were exposed against Cronex (Dupont) medical screen radiograph 
film inside a radiographic cassette at room temperature overnight and developed as a 
normal X-ray-film. Image intensities on the developed films determined the length 
of exposure of the slides after dipping in the autoradiographic emulsion.
g) Solutions
(1) DEPC treated water
(Use ddHJO)
1% DEPC of a 10% solution in ethanol at room temperature for 10 min. 
Autoclave and check smell (If DEPC is present heat at 90° C water bath until no 
smell).
(2) Proteinase K
(Use DEPC water)
0.002% proteinase K;
0.05 M TRIS-HC1; pH 7.6;
0.005 M EDTA.
(3) Dithiothreitol (DTT)
Prepare solution 1 M in DEPC water;
Do not autoclave.
(4) Hybridization mix
50% Formamide;
10% Dextran sulphate (50% solution);
20 mM TRIS-HC1, pH 8.0 (1 M solution);
0.3 M NaCl (5 M solution);
5 mM EDTA (0.1 M solution);
10 mM NaH^PCE, pH 8.0 (0.1 M solution);
0.5 mg/ml yeast tRNA (10 mg/ml);
Store at -20°C.
(Stock concentrations in brackets.)
(5) 2Qx Standard Sodium Citrate (20x SSC)
3 M NaCl;
0.3 M Trisodium Citrate;
(6) Wash Solutions
(a) Wash 1 (Wl)
625 ml 20 x SSC;
185 ml dKLO;
2.5 ml DTT just before use.
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(b) Wash 2 (W2)
4 ml 20 x SSC;
12 ml dH20;
20 ml formamide;
8 ml DTT add just before use.
(c) Wash 3 (W3)
0.5 M NaCl;
10 mM TRIS-HC1, pH 7.5;
5 mM EDTA.
(d) Wash 4 (W4)
50 ml 20 x SSC;
450 ml dH20 .
(e) Wash 5 (W5)
25 ml 20 x SSC;
475 ml dH20 .
h) Glassware treatment
Soak in 6.0% sulphuric acid; 6.0% potassium dichromate solution overnight. 
Rinse for 2-4 hr in running tap water; then in deionised water 9 times and once in
0.01% DEPC water. Shake dry and wrap in aluminium foil. Bake in sterilising 
oven 180° C for 4 hr.
The slides were coated with Poly-L-lysine as for morphological studies but 
RNase-free slides were used as well as DEPC-treated water (see X.A.). The 
coverslips were siliconised to decrease probe binding. These were soaked in 1 M HC1 
for 30 min; washed in ddH20  x 3 and air dried; siliconised by immersion in 
Repelcot(TM) for 20 min; rinsed in ddH20 and baked at 130° C for 90 min.
3. QUANTIFICATION OF AUTORADIOGRAMS
The average signal per cell was compared in enzymaticaly dissociated cells 
allowed to adhere to coverslips for 2 hr. Cells from both groups were processed in 
parallel to allow direct comparison. Following hybridization and development of the 
autoradiograms the integrated optical density of the signal from 150 cells of each 
group was measured using a Quantimet 970 (Cambridge Instruments) with a 
measuring frame to include the oligodendrocyte cell body area. The optical density 
of the background of a the same coverslip was subtracted from the antisense signal. 
The mean values were compared by grouped t test.
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F. AUTORADIOGRAPHY
1. METHOD
a) Slide Dipping
Clean, dry slides were dipped a solution of Ilford emulsion K5 for [^^S] or K2 
for [^H] mixed in a 1:1 ratio with ddH20 containing 1.0% glycerol to provide a thin 
layer over the specimen. The emulsion was maintained at 42° C in a water bath. 
After dipping, the slides had their backs cleaned and were air-dried in a plastic box 
together with silica gel for 4 to 6 hr. They were then stored in tape-sealed light-tight 
boxes containing a sachet of silica gel inside a black plastic bag, at 4° C for the 
required exposure time as determined by the test exposure against the radiographic 
film (time could vary between 4 to 30 days depending in the isotope and emulsion 
used).
b ) Developing
The autoradiograms were developed under safe light conditions by immersion 
in undiluted Kodak D 19 developer at 18° C for 4 min. The action of the developer 
was stopped by immersing for 1 min in a 1% acetic acid/1% glycerol solution in 
water. The slides were fixed for 3 min in 30% sodium thiosulphate solution and then 
washed in water for 20-30 min in the dark before air drying.
c) Haematoxylin Counterstain
Autoradiographs were counterstained as follows:
ddH20  for 2 min;
Haematoxylin for 30 sec; 
ddH20  for 2 min;
Scots water for 15 sec;
Dehydration and mount.
2. CELL COUNTS
The cell counts were performed on haematoxylin-counterstained 
autoradiograms. Up to 4 spinal cord sections were counted, 1 to 6 fields per section. 
One to 3 transverse sections of optic nerves were counted. The cells were then 
allocated as positive or negative depending on the degree of silver grains accumulation 
over the nucleus related to the background. The total glial cell count was corrected 
using Abercrombie's formula as described section C .l. of this chapter.
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G. CELL CULTURE
1. TISSUE PREPARATION
a) Optic nerve dissection
About 10 to 20 mice were killed by an overdose with halothane in a closed 
chamber. The animals were sprayed with alcohol and decapitated. The skin of the 
head was removed; the skull cut and the brain exposed. This structure was then 
pulled backwards very slowly detaching the optic chiasm. Two small incisions were 
performed behind each eye ball releasing the optic nerves which were transferred to a 
6 cm petri dish containing 6 ml of sterile HBSS (Ca+ +  and M g+ + free).
The connective tissue and the optic chiasm were removed from the optic nerve 
under a dissecting microscope, the nerves were immediately transferred to a fresh 
HBSS-filled petri dish which was removed to a laminar FLOW hood.
b) Spinal Cord Dissection
The skin and muscles from the neck and back were dissected and the dorsal 
arches of the cervical vertebrae removed to expose the cervical area of the spinal 
cord.
The meninges and dorsal columns of the spinal cord were cut longitudinally 
using a pair of sharp sterile forceps exposing the ventral columns which were then 
dissected free and placed in a sterile petri dish containing 6 ml of HBSS.
Under a dissecting microscope the grey matter was removed and the meningeal 
membranes were pulled out together with the ventral nerve roots. The clean tissue 
was immediately transferred to a fresh HBSS-filled petri dish inside a laminar FLOW 
hood.
c) Cell dissociation
The dissected tissue was collected on the inside of the lids of the petri dishes 
and minced with a scalpel blade (No. 10) and then transferred into a sterile centrifuge 
tube by adding and sucking back the 600 collagenase solution. This was incubated 
at 37° C for 30-45 min.
The tube was centrifuged at 1000 rpm. for 3 min and the supernatant was 
removed. 1 ml of 0.05% trypsin/0.02% EDTA solution was then added to the pellet 
and incubated at 37° C for 30 min after which 1 ml SD solution was added for 2 min 
to stop the enzymatic activity and prevent tissue clumping. The suspension was then 
centrifuged at 1000 rpm for 3 min and the supernatant removed.
The tissue was triturated in warm HBSS through needles of different gauges 
(21x1, 23x5/8, 25x5/8 and finally 27x1/2). The cell suspension was then centrifuged
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at 1000 rpm for 10 min and resuspended in 200 ^1 of 50% HBSS, 50% Sato/0.1% 
FCS medium.
The cell density was calculated using a regular Levy counting chamber with a 
Neubauer ruling by counting the four large ruled squares in the comers (1 mm2 = 16 
squares) and the cell numbers were adjusted to 400.000-500.000 cells/ml with the 
same solution.
d) Plating
The cells were plated at 8.000-15.000 cells/coverslips (20 ^1 drops of the 
above cell suspension) onto 13 mm warm Poly-L-lysine-coated coverslips placed 
inside FLOW 24 well plates.
The culture plates were placed in the incubator at 37°C 5 %, CO2 until cells 
had attached (10 to 30 min).
The cultures were fed with 600 ^ 1 of Sato/0.1 % heat inactivated FCS media. 
The culture medium was changed after 24 hr to eliminate myelin and cell 
debris if this was present.
e) Culture conditions
The cultures were maintained at 37°C and 5% CO2 in Sato/0.1% heat 
inactivated FCS media until immunofluorescence was performed.
2. SOLUTIONS
a) Hanks Balanced Salt Solution (HBSS)
C a + +  and M g + +  free solution.
(FLOW laboratories or SIGMA.)
b) Collaf>enase
50mg/ml stock solution of approximately 200 unit/mg collagenase (COUPER 
BIOMEDICAL) in HBSS (C a+ +  and M g+ + free);
200 jul aliquotes were stored at -20° C and diluted 1:3 in L15 or HBSS 
(Ca+ +  and M g+ +  free) for use.
c) Trvpsin/EDTA
0.1% trypsin (FLOW laboratories) solution in HBSS (Ca+ + and Mg+ + 
free) in 0.5 ml aliquotes stored at -20° C.
0.04% dilution of EDTA (FLOW laboratories) in HBSS (C a+ +  and Mg+ +
free).
A 1:1 mixture of both solutions was used.
d) SD Solution
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0.52 mg/ml soybean trypsin inhibitor (SD);
0.04 mg/ml bovine pancreas DNase;
3mg/ml of factor V bovine serum albumin;
Made up in HBSS (Ca+~*" and M g-*--1" free) or L15.
1 ml aliquotes of SD solution were stored at -20° C until usage.
e) SATO media
Glucose 1 g/1;
Glutamine 2 mM;
Insulin (bovine) 10 jim/ml;
Transferrin (human) 100 ^im/ml;
BSA-pathocyte 0.0286%;
Progesterone 0.2 juM;
Putrescine 0.1 juM;
Thyroxine 0.45 juM;
Selenite 0.224 ^M;
Tri-iodo-thyronine 0.5 ^iM;
Made up in DMEM.
30 and 200 ml aliquotes were stored at -20° C.
NB: All these solutions used for the cell dissociation, plating and feeding are pre­
warmed to 37°C before use.
3. CELL COUNTS IN CULTURE
Performed using a x50 oil objective for 2 hr cultures and at x40 for all the 
other cultures.
100 "healthy-looking" labelled cells (those that generally showed a bright even 
distribution of the immunofluorescent label as well as no signs of cell disintegration 
like the detachment of the cell processes from the cell body) were counted starting 
from a random field and scanning horizontally from that point.
The percentage of 0 4 +  cells was taken as a 100%. The percentage of 
GalC+ cells of the 0 4 +  was used to obtain the rest of the cell percentages. 
Therefore, cell percentages are expressed as the percentage of the 0 4 +  population.
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H. CELL MITOSIS STUDY
1. MATERIALS AND METHODS
a) Isotope preparation
The isotope was obtained from AMERSHAM as a 1.0 ^Ci/ml aqueous 
solution containing 2% ethanol of [methyl-^H] thymidine (9.25 megaBq.).
In order to reduce the volumes to be injected in the animals, the isotope was 
evaporated to dryness in a stream of nitrogen and reconstituted at a concentration of 5 
/LtCi//xl in 0.85% sterile saline.
b) fmeth\l-2-Hl-thvmidine labelling
Mice were injected 5 n d  per gram of body weight at the above concentration 
intra-peritoneally. The number of injections varied depending on the expected cell 
division rate.
Animals up to 50 days-old were injected once; 50 days-old were injected twice 
and 100 day-old mice were injected three times respectively. Repeated injections 
were given at 2 hr intervals.
Perfusion of the animals with Kamovsky's modified fixative 
(Paraformaldehyde/Glutaraldehyde) was performed two hr after the last isotope 
injection.
c) Samples, sections and autoradiography
1 ^m thick tissue sections of araldite resin-embedded spinal cord samples were 
cut and placed onto gelatin-coated slides (see section J.).
The sections had the resin removed (see section A.IV.) before proceeding with 
autoradiography (see section F) to improve the counterstaining.
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I. BUFFERS
1. PHOSPHATE BUFFER
Approximately 80% of 0.2 M Na2HP0 4 in dH20  plus
approximately 20% of 0.2 M KH2PO4 in dH20  added to achieve a pH of 7.4.
Dilute 1:1 with ddH20  to give final 0.1 M buffer.
2. PHOSPHATE BUFFERED SALINE (PBS1
8.006. g NaCl;
0.2012 g KC1;
0.2042 g KH2P 0 4;
1.1356 g Na2H P04.
Buffer solution to achieve pH 7.3 in 1 litre of ddH20 .
3. CACCODYLATE BUFFERS
The different caccodylate solutions were buffered to pH 7.2 to 7.3 with HC1.
The following caccodylate buffer solutions were used:
For fixative solutions:
A 0.08 M sodium caccodylate made up in ddH20 .
Isotonic caccodylate buffer fo r  routine electron microscopy processing:
16.05 g sodium caccodylate;
3.8 g NaCl;
0.055 g CaCl2 ;
0.102 g MgCl2 ;
made up to 1 1 with ddH20 .
Electron microscopy caccodylate buffer fo r  modified Kamovsky 's processing:
0.1 M sodium caccodylate in ddH20 .
J . SLIDE AND COVERSLIP COATING
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1. POLY-L LYSINE
Poly-L-lysine slides were prepared by covering clean glass slides with 0.01% 
Poly-L-lysine in ddH20  at room temperature for 10 min. The excess Poly-L-lysine 
was then removed and the slides air-dried; rinsed in ddH20  and air-dried again. 
They were kept at -70° C if not used immediately.
Coverslips were coated by immersion in a 1% solution of Poly-L-lysine in 
sterile ddH20  for over 40 min. The coverslips were then washed twice in sterile 
ddH20  for 40 min each time, air dried and fr^ezed until usage.
2. GELATIN COATED SLIDES (SUBBED")
The gelatin solution was freshly made up for every experiment. Cleaned 
slides were dipped into a 1/1 gelatin emulsion in 1% glycerol at 43° C for 2 min. 
The slides were then oven dried until the emulsion gelled.
NB: Gelatin composition: 5.0 g gelatin made up in a 1 of boiling ddH20 . After
cooling down, 0.5 g. Chrome alum (K2S04Cr2(S04)324H20 ) were added and the 
solution was filtered.
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CHAPTER 3: iprsh NFURomnT n a y
A. INTRODUCTION TO THE jp ^ h  STUDY
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1. OBJECTIVES OF THE STUDY OF THE MUTANT iprsh
The description of the jp rsh mutation is presented in the following sections. 
Firstly, an outline of the general phenotypic characteristics of the mutation including 
clinical signs, age of development, breeding characteristics and weight gain and 
tremor development studies will be given. In the next three sections the morphology 
of jp rsh will be defined starting with the description of the immunochemical and 
morphological features on tissue sections of the mutant CNS completing the study 
with the investigation of the PLP mRNA expression. Finally, the last two sections of 
this chapter are focused on the development of cultured mutant oligodendrocytes and 
the in vivo cell division. The final chapter of the study concentrates in the 
description of the heterozygous female.
2. HISTORY OF THE MUTATION
The spontaneous "rumpshaker" (jprsh) mutation was first identified at the 
MRC Radiobiology Unit in 1988 and donated to Glasgow University Veterinary 
School for further investigation. Initial studies identified a generalized tremor 
associated with hypomyelination in the CNS (Griffiths et al., 1990) and an X-linked 
inheritance pattern suggesting possible involvement of the PLP gene. Recent studies 
have characterised the jp rsh as a recessive point mutation of the PLP gene involving a 
single amino-acid substitution (Ilei86 -*Thr) (Schneider et al., 1992).
The first mutant animals, which were characterized by the tremor were 
detected among the progeny of a single pair mating in a small stock of mice housed at 
the MRC Radiobiology Unit. These mice were homozygous for Robertsonian 
translocation Rb(1.3) IBnr. Evidence that the condition was inherited was provided 
by preliminary crosses using a distantly-related Rb(1.3) IBnr stock. The mode of 
inheritance was determined by breeding studies using the shaking or tremor as the 
phenotypic expression of the mutation. Routine histological and
immunocytochemical experiments revealed that the jp rs^ mutation affected PLP 
production (Griffiths et al., 1990). The other CNS proteins including DM-20 which 
is another product of the PLP gene were either unaffected or involved to a much 
lesser degree. jp rs^  had phenotypic differences from other PLP mutants suggesting 
that it would provide a useful model to study the PLP gene, its products, regulatory 
mechanisms and functions.
3, PHENOTYPICAL DESCRIPTION OF THE MUTANT
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a) Clinical signs
The jp rsh mutation is phenotypically recessive, which means that homozygous 
females and hemizygous males show clinical signs. Affected mice, both males and 
females, develop a generalized tremor at about 10 to 15 days of age which is activated 
by movement and disappears at rest. The tremor reaches its peak of expression at 
around 25 to 30 days being then detectable in inactive mice. After this age, the 
tremor is confined to the rear end during ambulation, generally persisting throughout 
the life of some of the oldest mutant animals (1 year old.). Mice remain agile and 
can climb cage bars. Viability, fertility and weight gain appear normal (see below).
b) Breeding and litter number studies
Hemizygous jp  male (jp/Y) mice are sterile but the jp rsh mutant do not show 
any sign of altered reproduction. The litter sizes were calculated by counting the 
number of pups per mutant and control litters one or two days after birth. No 
significant differences were found in the distributions of the number of pups per litter. 
The results are shown in figure 6.
c) Weight studies
Weight gain is one of the parameters indicating the degree of physical 
development. It can be affected by the mutation either directly or indirectly as a 
result of a deficient milking or feeding consequent of the excessive tremor of the 
pups.
Over a period of one year, 400 to 500 wild type and jp rs^ mice from our 
colonies were randomly picked and weighed inside a closed chamber as they were 
anaesthetised prior to euthanasia. There were no significant differences in weight at 
different ages between jp rs^  and control mice (figure 7) in contrast to jp  mice which 
were abnormally small on visual inspection.
d) Tremor studies
The beginning of the tremor and its later progression in life was closely 
followed during the development of 24 jp rsfl litters. Four different degrees of tremor
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were recorded: grade "0" for mice not showing the jp rs^  phenotype; grade "1" for 
animals with a certain degree of stiffness in the walk and/or occasional mild tremor; 
grade "2" for mice which showed tremor activated by movement and disappearing at 
rest; and finally, grade "3" for those mutants that showed tremor at rest. The 
commonest age of onset, of a grade "1” or "2" tremor was, generally, around 15 
days. By 22 days of age all the pups used for this study showed either grade "2" or 
"3” tremor. The peak of expression was about 25-30 days of age.
The onset and degree of tremor showed by mutant mice was correlated to the 
physical development of the pups; the more developed the pups, the greater the signs. 
Grade "3” tremor was present only in young and physically well-developed mice, 
generally from small litters, and would last for approximately a week to then become 
grade "2”. All mice reached at least grade "2” tremor persisting for a variable length 
of time; weeks, months or as long as a year. Eventually, the clinical signs declined 
until the tremor could be observed only when activated by movement while 
disappearing at rest. Slight clinical signs persisted in adult mice. These signs were 
confined to the rear end and included an abnormal gait or straight tail carriage. No 
obvious differences were found in the timing or the degree of the tremor between 
hemizygous males and homozygous females.
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B. HISTOCHEMISTRY IN jp ^ h
1. INTRODUCTION AND AIMS OF THE STUDY
In previous studies, immunostaining for myelin proteins in spinal cord sections 
of jp rsh mice identified virtually no reaction for PLP in the myelin sheaths (Griffiths 
et al., 1990). The reduced, but definite, immunostaining with antiserum recognizing 
both PLP and DM-20 indicated a disproportionate expression of the two proteins as 
previously described in the sh pup and jptnsd mutants (Yanagisawa et al., 1987; 
Gardinier and Macklin, 1988).
Quantitative immunoblotting studies of the spinal cord of jp rsh showed a 
markedly reduced intensity of the PLP band at 10 and 40 days while the intensity of 
the DM-20 band relative to PLP was proportionately greater in the mutant (Griffiths 
et al., 1990); staining for all four MBP isoforms was also reduced (Griffiths et al., 
1990). Other X-linked mutations such as the md rat (Yanagisawa et al., 1986) and 
jp  mouse (Sorg et al., 1987) with undetectable PLP and DM-20 by immunoblotting, 
also exhibit a marked reduction of the other major myelin proteins. 
Immunocytochemistry was used to evaluate both the overall myelin proteins in 
paraffin sections as well as the composition of individual myelin sheaths in resin 
sections, so evaluating the quantity and quality of the myelin sheath produced. The 
relationship between the absence of PLP and abnormalities of the myelin sheath such 
as defects in the IPL can be investigated.
2. MATERIALS AND METHODS
The PAP technique was chosen for the detection of protein in paraffin and 
resin-embedded tissue sections of the CNS. The paraffin-embedded sections were 
used to assess the overall protein present. The resin-embedded sections allowed the 
identification of individual sheaths. The ages of the mice, dissection and processing 
procedures as well as the antibodies used for all the following experiments are fully 
described in chapter 2 and table 6.
78
3. RESULTS
a) Mvelin proteins in ip™h
Paraffin sections of brain, optic nerve and spinal cord, as well as selected 
resin-embedded areas of the spinal cord stained intensely for MBP although the 
overall intensity was less in jp rs^  than age-matched controls due to the reduced 
quantity of myelin (figures 8, 9). Immunostaining for GFAP indicated that the 
number of astrocytic processes and intensity of staining increased moderately with age 
in jp rsh compared to age-matched wild type. Early studies of the mutant tissue 
reported that the overall reactivity for MAG was decreased presumably due to the 
number of non-myelinating fibres. Those fibres with myelin sheaths immunostained 
normally for MAG (Griffiths et al., 1990).
In control wild type mice both anti serum recognizing PLP and DM-20 (anti-C 
terminal antibody) stained myelin intensely (figures 8 to 10). In contrast jp rs^  
myelin showed a marked reduction of PLP (anti-PLP-specific antibody) staining 
whereas the intensity of staining for PLP and DM-20 was only moderately decreased. 
No reaction was present in paraffin-embedded sections from the spinal cords of 20 
day-old mutant mice immunostained with the anti-PLP-specific antiserum, while the 
anti-C-terminal staining was reduced (Griffiths et al., 1990). When optic nerve 
sections from mutant and control mice between the ages of 20 and 90 days were 
processed in parallel, PLP/DM-20 and PLP staining seemed to increase with age 
(figure 8, 9, 11) in the mutants but was always less than in the age-matched normal 
mice. PLP immunoreactivity on resin-embedded sections of the jp rsh spinal cord 
also increased with age. However, the PLP positive immunoreactivity was 
frequently localized in clumps generally at the periphery of the smaller sheaths 
increasing with age when the antibody was applied at a 1:250 concentration or higher 
(figure 10).
b) Serial section immunostaining
Immunostaining of serial resin-sections of the spinal cord revealed two main 
types of fibres MBP+ /PLP/DM-20+ /PLP- and MBP+/PLP/DM-20-/PLP-, very 
occasional MBP+ /PLP/DM-20+ /PLP+ fibres were also seen, generally presenting a 
focal staining of the outer edge of the sheath (figure 10d ,10e ,12).
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c) Peripheral myelin assessment
Serial paraffin-embedded sections of the brain and resin-embedded sections 
from the spinal cord of 1 year-old mutant mice were immunostained for PQ, a major 
PNS protein, to assess for any possible Schwann cell invasion of the jp rsh mutant 
CNS. No evidence of peripheral myelin was found (figure 13).
4. DISCUSSION
Immunocytochemical studies in jp rsh revealed reduced levels of PLP staining 
particularly in compact myelin, with a relatively normal intensity of presumed DM-20 
protein; thus, the PLP/DM-20 protein ratio was inverted even after the period of 
active myelination (Mitchell et al., 1990). (The presence of DM-20 can be inferred 
only by immunostaining by using the two antibodies described). Previous studies on 
this mutation demonstrated that MBP and MAG proteins were also moderately 
decreased with respect to the wild type mice (Griffiths et al., 1990). This is also the 
case for jp  mice, the md rat and the sh pup (Quarles, 1990). Occasional PLP 
positive clumps of immunostaining were detected in jp rs^  spinal cord tissue. 
However, as the anti-PLP specific antibody recognizes a part of the PLP protein 
which should not be mutated in jp rs^, there is a possibility that the antigen was 
recognizing an abnormal or an immature form of the PLP protein unsuitable for 
incorporating into the myelin sheath and so accumulating in the oligodendrocyte 
cytoplasm which surrounded the axons. The staining for both PLP/DM-20 and PLP 
increased with age although never achieving the same levels as in age-matched normal 
mice. The increased intensity of the PLP/DM-20 immunostain could be a 
consequence of the increased myelination of this tissue (see next section for more 
detail).
The disproportionate DM-20 expression seen in jp rs^  has previously been 
reported in other hypomyelinating mutants carrying a point mutations of the PLP gene 
which cause single amino acid substitutions in both PLP and DM-20 such as the sh 
pup and jpmsd  m0use (Nadon et al., 1990; Gencic and Hudson, 1990; Macklin et al., 
1991; Gardinier and Macklin, 1988; Yanagisawa et al., 1987). However, the fact 
that these mutants produce some DM-20 in their myelin does not imply that the 
elevated DM-20 levels are necessarily functionally active. Recent studies have 
revealed that the jp rs^ mutation is the result of a single amino acid substitution (lie186 
-»Thr) included in a putative membrane-embedded domain of the PLP/DM-20 
molecule (Schneider et al., 1992). Yet, compared to the other PLP mutants major 
differences in oligodendrocyte survival and development occur. Mutants with defects 
in other major myelin protein genes like shi (MBP gene (Roach et al., 1985)) or those
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of an unidentified nature (but not involving the PLP gene) like qk (Friedrich, 1974; 
Fujita et al., 1990) do not exhibit increased glial cell death (Friedrich, 1975), while 
all PLP mutations affecting DM-20 are believed to be associated with increased 
oligodendrocyte death (Nave and Milner, 1989; Duncan, 1990). Comparing 
oligodendrocyte survival in jp rs^  with that in jp , jptnsd. or sh p Up  suggests that a 
product of the PLP gene has a critical function in these cells before myelin assembly; 
this function, lost in most myelin mutants but sufficiently preserved in jp rsh, enables 
most oligodendrocytes to survive, differentiate and produce myelin. The early 
expression of DM-20 and its relative abundance in jp rsh suggests it as a candidate for 
this role.
Histochemical studies correlating protein composition with morphological 
appearance of myelin sheaths revealed that some myelin could be assembled even in 
the absence of PLP. However, both types of immunocytochemically defined myelin 
sheaths detected in jp rsh (MBP+ /PLP/DM-20+ /PLP- and MBP+ /PLP/DM-20- 
/PLP-) presented ultrastructural abnormalities of the IPL which is consistent with the 
structural function of PLP. Spinal cord sections from older jp rsh mutants 
demonstrated a higher immunoreactivity against PLP. This could be the consequence 
of a slow but progressive PLP accumulation and insertion in the membrane as jp rs^ 
mutants have been reported to produce some detectable PLP in western blots 
(Griffiths et a l. , 1990).
The possible presence of myelin repair by Schwann cells, as described for 
older strains of the sh pup (Duncan, personal communication), was assessed in 1 year- 
old mutant mice by immunostaining for PQ, a major peripheral myelin protein. 
Results indicated that no Schwann cell invasion was present in old mutant spinal 
cords. Further morphological examination of the PNS/CNS transition area also 
supported these findings.
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C. MORPHOLOGICAL STUDIES
1. INTRODUCTION AND AIMS
The description of the pathological changes resulting from a mutation is an 
important step to define the role of a particular gene in the normal animal. The aim 
in this section was the description of morphology in the mutant tissue and possible 
repair of the lesion in order to overcome the deficiency.
2. MATERIALS AND METHODS
The tissue was prepared as described in chapter 2. Briefly, mice were 
anaesthetised until overdose and fixed by intracardiac perfusion with normal saline 
followed by a modified Kamovsky's paraformaldehyde/glutaraldehyde (2%/5%) 
fixative. Tissue was post-fixed in either 1 % osmic acid or an osmic acid/potassium 
ferricyanide mixture. The blocks for the study were removed from C1-C2 segments 
of the spinal cord and mid portion of the optic nerves. The morphological studies 
were performed following the methods described in chapter 2 .
3. DISTRIBUTION AND DEVELOPMENT OF THE LESION
The ventral spinal cord and the mid-optic nerve were chosen as representative 
areas of the diversity of the CNS. Although hypomyelination of the CNS was 
generalised, the pathological abnormalities were most marked in the spinal cord. 
Other CNS locations, although affected, did not show such a remarkable pathology. 
No abnormalities were seen in the PNS (figure 13c).
4. DESCRIPTION OF THE LESIONS
Myelination in jp rs^  commenced at the correct time in all the CNS locations 
examined when compared to the wild type mice.
a) Spinal Cord
(1) LM  features
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Light microscopic examination of methylene blue/azure II-stained resin- 
embedded sections of the spinal cord of jp rsfl mice revealed a reduction in the amount 
of white matter area at all ages (figure 14). There were no other overt changes up to 
the age of 16 days, although a reduced myelin content was noted in quantification 
studies performed on 10 day-old jp rsh (Griffiths et al., 1990) (figures 15, 16, 17). 
A characteristic increase in numbers of all glial cell types, particularly those of the 
oligodendrocyte lineage, was observed at all ages. Cell counts in older mutants 
revealed that the oligodendrocyte population increased progressively in the spinal 
cord.
Recent observations of spinal cord sections at various ages before and after 
myelination revealed occasional dying cells. These resembled the cells described by 
Raff (Raff, 1992) (figure 3, 17) as suffering apoptosis (see discussion). However, 
despite the occasional cell death in younger mutants, jp rs^ presented adequate 
numbers of "metabolically active" oligodendrocytes at the time of myelination 
displaying a large, pale and evenly stained cytoplasm, numerous processes many of 
which actively ensheathed unmyelinated or poorly myelinated axons. 
Oligodendrocytes embracing single large axons in a "Schwann-cell-like" fashion were 
a frequent finding in younger mutants (figure 15, 16). Astrocytes and microglial 
cells did not exhibit any abnormal appearance at the light microscopic level.
A marked myelin deficiency was noted in the ventral columns from jp rsh. In 
the white matter large areas of tissue devoid of myelin sheaths were common. With 
increasing age there was an increased myelin staining mostly involving axons of with 
small diameters (figures 18, 19). The dorsal columns of the spinal cord were also 
morphologically examined. Cells resembling oligodendrocytes were obviously 
increased in number as the seen for the ventral columns. Although no fibre 
morphometry of the area has been performed, light microscopy revealed a moderate 
increase in the total amount of myelin with age. Vacuolation of some of the sheaths 
was occasionally present (figure 20).
(2) EM features
Electron microscopy of the spinal cord tissue confirmed the light microscopic 
observations. Mutant oligodendrocytes contained abundant rough endoplasmic 
reticulum, numerous free ribosomes and Golgi apparatus at all ages (figure 21). In 
very occasional cells the cistemae of the rough endoplasmic reticulum, but not the 
perinuclear cistemae, were slightly distended and many of the free ribosomes were 
monosomes rather than polysomes. Although oligodendrocyte processes were 
frequent and prominent during myelination they were often located adjacent to naked 
axons but did not myelinate them. Many oligodendrocytes embraced axons in a 1:1
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ratio but frequently produced no compact myelin. This was a common finding in 
spinal cord sections from younger mutants (figure 21). Occasional oligodendrocytes 
contained dense inclusions with lamellar profiles similar to those illustrated by 
Lassman and co-workers in degenerating optic nerve (Lassmann et al., 1978). Dying 
cells were conspicuous in the samples examined from mutant and wild type mice.
An atypical cell, not present in wild type mice, was also occasionally observed 
in spinal cords from older mutants (and some heterozygote females). These cells 
resembled those described in the monkey developing cord (Phillips, 1973) termed 
"primitive oligoblast". They were generally rod shaped and smaller than more 
mature oligodendroblasts and exhibited no apparent processes. Their nuclei were rod 
shaped or oval with an evenly contoured outline and contained very few, if any, 
chromatin clumps. Definitive nucleoli were not distinguishable. The cytoplasm was 
sparse and contained short straight cistemae of the rough endoplasmic reticulum with 
contents that resembled the cytoplasmic matrix. Vesicles resembling smooth 
endoplasmic reticulum were present, occasionally elongating resembling the Golgi 
apparatus. Mitochondria were conspicuous. Microtubules or centrioles were not 
encountered (figures 22, 23). These cells were easily overlooked at light microscopy 
because of their small size and indistinctive staining.
Astrocytes were similar to those in wild-type mice. There appeared to be a 
minimal increase in astrocytic processes in older mice but this was not uniform and 
varied between mice and within a given region of the spinal cord. Astrocytic 
processes were occasionally observed inserted between myelin lamellae or between 
axon and sheath as described in other myelin mutants (Griffiths et al.y 1981; 
Rosenbluth, 1987).
Hypomyelination of the spinal cord was probably the most characteristic 
finding in j p rsh and became more obvious after 30 days of age. The majority of 
axons were either naked or, more commonly, surrounded by a disproportionately thin 
myelin sheath which was often irregular in outline. Occasional well compacted small 
myelin sheaths were present (figure 21). In many sheaths, one or several turns of 
uncompacted processes were interposed between compacted lamellae. Excessively 
prominent inner tongues were a frequent finding in younger mice. Redundant folds 
of myelin sheath were more common than in normal mice. Late-appearing myelin 
sheaths surrounding smaller fibres present in the older mutant spinal cord showed a 
reasonably thickness for the axonal diameter (figure 24). Some microglia containing 
myelin debris or membranous inclusions, either lamellar bodies as described below in 
oligodendrocytes or more wispy membranes, could be seen in younger mutants. The 
lesion did not reflect active demyelination as myelin debris was a relatively 
uncommon finding.
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Myelin sheaths from jp rsh mice displayed abnormalities of the IPL which was 
either absent, split, vacuolated or indistinguishable from the MDL (figure 25). The 
periodicity of jp rsh and wild type myelin sheaths of fibres with a similar axonal 
diameter was mostly similar or identical, although in a significant minority of sheaths 
it was difficult to identify the MDL and IPL as separate entities. In some of these 
the periodicity of the putative MDL was normal and in others the distance was 
reduced (figure 25). The vast majority of the axons in the mutant were normal 
although occasional axons filled with swollen organelles were observed. No 
abnormalities were observed in sciatic nerves and nerve roots (Griffiths et al., 1990).
b) Optic nerve
(1) LM features
No conspicuous abnormalities were recognised by light microscopy on resin- 
embedded sections of the mutant optic nerves. Necrotic cells were not detected at any 
age. Optic nerves from older mutant mice were reduced in calibre when compared to 
age-matched controls (figure 26). Total myelin detected by methylene blue/azure II 
staining was decreased indicating a smaller amount of myelin, yet individual fibres 
could not be analysed as the fibre diameters in the optic nerve were too small to 
enable axonal identification. Occasionally vacuolated sheaths were observed in the 
younger mice.
(2) EM features
Ultrastructural changes in the mutant optic nerves were not conspicuous until 
about 30 days of age at which time wild type nerves exhibited a homogeneously 
myelinated appearance (figure 27). As myelination progressed, many variably sized 
patches of amyelinated axons were observed adjacent to sheaths of normal 
compaction. The severity of this abnormality varied between animals with some 
showing considerably more myelinated fibres than others. A patchy appearance of 
the lesion could be seen sometimes in 90 day-old mutant optic nerves (figure 28). 
Variation in the thickness of the myelin sheath relative to axonal size was common. 
Occasional sheaths exhibited disproportionately thick myelin sheaths (figure 28b)
Glial cells appeared morphologically normal and cell death was not observed 
at any age. Oligodendrocytes did not contain abnormal inclusions. Astrocytic 
processes were slightly more prominent in older mutants. Undifferentiated cells such 
as those seen in the spinal cord, were not detected. Occasional degenerating axons 
were also seen in older wild type or jp rs^  mice.
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5. MORPHOMETRIC ANALYSIS AND GLIAL CELL QUANTIFICATION
a) Materials and methods
The morphometric analyses of the axon size, myelin sheath thickness, g ratio 
and myelin density were performed on electron-micrographs of the C2 spinal cord 
segment as described in chapter 2. Earlier investigations on jp rs^  demonstrated that 
the results from cervical and thoracic spinal cord were virtually identical (Griffiths et 
al., 1990).
b) Spinal cord
(1) Quantification o f  glia
Glial cell density, total glial cell numbers, and oligodendrocyte numbers were 
elevated in jp rs^ white matter in respect to wild type at all ages (figures 29, 30). 
Total astrocyte numbers were increased up to the age of 45 to 50 days following 
which values were similar to controls. Astrocytes represented a much smaller 
percentage of the total glia in the white matter as a consequence of the increased 
oligodendrocyte population (figure 31). Slightly higher numbers of microglial cells 
were present in mutants older than 40 days. Visual inspection of 1 year-old mutant 
spinal cord also revealed numerous glial cell bodies most of which resembled 
oligodendrocytes (figure 19).
Spinal cords of wild type and jp rsh mice showed very occasional dying or 
apoptotic cells (figure 3, 17). Although these cells have not been quantified yet, the 
live/dying ratio seemed identical for both types of mice. Gross cell counts revealed 1 
or 2 versus 1 to 3 dying cells per whole spinal cord section of wild type and jp rsh 
cervical white matter. Dead cells were observed in wild type spinal cords up to 30 
days-old, whereas they were still detected at 45 days in jp rs^  white matter. These 
cells were not detected at 60 days in the mutant tissue examined. Other cells which 
could not be catalogued as oligodendrocytes, astrocytes or microglial cells by their 
morphological appearance were labelled as unidentified cells. This group included 
glioblasts in neonatal mice, the previously mentioned "undifferentiated cells" seen in 
older mutant spinal cord sections and dying cells.
(2) Fibre morphometry
(a) Myelin thickness and g ratio
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Significant differences from wild-type occurred in myelin thickness and g ratio 
from 10 days onwards (figure 32). Mean myelin sheath thickness and myelin volume 
increased as the g ratio decreased with age in normal mice (figure 32). However, 
mutant fibres presented a markedly elevated g ratio and a reduced myelin thickness 
and density suggesting the presence of thin myelin sheaths. Scatter graphs of myelin 
sheath thickness and axon diameter showed no correlation between the two parameters 
in mutant mice whereas a significant linear relationship was present in wild-type 
mice. The vast majority of points from jp rsh ventral columns of the cervical cord 
were below the lower prediction band for the wild type (figure 33).
Significative axonal diameter differences were only detected at 45 days in the 
spinal cord (figure 34).
(b) Myelin density
Myelin density was markedly reduced at all ages in the spinal white matter of 
jprsh (figure 32).
c) Optic nerve
(1) Quantification o f  glia
Glial cell densities were reduced in jp rs^ during initial myelination, then 
recovered to be greater than in wild-type during and immediately following peak 
myelination, and were normal in animals over 50 days (figure 35). Total glial cell 
numbers in cross sections of the optic nerve of jp rsh were also reduced initially then 
ro-se over normal levels between 20 and 45 days, and finally failed below normal in 
older animals (figure 36). Cell types were only classified from 50 days onwards as 
their morphological characteristics became patent (figure 36). At this stage, the 
oligodendrocyte numbers were reduced in mutant mice and remained so at all ages 
examined. Total astrocyte numbers were not significantly different from controls in 
the mutant optic nerve at 60 days, however, the astrocyte percentages were 
significantly increased in the mutant optic nerve at the age of 90 days (figure 37).
(2) Fibre morphometry
(a) Myelin thickness and g ratio
No difference was present in mean myelin thickness between wild-type and 
jprsh miCe but the g ratio was slightly higher in mutant optic nerves at younger ages. 
This suggests that a small number of mutant sheaths were thinner than those in age
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matched controls (figure 38). Scatter graphs of myelin thickness against axonal 
diameter showed that the vast majority of points for the two groups coincided (figure 
39).
Mean axonal diameter and the axonal diameter frequency distributions were 
indistinguishable between wild-type and jp rs^  mice (figure 34).
(b) Myelin density
The total amount of myelin, as determined by point counting, was significantly 
reduced in the mutant mice (figure 38).
6 . CHANGES IN ONE-YEAR OLD MICH
Light microscopic observations of jp rsh tissue at 12 months of age revealed 
that the oligodendrocyte numbers in the spinal cord were still increased (figures 19, 
20). Large fibres still demonstrated obvious hypomyelination while smaller fibres 
had acquired appropriate myelin sheaths. Microglial cells were more obvious than at 
younger ages in both jp rs^  and wild type.
No Schwann cell invasion was detected in semi-serial resin-embedded sections 
of the C1-C2 segments of the spinal cord stained with methylene blue/azure II or 
immunostained for PQ (figure 13).
7. DISCUSSION
Quantification of the glial cell population in jp rsh optic nerve and spinal cord 
revealed differences between these locations. Glial cell numbers in the mutant spinal 
cord remained elevated throughout life while, in the optic nerve following a peak at 
20 days, numbers decreased to slightly below normal levels in the adult nerve. Both 
variations in cell numbers were due mainly to changes in the oligodendrocytes. 
Appropriate numbers of oligodendrocytes were present at myelination in jp rsh . 
Therefore, we conclude that the hypomyelination present in jp rs^  CNS is not due to a 
lack of oligodendrocytes. Previously described X-linked mutations of myelination 
are associated with hypomyelination with varying degrees of oligodendrocyte loss 
(Skoff, 1976; Duncan et al., 1983; Dentinger et al., 1982). In the case of jp, 
premature cell death occurs prior to the time at which PLP is expressed (Vermeesch et 
a l., 1990; Ghandour and Skoff, 1988). A similar paucity of oligodendrocytes is not 
seen in non-X-linked mutations such as shi or qk (see previous discussion) and has
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lead to the suggestion that a product of the PLP gene may be required for cell survival 
(Gencic and Hudson, 1990; Hudson, 1990b; Vermeesch et al., 1990; Nadon et al., 
1990). Recently, tr, a peripheral dysmyelinating mutant has elucidated a peripheral 
protein termed PMP-22, involved in Schwann cell survival and proliferation (Suter et 
al., 1992). Perhaps DM-20 represents the equivalent protein in the CNS. This 
hypothesis will be considered further over the next chapters.
The myelin deficiency exhibited in jp rsh spinal cord was more marked at 
younger ages. Large axons were the first to be myelinated in the mutant ventral 
columns, although the myelin sheaths produced were abnormally thin and frequently 
vacuolated or uncompacted. Oligodendrocytes embracing single axons, and large 
patches of unmyelinated fibres, were a frequent finding in spinal cord sections from 
young mice. However, the initial jp rs^  myelination pattern evolved as the animal 
aged. Smaller fibres progressively acquired myelin sheaths of reasonably normal 
thickness, hence, by the age of 90 days most smaller axons were myelinated. Such 
fibres, despite being reasonably compacted, still exhibited abnormalities in the IPL 
and periodicity. This is to be expected as PLP is believed to be important in 
maintaining the close apposition of the extracellular face of the lipid bilayer to form 
the double intraperiod line (Duncan et al., 1987b; Duncan et al., 1989). Findings in 
jprsh t therefore, support the previous observations in other PLP mutants like the jp  
mouse and the md rat which are deficient in both PLP and DM-20 yet are able to 
produce compact myelin (with abnormal intraperiod lines). The production of extra 
sheaths was reflected in the slight increase in the spinal cord myelin density between 
50 and 90 days in the mutant (figure 32). Abnormally myelinated large fibres 
demonstrated very little increase in myelin thickness during development. Age- 
related increments in myelin in the spinal cord have also been reported in other 
mutants such as the md rat and sh pup (Jackson et al., 1988). Schwann cell invasion 
of the spinal cord as seen in a 22 month old sh pup (Duncan, personal 
communication) was not a feature in 1 year-old jp rs^  mice. The deficiency in the 
myelin content of the optic nerves was manifest as a lack of myelin sheaths rather 
than a reduction of the myelin per sheath as indicated by their g ratio (figure 38) and 
in the scattered graph of the myelin thickness against axonal diameter (figure 39). 
Although oligodendrocyte numbers in the optic nerve were slightly reduced in older 
mutants, this occurred much later than the period of myelination during which time 
cell numbers were actually higher (figure 35, 36). No noticeable recovery or 
evolution of any kind was seen for this structure. Differences *n the severity of 
hypomyelination between early and later myelinating tracts have also been described 
for other PLP mutants (see review in: Duncan, 1990).
The optic nerve and spinal cord are known to differ in many aspects which 
may explain the disparity of findings between the two. First of all, both nervous
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tracts have a very different embryological development and myelinate at different 
times (see introduction of the thesis for further details). Differences in the axonal 
populations (McQuarrie et al., 1986), and more recently, in the glial cell lineages 
have also been reported (Fok-Seang and Miller, 1992). On the other hand, 
oligodendrocytes are known to be heterogeneous in terms of their myelination 
potential relative to axon size; the myelination unit has been seen to vary from a 
single axon of large diameter to many smaller axons myelinated by a single cell. 
One possible reason is that more myelin membrane is required for a single intemode 
of a large axon than for multiple intemodes of smaller axons (Blakemore, 1982; 
Remahl and Hildebrand, 1990). Consequently these facts may well underlie the 
presence of smaller fibres, either normally-myelinated or naked, and large fibres 
displaying a disproportionately thin myelin sheath often vacuolated or uncompacted. 
As the optic nerve is composed mainly of smaller axons, while the spinal cord 
comprises fibres of various diameters, the optic nerve would show either 
unmyelinated or normally myelinated fibres. However, the spinal cord would exhibit 
these two types plus a third variety of large hypomyelinated fibres.
The progressive increase in myelin seen in the ventral columns of the spinal 
cord could also be explained by examining the evolution of tissue myelination 
together with the oligodendrocyte population. Reports on early myelination in the 
developing feline spinal cord suggest a two step myelination process (see chapter I.) 
where large fibres myelinate earlier than smaller fibres (Remahl and Hildebrand, 
1990). A similar myelination course has been reported for the PNS (Hahn et al.,
1987). Large fibres are myelinated by a different type of oligodendrocyte which 
produced a single intemode in a Schwann-cell-like fashion; thus, an 
oligodendrocyte/intemode ratio of 1:1 (Remahl and Hildebrand, 1990). These 
oligodendrocytes have also been reported to be morphologically more mature than the 
rest of the glial cells present in the spinal cord at the time (Remahl and Hildebrand, 
1990). The second stage of myelination involves the differentiation of the 
oligodendroblasts which have been actively dividing and the production of myelin 
sheaths for the small calibre fibres with one oligodendrocyte myelinating several 
fibres (Remahl and Hildebrand, 1990). It is unknown if there is a feed-back signal 
from the unmyelinated tissue that would stimulate the division of these "later- 
myelinating" oligodendrocytes. But if this was the case, jp rs^ unmyelinated axons 
would promote myelination until all unmyelinated fibres were ensheathed. However, 
the optic nerve does not acquire detectable extra myelin sheaths. It is unknown yet 
why these separate tracts evolve differently in jp rsh although most reasons point to the 
different nature of the axonal population in both structures. The presence of 
undifferentiated cells corresponding to those immature oligodendroblasts named 
"primitive oligoblasts" described in the developing monkey spinal cord (Phillips,
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1973) may underlie the possible explanation of this phenomenon. This hypothesis 
will be considered further in section F after the presentation of more data.
In order to test the previous hypothesis the dorsal columns of the spinal cord 
were examined. These CNS tracts also present a homogeneous small diameter fibre 
distribution and myelinate after the ventral columns, closer to the myelination time of 
the optic nerve. Although no fibre morphometry of the area has been performed, 
light microscopy revealed a noticeable increase in the total numbers of myelinated 
fibres in older mutant mice (figure 20). Labelling of the dividing cells in these areas 
revealed an increased cell division at all ages as seen for the ventral columns of the 
spinal cord thus, differing from the optic nerve (see section F).
Therefore, there is a possibility that the oligodendrocyte population is divided 
into, at least two types of myelinating oligodendrocytes which have affinity for 
different diameter fibres. The two types would be present in the ventral columns of 
the spinal cord but only one type would occur in the optic nerve or dorsal columns of 
the spinal cord. Both types of oligodendrocytes, affected by the jp rs^ mutation, 
would exhibit a different programme of myelin production and turnover which is 
reflected in different patterns of myelination in the mutant CNS tissue (figure 20). 
Further investigation will be necessary to determine whether some oligodendrocytes 
are generally programmed to myelinate only certain types of fibres in the CNS. The 
jp rsh mutation represents an example where the oligodendroglial diversity is separated 
by the mutational defect.
D. IN SITU HYBRIDIZATION STUDIES
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1. INTRODUCTION
In situ hybridization (ISH) represents a valuable tool that enables the study of 
the expression of a particular gene. It offers the advantage of identification and 
location of the cells where that information is expressed. Thus, the developmental 
expression of PLP/DM-20 can be monitored in different anatomical regions of the 
CNS and mutational changes affecting the transcription of the gene can be detected.
2. AIMS OF THE STUDY
The aim was to quantify the numbers of PLP/DM-20-expressing cells and the 
intensity of the PLP/DM-20 signal in individual cells. It has been demonstrated for 
other mutations like jp  and its allele jpmsd  (Jordan et al., 1989; Gardinier et al., 
1986; Gardinier and Macklin, 1988; Sorg et al., 1987; Sorg et al., 1986; 
Campagnoni and Macklin, 1988; Nave and Milner, 1989), shi and shimM (Popko et 
al., 1987), mid (Tosic et al., 1990; Fremeau and Popko, 1990), md rat (Kumar et 
al., 1988; Boison and Stoffel, 1989; Gordon et al., 1990), and sh pups (Nadon et al., 
1990) that the levels of mRNA frequently do not correlate with the final protein levels 
and that post-translational events were in many occasions involved in the low or null 
protein production in these mutants (Tosic et al., 1990). The detection of 
oligodendrocytes using a cell-specific gene expression also complements identification 
based on cellular morphological characteristics.
3. MATERIALS AND METHODS
The basic procedure was as described by Cox et al. (Cox et al., 1984) and 
modified by Wilkinson et al. (Wilkinson et al., 1987). The method is fully 
described in chapter 2. A 35S-labelled mRNA probe for PLP and DM-20 was 
hybridized to paraffin-embedded tissue sections of the spinal cord and brain of wild 
type and jp rsh mice between 10 to 90 days of age.
The individual cell signal was identified on enzmatically dissociated cells. 
Oligodendrocytes obtained from the ventral columns of the spinal cord of 16 day-old 
mutant and wild type mice, were allowed to adhere to coverslips for 2 hr. These 
cells were then fixed and processed in parallel to allow direct comparison (see chapter
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2 for more detail). Following development of autoradiograms the optical density of 
the signal from 150 cells of each group was measured and the mean values compared 
by t test. The average signal per cell for PLP/DM-20 mRNA was compared in both 
groups as described in chapter 2. Some dissociated cells from 7 day-old wild type 
and mutant mice spinal cords were cultured for a week, immunostained for GalC and 
hybridized over the same slide for visual inspection.
4. RESULTS
The cell density and total numbers of PLP/DM-20 mRNA-expressing 
oligodendrocytes were evaluated in paraffin-embedded sections. Positive 
oligodendrocytes were readily identifiable throughout the CNS of wild type and jp rs^  
mice at all ages examined. The spinal cord of jp rs^  had increased PLP-expressing 
cell densities which continuously increasing with age (figures 40, 41). However, the 
percentage of PLP-expressing cells in the mutant, which was lower from 16 days of 
age, recovered by the age of approximately 80 days (figure 42). The optic nerve cell 
densities and numbers were slightly increased for both types of animals during early 
myelination, with a peak at 20 days. After the age of 40 days, numbers of PLP- 
expressing cells declined relative to wild type (figures 43, 44).
Visual inspection of the autoradiograms of tissue sections suggested that the 
signal intensity of PLP/DM-20 message per individual cell was less in jp rsh at all 
ages in the spinal cord (figures 45, 46) becoming more conspicuous in 30 day old 
spinal cord (figure 47) and in the optic nerve (figure 48).
Quantification of individual cell expression was only performed at 16 days 
using freshly dissociated cells from the ventral columns of cervical spinal cord of wild 
type and jp rs^  mice (figure 49). The mean optical density of the signal from mutant 
cells was only 50% of that from the wild type (OD. Mean + SEM; wild type 0.428 
+  0.029; mutant 0.211 ±  0.041; p < 0.001; 300 cells) examined. Dissociated 
spinal cord oligodendrocytes immunostained for GalC and hybridized for PLP 
demonstrated that morphologically mature oligodendrocytes which were GalC + did 
not achieve the same degree of PLP mRNA expression as wild type cells processed in 
parallel (figures 50 to 53).
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5. DISCUSSION
As mentioned previously, jp rs^ nervous tissue contains adequate numbers of 
oligodendrocytes throughout myelination, and indeed the number in the spinal cord is 
elevated. This has been shown by two independent techniques, cell counts based on 
morphology and ISH which demonstrate that jp rs^  mutation is compatible with 
oligodendrocyte survival and their differentiation to the stage of expressing PLP/DM- 
20 mRNA. This contrasts with the jp  mutant where the PLP/DM-20 expressing 
oligodendrocytes are reduced (Verity et al., 1990) presumably as a result of the 
increased oligodendrocyte death (Knapp et al., 1986; Knapp et al., 1990; Meier and 
Bischoff, 1975; Privat et al., 1982; Vermeesch et al., 1990). The confirmation that 
cells of the oligodendrocyte lineage increase in numbers throughout life in jp rs^  spinal 
cord suggests that those previously described undifferentiated cells (figures 23, 24) in 
older mutants which morphologically resembled "primitive oligoblasts" (see section 
C.4.) were possibly a sort of oligodendrocyte progenitor cells or oligodendroblasts.
The average PLP/DM-20 message level per cell was reduced in jp rsh when 
compared to the final protein levels were proportionately lower than the mRNA 
message. Similar findings have been reported for jp  and md rat (Verity et al., 1990; 
Sorg et al., 1986; Hudson et al., 1987; Kumar et al., 1988). This suggests that the 
phenotypic effects of the mutation may be associated with reduced translation of 
major myelin proteins, in particular PLP causing a marked differential effect on the 
levels of PLP mRNA and protein (Mitchell et al., 1992). However, it is unknown 
why there is a disproportionate expression of DM-20 protein in the mutant tissue.
E. CELL CULTURE
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1. INTRODUCTION
Glial cell culture represents an excellent tool for the study of the plasticity of 
mutant cells as it enables the isolation and manipulation of individual 
oligodendrocytes from very early stages of differentiation to the most mature 
development.
Oligodendrocytes are known to undergo a complex differentiation pathway 
from progenitor cells to fully mature cells (Raff, 1989) involving the expression of 
different antigenic markers, of which, GalC is considered to indicate commitment to 
the oligodendrocyte lineage. The GalC antigen expression be followed by the 
synthesis of the myelin proteins and the expression of the antigens recognized by the 
antigens 010 and O i l  (tables 1, 2). In recent years evidence has accumulated that a 
product of the PLP gene has some biological role other than as a structural component 
of myelin, possibly involved in the survival and perhaps differentiation of the 
oligodendrocytes. Cultures from PLP mutants have revealed the importance of the 
cell-cell interaction for the development of defective glial cells. In vivo, jp  
oligodendrocytes exhibit a cell cycle defect associated with the premature death of 
many cells as they begin to differentiate (Skoff and Knapp, 1990; Knapp et al., 1986; 
Vermeesch et al., 1990). In vitro, however, they are able to differentiate when 
cultured in medium conditioned by normal glial cells (Bartlett et al., 1988). 
Oligodendrocytes in the md rat have also been seen to recover partially in vitro when 
cultured under regular conditions (Espinosa de los Monteros et a l., 1990). The jp rsh 
mutation represents a model for the study of the influence of DM-20 and PLP on 
oligodendrocyte survival and differentiation as DM-20 is expressed disproportionately 
in respect to PLP. The appearance of DM-20 with respect to PLP also can be 
monitored in cultured jp rsh oligodendrocytes.
2. AIMS
The purpose of these experiments was to study the influence of the jp rs^ 
mutation on oligodendrocyte survival and differentiation. The plan was to culture 
and compare cells from dissociated spinal cord and optic nerve and study their cellular 
morphology and antigenic profile as they developed in culture. The study was 
focused in the oligodendrocyte later stage of developmental markers such as 010, 
O il  and, of course, the products of the PLP gene.
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3. MATERIALS AND METHODS
a) Oligodendrocyte development markers
The following antibodies were used for immunofluorescence. Mouse 
monoclonal antibodies 04, 010 and O il (all IgM) and R-mAb (IgG3) (see below) 
were all obtained as tissue culture supernatants, together with antiserum against MBP 
and two antisera for PLP; one directed against the PLP-specific region of the 
molecule and the other against the C-terminal common to PLP and DM-20 (PLP/DM- 
20) (Griffiths et al., 1990; Fanarraga et al., 1991; Fanarraga et al., 1992a).
Secondary antibodies FITC, TRITC or Texas Red-labelled were used as 
appropriate (see table 7).
GalC has been detected with the R-mAb which recognizes GalC and Sulfatide. 
Results have been labelled as GalC.
b) Ages o f  mice and culture duration
(1) in vivo study
In order to investigate and compare the antigenic development of 
oligodendrocytes in vivo, cells were dissociated from spinal cords of both jp rs^  and 
wild type mice aged 3, 7, 10 and 16 days. Optic nerve cells were cultured from 7,10 
and 16 day-old animals. The cells were allowed to adhere to the culture surface for 2 
hr prior to the immunostaining with the above markers. This short duration in 
culture is insufficient for a significant differentiation of cells and the profile should 
indicate their in vivo status.
(2) in vitro development study
Oligodendrocytes from 3 and 7 day-old spinal cords and 7 and 10 day-old 
optic nerves were cultured in SATO/0.1% FCS medium up to 120 hr. The 
immunostaining was performed at 2, 24, 72 and 120 hr, after plating using the same 
markers as for the in vivo study (see above).
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c) Method and percentage calculations
Double immunofluorescence labelling was performed at all time points as 
described in chapter 2. R-mAb immunostaining which was taken to indicate 
predominantly GalC, was the constant parameter in all double immunofluorescence 
experiments (GalC/04; GalC/OlO; G alC /O ll; GalC/MBP; GalC/PLP/DM-20 and 
GalC/PLP-specific), being always detected with an anti-IgG3 conjugated to TRITC. 
Taking the percentage of 0 4  positive cells as 100% for all cultures, the percentage of 
cells positive for the immunostaining with any of the mentioned antibodies was 
obtained from the double immunostaining using the percentage of GalC +  cells within 
the 0 4 +  population. Results are expressed as the percentage of the 04  population.
The expression of A2B5 antigen was examined in some of the initial 
experiments but, as explained in the introduction of the thesis, the A2B5 +  lineage is 
known to be different for various locations of the rat CNS as well as for different 
animal species (Schnitzer and Schachner, 1982; Fok-Seang and Miller, 1992). On 
the other hand, the A2B5 immunostain of mouse oligodendrocytes does not coincide 
with the rat (unpublished observations). Therefore, in order to simplify the situation, 
we used 0 4 +  cells as the indicator of the least differentiated cells (Sommer and 
Schachner, 1981).
4. RESULTS
Cultured jp rsh oligodendrocytes did not show obvious morphological 
differences from controls. Mutant cells produced a normal number of processes 
which, eventually, developed myelin sheets of comparable dimensions at the expected 
time in a similar manner to wild type cells (figure 54 to 56). Preparation of cultures 
from the mutant optic nerves required larger amounts of tissue than from wild type 
and the cell survival was possibly reduced, but no detailed investigations have yet 
been performed.
jprsh  oligodendrocytes commenced their development by following the normal 
sequence of antigen expression. No difference in the number of 04 and GalC 
positive cells was detected in either the spinal cord or optic nerve cultures in jp rsh 
versus wild type mice (figure 57). This indicated that mutant oligodendrocytes 
achieved the early stages of antigen expression, as shown in figures 58 to 63.
The first abnormalities were detected with the MBP immunostaining. 
Although jp rsh oligodendrocytes started producing MBP simultaneously to wild type, 
the total number of cells expressing MBP was reduced in cultures from 3 and 7 day-
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old spinal cords (figures 58, 59) as well as in 7 and 10 day-old optic nerve cultures 
(figures 61, 62). However, the expression in individual positive cells was identical 
to control wild type oligodendrocytes (figures 64 to 66). The MBP production in the 
2 hr cultures, representing the in vivo situation, seemed to be less affected by the 
mutation (figures 66, 67). MBP positive cell counts reached values equivalent to 
wild type or even higher in 2 hr cultures from 10 and 16 day-old spinal cords (figure 
60).
The most outstanding feature of the cultured jp rsh oligodendrocytes compared 
to wild type cells was the in vivo and in vitro impaired expression of those antigens 
indicating mature cell differentiation (figures 58 to 63). PLP/DM-20 expression was 
reduced for all cultures at all ages and times examined. However, the onset of the 
immunoreactivity against this C-terminal antibody coincided with the wild type and 
occurred approximately 2 days prior the expression of the PLP-specific antigen in 
wild type cells. This indicates that those mutant oligodendrocytes capable of 
expressing PLP/DM-20 developed at the normal pace. The individual cell expression 
was variable but generally reduced when compared to controls (figures 68 to 70). 
PLP-specific immunoreactivity was virtually absent in most cultures. Those cells 
positive for PLP, which were found mainly in the optic nerve showed a very weak 
immunoreactivity when compared to wild type cells localized in small lumps in the 
processes (figures 71 to 73). Antibodies 010 and O il antibodies which immunostain 
mature wild type oligodendrocytes, were negative in almost all jp rs^  cultures (figures 
58 to 63). Very occasional 0 1 0 +  or 011 +  cells were detected although the 
immunostaining was very poor (figures 74, 75).
The comparison between in vivo and in vitro oligodendrocyte development 
revealed that although the main characteristics of the mutant cells were the same, the 
production of MBP was improved in vivo (figure 67). However, a similar 
phenomenon did not occur for PLP/DM-20, PLP, 010 and O il expression (figures 
76 to 79).
5. DISCUSSION
This study has examined the in vivo and in vitro differentiation of wild type 
and jp rsh oligodendrocytes from the optic nerve and the spinal cord. The most 
important outcome was that jp rsh oligodendrocytes were capable of developing in 
culture a considerable way to full maturity before further differentiation was blocked. 
Such cells when allowed to grow in culture were morphologically similar to those 
from wild type showing numerous processes that would develop membrane sheets of 
normal dimensions.
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The A2B5 antibody was not used to recognize immature progenitor cells as 
previous investigations demonstrated that A2B5 does not consistently stain putative 
glial precursor cells in the mouse (Schnitzer and Schachner, 1982). It is also known 
to recognize several gangliosides present on neurons and astrocytes (Einsenbarth et 
al., 1979; Schnitzer and Schachner, 1982; Berg and Schachner, 1981). Therefore, 
04  was used to label 0-2A progenitor cells instead. This antibody reacts with these 
cells at a later stage of development (Trotter and Schachner, 1989) recognizing a yet 
unknown antigen termed POA (Bansal et al., 1992; Bansal et al., 1989; Warrington 
and Pfeiffer, 1992) prior to the appearance of sulfatide and GalC (Bansal et al., 
1992). Antibodies against these two galactolipids have been pivotal in the study of 
oligodendrocyte development (tables 1,2).
The GalC stage was achieved normally by jp rsh oligodendrocytes, which is not 
surprising after examining the number of PLP/DM-20 mRNA expressing cells in 
jprsh CNS. However, the number of MBP expressing cells was reduced as much as 
50% relative to the wild type although the expression in individual cells was not 
diminished. Immunostaining with the anti-C-terminal antibody recognizing PLP and 
DM-20 was also reduced both quantitatively and qualitatively, as individual mutant 
cells stained less intensively than wild type oligodendrocytes as expected according to 
previously dissociated spinal cord oligodendrocytes immunostained for GalC and 
showing a low PLP/DM-20 mRNA levels (see previous section). The 
immunoreactivity against the PLP-specific antibody was virtually absent, suggesting 
that DM-20 was being detected by the anti-C-terminal antibody. These results are 
supported by electrophoretic and immunoblotting data which show the virtual absence 
of PLP but presence of DM-20 (Mitchell et al., 1990; Mitchell et al., 1992). The 
jprsh reached the MBP and PLP/DM-20 positive stages at the same time as the wild 
type oligodendrocytes suggesting that those mutant oligodendrocytes persisted beyond 
early development following the normal timing of protein production. Those very 
few mutant oligodendrocytes that produced PLP stained very weakly when compared 
to positive cells from age-matched wild type cultures. However, the fact that some 
jprsh cep s were positive for PLP does not imply that normal protein it has been 
detected, as we could be recognising abnormal products of the PLP gene.
010  and O il  immunostain was also virtually absent in all cultures, although 
very occasionally positive cells were recognised in some cultures. As 010 and O il 
have been poorly characterised, it is possible that abnormal proteins and lipids were 
recognised on the surface of the labelled mutant oligodendrocytes. Alternatively, all 
jprsh oligodendrocytes may not follow the regular differentiation pathway. A similar 
phenomenon also takes place in jp  mutant oligodendrocytes which immunostain for 
O il while being negative for 010 (Sommer and Schachner, 1984). As 010
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recognizes a molecule defective in jp  and jp rsh which may be a product of the PLP 
gene. These conclusion would need further investigation.
The exact time at which normal oligodendrocytes express DM-20 is still 
uncertain. However, this protein is known to be present before PLP (Gardinier and 
Macklin, 1988; Van Dorsselaer et al., 1987; Schindler et al., 1990). According to 
the results from this present study, PLP/DM-20 antiserum immunostained cells which 
were already expressing MBP, while the PLP-specific antibody immunostained cells 
approximately 48 hr after detecting PLP/DM-20. Examination of the timing of the 
various antigenic markers in jp rsh suggested the following antigenic profile sequence: 
04, GalC, MBP, DM-20, PLP. 010 and O il reactivities occur after the GalC stage 
(Kuhlmann-Krieg et al., 1988), and approximately overlap with the DM-20 and PLP 
stages respectively.
Present results support our previous immunocytochemical and immunoblotting 
studies (Griffiths et al., 1990; Fanarraga et al., 1992a; Mitchell et al., 1990; Mitchell 
et al., 1992) which indicated that these mutants expressed MBP and DM-20 but 
virtually no PLP in their myelin. Although the major abnormality in the 
differentiation of the jp rsh oligodendrocytes appeared between the stages of MBP and 
PLP expression, each antigenic step from MBP onwards was reached by a lower 
proportion of cells. Oligodendrocyte differentiation has been examined in other PLP 
gene mutants, principally jp . The data from in vivo and in vitro studies (Omlin and 
Anders, 1983; Ghandour and Skoff, 1988; Bartlett et al., 1988) indicate that early 
differentiation of jp  oligodendrocytes is relatively normal. The majority of cells 
express GalC and CNPase; some also produce MBP (Omlin and Anders, 1983) but 
reactivity for PLP (Ghandour and Skoff, 1988) or 010 (Sommer et al., 1982; 
Sommer and Schachner, 1984) is rare or absent. Cultured oligodendrocytes from md 
rat also show retarded expression of both early and late differentiation markers, 
including MBP (Duncan et al., 1987b), but some recovery occurs with prolonged 
culture particularly in the earlier-expressed antigens (Espinosa de los Monteros et al., 
1990). jp  oligodendrocytes cultured in medium conditioned by normal glial cells 
have an improved survival and a more differentiated morphology (Bartlett et al.,
1988) suggesting that factors in the extracellular environment of mutant 
oligodendrocytes may partially inhibit their maturation.
An important question is why the phenotype of jp rsh, particularly in relation to 
oligodendrocyte survival and maturation, is different from the other PLP mutations. 
DM-20 protein, a postulated factor in cell survival, is detectable in approximately 30 
% of spinal cord oligodendrocytes of jp rsh at 16 days of age and biochemical and 
immunocytochemical studies have also identified a relatively high level in myelin 
(Griffiths et al., 1990; Mitchell et al., 1990; Mitchell et al., 1992). However, two
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other mutants sh pup and jpwsd  aiso have disproportionate expression of DM-20 
(Yanagisawa et al. , 1987; Gardinier and Macklin, 1988), yet oligodendrocytes are 
depleted. In all three mutations the defect involves regions of the PLP gene encoding 
DM-20, so that this protein is defective. However, the resultant amino acid 
substitutions (sh pup, His36 -*Pro; jpmsd i Ala242 -»Val and jp rs^, lie186 -*Thr) affect 
different regions of PLP/DM-20. It is quite possible that the survival of 
oligodendrocytes in the jp rs^  phenotype indicate that the mutation lie186 affects a 
region of the PLP/DM-20 molecule which is not involved in vital membrane-related 
functions during cell development. Nevertheless, as the topography of PLP/DM-20 
proteins in the cell membrane are still unknown the jp rsh mutation could either affect 
an intramembrane domain or be exposed on the external or cytoplasmic surfaces 
depending on the model selected (see review in chapter 1, section A.3.).
An additional question is why normal or even increased numbers of 
oligodendrocytes survive in jp rsh when only 30%, relative to wild type at 16 days of 
age, contain detectable DM-20 protein. It is possible that DM-20 is present in the 
remaining oligodendrocytes in amounts too low to be immunolabelled. Another 
explanation could be that DM-20 (or another minor proteolipid) is critical only at a 
specific stage of differentiation and that its absence at other times will not affect cell 
survival. A further possibility to consider is that due to the pleiotropic effects of 
mutations in the PLP gene the critical factor for cell survival is actually the product of 
a separate gene whose normal expression is dependent on some function of the PLP 
gene.
F. CELL DIVISION STUDY
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1. INTRODUCTION AND AIMS
Many developmental studies have examined cell proliferation and turnover 
using tritiated thymidine labelling as an index of the DNA synthesis. [methyl-3H] 
thymidine is a precursor of the DNA incorporated by a sequence of phosphorylation 
steps together with the other nucleoside triphosphates, into DNA during the S phase 
of the cell cycle (Knapp, 1992). Recently, the development of antibodies to the 
thymidine analogue 5-bromo-deoxyuridine (BrdU) has allowed the development of an 
immunocytochemical method analogous to the thymidine autoradiographic technique 
(Knapp, 1992). However, the inability of BrdU to cross the blood brain barrier in 
older animals and the fact that it labels more cells than [methyl-^H] thymidine in 
culture (Knapp, 1992) lead our research to the use of the traditional radioactive 
method.
One of the most striking features of the jp rsh phenotype is the increased 
oligodendrocyte population in the spinal cord which increases progressively and 
constantly from early myelination onwards. This project was commenced towards 
the end of my post-graduate study period; the results represent a preliminary 
examination of the problem which will require further studies. Similar studies have 
been started recently in the optic nerve but results are not yet available.
2. MATERIALS AND METHODS
Two jp rsh and two wild type mice at 5, 10, 15, and 100 days-old and one at 
50 days old were injected 5pCi/p\ [methyl-^H] thymidine in saline at a dose of 
5/iCi/g body weight as described in chapter 2. Two hours later mice were perfused 
with Kamovsky's modified fixative (Paraformaldehyde/Glutaraldehyde); their CNS 
tissue was dissected and processed following routine techniques for resin embedding. 
One pm  thick tissue sections of spinal cord were cut, placed onto gelatine-coated 
slides, dipped in Ilford emulsion K2 and exposed for periods up to 4 weeks. 
Defaults of the methodology are given in chapter 2.
Cell counts were performed under regular light microscopical conditions. 
The nuclei of dividing cells which were evenly covered with silver grains, were 
counted. Only glial cell nuclei were counted, other dividing cells such as 
endothelial cells were not included in the cell counts.
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3. RESULTS
The spinal cord of jp rsh mutants demonstrated ^H-thymidine labelled cells at 
all ages examined. The density of labelled cells and total numbers of labelled cells 
in the mutant spinal cord was slightly increased from the very early stages of 
development up to the latest ages examined (100 days of age) (figures 80, 81). The 
percentage of labelled cells relative to the total number of glial cells was also 
increased in the mutant spinal cord from 15 days of age onwards (figure 82).
Wild type spinal cord showed a peak of glial cell division between 10 and 20 
days of age coinciding with the beginning of myelination in the ventral columns of the 
spinal cord. After the age of 20 days, about the end of the myelination in the spinal 
cord, glial cell mitosis declined substantially. This same peak of cell division also 
occurred in jp rs^  at that time (figure 80, 81), however, the density of labelled glial 
cells and total labelled glial cell counts remained high respect to controls, after the 
complete myelination of the spinal cord. Although these dividing cells have not been 
ultrastructurally classified yet, most of them resembled cells of a possible 
oligodendroglial origin (figure 83). Other labelled cells, such as endothelial cells 
from the blood vessels, were also present in some of the sections but were not 
included in the counts (figure 84). Occasional astrocytes were also labelled (figure 
84).
4. DISCUSSION
The spinal cord of the mouse shows a peak of glial cell division between 10 
and 20 days of age coinciding with the increased demand for oligodendrocytes at 
myelination. It is know that once myelination ends, glial cell mitosis declines 
substantially and is mainly restricted to microglial cells.
The most important feature in jp rs^  spinal cord when compared to other PLP 
mutations is the progressively increasing oligodendroglial population. Findings such 
as the ultrastructural presence of possible undifferentiated oligodendrocytes 
("primitive oligoblasts": Phillips, 1973), together with the in situ hybridization 
studies, which demonstrated a progressive increase of PLP-expressing cells, suggested 
an increased oligodendroglial proliferation. [Methyl-^H] thymidine, a well known 
precursor of DNA, was used to label the dividing cells in the tissue. The results 
indicated that the density of dividing cells, total labelled counts and percentages of 
dividing cells are all increased in jp rs^  at all ages after myelination. This could 
account for the continued supply of oligodendrocytes in the mutant cord. Other 
mutants such as jp , md rat and sh pup also exhibit an increased glial cell proliferation
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rate in the spinal cord (Jackson and Duncan, 1988; Knapp et al., 1986; Macklin et 
al., 1991; Gencic and Hudson, 1990). However, it is accompanied of premature 
death of the oligodendrocytes especially in jp  (Knapp et al., 1986; Knapp et al., 
1990; Privat et al., 1982; Skoff and Knapp, 1990; Vermeesch et al., 1990) but also 
in md rat (Boison and Stoffel, 1989; Jackson and Duncan, 1988) thus there is no 
increase in the total glial cell population.
As it has been explained in the introduction of the thesis, there are some 
theories that differentiate the oligodendroglial population into "early” (Schwann cell­
like) and "late" myelinating oligodendrocytes (Remahl and Hildebrand, 1990). The 
second type of oligodendrocytes proliferates actively later in myelination possibly 
commanded by a feed-back signal from the myelinated axons. Morphological 
findings together with a progressively increase of the PLP expressing cells, indicated 
an extra supply of oligodendrocytes or their progenitors in jp rs^  spinal cord. 
Although the thymidine labelled cells in the mutant cord have not been 
ultrastructurally identified yet, cells resembling very immature oligodendroblasts 
(such as those termed "primitive oligoblasts": Philips, 1973) were detected from 50 
days onwards (figures 22, 23). These newly-produced cells would possibly 
correspond to the previously described second type of oligodendrocytes in charge of 
the myelination of the smaller fibres. Unmyelinated axons in the mutant cord might 
stimulate oligodendrocyte proliferation until complete myelination. As jp rsh 
oligodendrocytes were not capable of myelinating the expected number of intemodes 
the oligodendrocyte proliferation would continue until advanced ages.
A further question here will be to determine whether these cells are produced 
locally, as a consequence of a maintained basal division rate or if they are the result 
of the migration of oligodendroblasts from neighbouring areas, such as the grey 
matter or other regions along the spinal cord. The ultrastructrural presence of very 
immature glial progenitor cells suggests that these cells have been probably produced 
locally as 0-2A progenitor cells are known to mature as they migrate while dividing 
(see chapter 1).
A remarkable finding in jp rs^  is that the percentage of dividing cells at a 100 
days of age is greater than 0.8% over 6 hours, thus more than 3 %/day. Although 
there is an obvious increment in the glial cell numbers in the mutant spinal cord this 
glia cell over-production never reaches the forecasted levels. Therefore, cell death, 
probably apoptosis is suspected as morphological examination of the tissue did not 
revealed conspicuous cell death (see chapter 1). Apoptosis would probably be the 
result of a competition for the insufficient supply of growth factors such as PDGF and 
FGF rather than a direct consequence of the mutation as jp rs^  oligodendrocytes seem
to survive well. Further work has been planed in order to identify the dividing cells 
ultrastructurally.
Optic nerve labelling is not yet concluded but preliminary results indicate that 
the cell division rate is not noticeably increased which is consistent with the glial cell 
counts in this tract (figures 35, 36). Findings suggest that the environment where the 
mutant oligodendrocytes develop may be also responsible for the cell proliferation. 
Environmental factors or feed-back signals from the tissue, other than DM-20, appear 
to be necessary for the oligodendrocyte proliferation, which occur in the spinal cord 
but not in the optic nerve. DM-20 would, therefore play the role of a survival factor 
involved in the oligodendrocyte development and differentiation, rather than affecting 
cell division. Recently similar roles have been attributed to the PNS protein PMP-22 
mutated in tr mouse (Suter et al., 1992) or to PDGF and IGFs in cultured 0-2A 
(Barres et al. , 1992).
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CHAPTER 4: iprsh HETEROZYGOTFS
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A. INTRODUCTION
1. X-CHROMOSOME INACTIVATION AND MOSAICISM
Lyon's hypothesis in 1972, (Lyon, 1972) supported by further studies in the 
mouse (Nesbitt, 1971), demonstrated X-chromosome inactivation during the early 
stages of the embryonic development as a regulatory mechanism to eliminate the 
aneploidy effects in female somatic tissue and still have a normal germinal function. 
The X-chromosome will remain inactivated through subsequent cell divisions and 
differentiation, thus many cell lines are established with each individual cell in the 
line having either the same maternal or the paternal active X-chromosome (Nesbitt, 
1971). Hence heterozygotes for any X-linked genes would consist of two different 
clones of cells, consequently a mosaic (Nesbitt, 1971; Falconer and Avery, 1978; 
Nesbitt and Gartler, 1971) (figure 85).
As the PLP gene is known to be located on the X-chromosome (Mattei et al. , 
1986), heterozygotes for PLP mutations such as jp , md rat and sh pup are, therefore, 
chimaeras for the oligodendrocyte population since two different clones of 
oligodendrocytes exhibiting different properties are generated after the inactivation. 
This results in the "wild type" clone, where the mutant X-chromosome has been 
inactivated, and the "mutant clone" where inactivation of the normal X-chromosome 
occurred (Lyon, 1972) (figure 85). Several PLP mutant heterozygotes have been 
studied for the presence of mosacism in the CNS (table 8) where patchy areas of 
hypomyelination/amyelination have been observed (see below).
2. REVIEW OF OTHER CNS X-LINKED MUTANT HETEROZYGOTES
Heterozygote females for X-linked mutations affecting myelination such as jp  
in mice, md in rat and sh pup in dogs, typically exhibit patches of 
hypomyelination/amyelination. These are most notable in the optic nerves and to 
lesser degrees in the ventral columns of the spinal cord of the female heterozygotes 
(Rosenfeld and Friedrich, 1984; Rosenfeld and Friedrich, 1986; Bartlett and Skoff, 
1986; Hatfield and Skoff, 1982; Benjamins et al. , 1984; Skoff and Montgomery, 
1981; Duncan et al., 1987a).
Another interesting feature of some heterozygotes such as jp , is the capacity 
for restoration of the myelin deficient areas (table 8). Phenotypically-mutant cells 
seemed to be influenced by phenotypically-normal clones of oligodendrocytes and, in 
some instances, capable of normal myelination (Bartlett and Skoff, 1986; Rosenfeld
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and Friedrich, 1984; Rosenfeld and Friedrich, 1986). This phenomenon has been 
observed at the hypomyelinated patches of the spinal cord and anterior commissure in 
jp  heterozygotes where hypomyelination of the tissue is not associated with mosaic 
pattern (Rosenfeld and Friedrich, 1984; Bartlett and Skoff, 1986; Rosenfeld and 
Friedrich, 1986) (table 8).
The summary of the most important characteristics of all the previously 
mentioned heterozygotes for PLP mutations indicated in table 8.
3. AIMS OF THE STUDY
As previous heterozygotes for PLP mutations showed myelin mosaicism at 
different locations of the CNS ascribed to the X-chromosome inactivation (Skoff and 
Montgomery, 1981; Hatfield and Skoff, 1982; Duncan et al., 1987a), we wished to 
determine if the heterozygotes for ]prs^  exhibited mosaic changes similar to 
heterozygotes for jp , md rat and sh pup and if so, whether the lesions recover with 
age.
4. MATERIALS AND METHODS
a) Breeding o f  the crosses
Several cages containing two wild type ( + /+ )  females of the same genetic 
background to the jp rs^  animals and a single hemizygous jp rsh (jprs^ /Y) male were 
established. It was predicted that the mat ings would produce heterozygous 
(jprsh/ + ) females and wild type (+/Y) males, which could be used as controls. 
Other wild type female mice of another strain (BALB/D2Ma) were also mated with 
hemizygous jp rs^ (jprs^/Y )  males at the same time to check the authenticity of the 
results.
Homozygous jp rs^ (jprs^/jprs^) females were also mated with wild type 
(+/Y ) males to demonstrate that the progeny resulting from the reverse cross 
followed the X-linked mutation patterns and that the carrier females produced were 
phenotypically similar to those obtained above. Additional identical crosses were 
also established and checked with wild type male mice of another strain 
(BALB/D2Ma).
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b) Morphological specimens
Glial cell and quantitative studies were performed using the progeny of the 
wild type (+ /+ )  females mated to the hemizygous (jprsh/Y) males. Groups of three 
heterozygous females and three wild type males mice from the same litter were used 
at 16, 30, 50 and 90 days of age for morphological studies. Additional females and 
males at other ages were also examined but were not included in the quantitative 
studies.
The tissue was prepared as described in chapter 2. Briefly, mice were 
anaesthetised until overdosed and fixed by intracardiac perfusion with normal saline 
followed by a modified Kamovsky's Paraformaldehyde/Glutaraldehyde (2%/5%) 
fixative. Tissue was post-fixed in either 1 % osmic acid or an osmic acid/potassium 
ferricyanide mixture. Additional mice were perfused with 4% paraformaldehyde and 
processed for paraffin embedding and serial-sectioning. The blocks for the study 
were removed from C1-C2 segments of the spinal cord and mid portion of the optic 
nerves. The morphological studies were performed following the methods described 
in chapter 2.
c ) ImmunoloQical techniques
The PAP technique was chosen for the detection of protein in paraffin and 
resin-embedded tissue sections of 90 day-old jp rs^  heterozygote females and male 
litter-mates CNS. Paraffin-embedded sections were used to assesse for the overall 
protein present and resin-embedded sections allowed the individual sheath 
identification. The ages of the mice, dissection and processing procedures as well as 
the antibodies used for all the following experiments are fully described in chapter 2.
The myelin protein composition of the individual sheaths was evaluated by 
immunostaining adjacent serial resin sections for MBP and 2 peptide regions of the 
PLP/DM-20 molecule one being PLP-specific and the other recognising the C- 
terminal common to PLP/DM-20, referred to as PLP/DM-20. The antibodies used 
for the study are also described in the materials and methods chapter 2 (table 6).
The ISH technique was based on that described by Cox et a l (Cox et al., 
1984) and modified by Wilkinson and co-worker's (Wilkinson et al., 1987). It was 
performed on 6/xm paraffin-embedded tissue sections of cervical spinal cord of 20 and 
30 day-old heterozygotes and controls as above. Sections of heterozygous and 
control spinal cords were cut and placed on the same slide. The probe recognizing 
the PLP/DM-20 mRNA and the technique used are described in chapter 2.
B. RESULTS
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1. CLINICAL SIGNS AND PHENOTYPIC EXPRESSION
Twenty-one female and 17 male progeny of the wild type ( + / + )  females and 
the hemizygous (jprs^ /Y ) males mattings were examined. These progeny were 
heterozygous (jprsh/ + ) females and wild type (+/Y) males, generating asymptomatic 
carrier females. A different cross between homozygous jp rs^(jprs^/jprs^) females 
with a wild type (+/Y) male demonstrated that the clinical phenotype of the progeny 
followed the X-linked mutation patterns producing tremor in the resulting (jprs^ /Y ) 
males and identical carrier females.
The conclusion of the mattings was that the jp rsh mutation followed an X- 
linked pattern of inheritance. The jp rs^  hemizygous males resulting from crosses 
involving other strains were phenotypically identical to the jp rs^ mutant.
2. MORPHOLOGICAL STUDIES:
a) Description o f lesions
No obvious patchy areas of hypomyelination/amyelination similar to those 
occurring in jp  heterozygous (jp/+) females were seen in these (jprs^ /+ ) animals. 
Abnormalities were detected in the spinal cord at all ages but were more conspicuous 
in older animals and most marked around the ventromedian fissure. These lesions 
were visible at light microscopy using resin sections whereas no definitive changes 
could be defined in paraffin sections of the brain and spinal cord. Optic nerve 
abnormalities were not noticeable though subtle defects were demonstrated by 
quantitative methods (see below).
(1) Spinal cord
Cross sectional areas from the whole spinal cord and white matter were the 
same in age-matched heterozygous female and normal male mice. The major 
abnormality in the spinal cord of heterozygous females was the presence of fibres with 
a disproportionately thin myelin sheath for the axon diameter (figures 86, 87). Such 
fibres were usually intermixed with those having a normal thickness of sheath; several 
such hypomyelinated fibres could be contiguous but large hypomyelinated patches 
were not found. Naked axons were present in the ventral columns of younger mice 
but were infrequent in older animals (figure 86). The majority of myelin sheaths,
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both of normal thickness and hypomyelinated, were well compacted although sheaths 
with uncompacted myelin or intramyelinic vacuolation were also observed as seen for 
jpTsh (figure 87). Folds of redundant myelin were present in the spinal cord sections 
at all ages at a higher frequency than seen in normal litter-mates (figure 86, 87). 
Glial cells appeared to be increased in number (see next section). No obvious 
ultrastructural degenerative changes in neither oligodendrocytes nor astrocytes were 
seen. Many oligodendrocytes appeared metabolically active with prominent rough 
endoplasmic reticulum and Golgi apparatus, even in older animals. Activated 
microglia/macrophages were a constant though not marked feature. Very 
occasionally macrophages were observed within the myelin sheaths. Also 
undifferentiated oligodendroblasts as those described in chapter 3 (section C.) were 
observed sometimes in 50 and 90 days old heterozygote spinal cords.
(2) Optic nerve
No major changes were expected in the optic nerve of these heterozygote 
females as some jp rs  ^ homozygous females (jprs^/jprs^) and hemizygous males 
(jprsh/Y) exhibited only small abnormalities in the optic nerves when compared to the 
spinal cord. Light microscopy revealed no evidence of hypomyelinated/amyelinated 
patches in optic nerve sections stained either with methylene blue/azure II or 
immunostained against MBP. Apart from this, only infrequently was a vacuolated 
myelin sheath noted in the nerves of animals older than thirty days. One of the 
females produced from the (+ / + x jp rs^/Y )  matings had no obvious abnormalities in 
the spinal cord although defects were detected in the optic nerve (see discussion).
Electron microscopical examination of the optic nerves of heterozygotes 
revealed reasonably well myelinated axons similar to those of the wild type (figures 
88, 28) although on occasions small groups of thin calibre, unmyelinated axons were 
present distributed randomly through the area of the nerve in older mice (figure 28a). 
This feature, which could also be observed in control optic nerves until about the age 
of 30 days, (figure 88) represented the only evidence of a mosaic pattern in these 
heterozygotes. Astrocytic processes were not obviously increased.
b) Glial cell quantification
(1) Glial cell densities
Total cell densities in the ventral columns of the spinal cord and optic nerve 
were significantly increased in the female heterozygotes, presenting values over the 
control but below the full jp rsh mutant (figures 29, 35).
I l l
(2) Total glial cell counts
These were greater in the spinal cords of heterozygotes from the ages of 50 
and 90 days than in the wild type male litter-mate (figure 89, 90). The total numbers 
of oligodendrocytes, astrocytes and other cells (microglial and unidentified cells) were 
all higher in the female heterozygote for jp rs^  although the major change was in the 
oligodendrocyte counts which were increased by 30 to 40% (figure 91). Similar 
differences were present in the optic nerve particularly at 50 days and older except 
that the total number of astrocytes was not increased (figure 92).
c) Fibre morphometry
(1) Myelin thickness and g ratio
In the ventral columns of the spinal cord the mean myelin sheath thickness was 
reduced and the mean g ratio increased in heterozygous females (figure 93). The 
differences were significant at all ages except 30 days. Scatter graphs of myelin 
sheath thickness and axon diameter indicated that many fibres in the spinal cord were 
within the limits of the normal male litter-mates although at each age a small 
proportion fell below the lower prediction band indicating a disproportionately thin 
myelin sheath (figure 94).
The results in the optic nerve contrasted with those in the spinal cord as 
neither differences in the mean myelin thickness nor mean g ratio were present 
between the two groups at any age (figure 95). Scatter graphs of myelin thickness 
and axonal diameter indicated that the vast majority of values in the heterozygotes 
were within the same limits as the normal male siblings as seen for the fully jp rs'1 
mutant.
(2) Myelin density
The reduction in optic nerve myelin density in the heterozygote female was 
due to a decreased number of myelinated axons as well as a reduction of the myelin 
sheath thickness. Point counting of the myelin of both spinal cord and optic nerve 
showed a significant reduction in the myelin density in the female heterozygote 
(figures 93, 95).
Axonal density was not significant differences between the two groups in the 
cord and optic nerve.
d) Mosaicism study through serial sections
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Myelin mosaicism present in the optic nerve is a feature of many X-linked 
myelin mutants. An optic nerve of a 30 day-old jp rsh heterozygote was serially- 
sectioned along its entire length and stained with methylene blue/azure II. No 
evidence of mosaicism was found. Paraffin-embedded semi-serial-sections of brain 
were also examined by haematoxylin/eosin staining and MBP immunostain. In no 
instance mosaic hypomyelinated/amyelinated patches were detected.
e) Age-related development o f  the lesions
One year-old heterozygotes and wild type males were perfused and compared 
to controls in order to evaluate the repair capacity as seen for other heterozygotes like 
jp  where complete morphological (Bartlett and Skoff, 1986) and biochemical (Kemer 
and Carson, 1984; Benjamins et al., 1989) recovery is almost achievable.
Unexpectedly, the CNS lesions in jp™*1 heterozygotes, were still detectable in 
sections of 1 year-old spinal cord. The myelin deficit in the optic nerve and spinal 
cord was maintained through the life of the heterozygote. Scattered hypomyelinated 
fibres, characteristic of the younger heterozygotes were still present although most 
smaller axons, initially hypomyelinated, had acquired normal myelin sheaths (figures 
19, 20). The oligodendrocyte numbers remain increased with respect to wild type 
males in the oldest mice examined (1 year-old). Microglial cells, as expected in old 
CNS normal tissue were seen to increase in the same manner for both types of mice.
3. DISCUSSION
The conclusion of all the previous findings was that the chimaeric state in 
jp™*1 did not involve a mosaic myelination pattern in the CNS. Heterozygotes for 
the majority of PLP, X-linked mutations like jp  in the mouse, md in the rat and sh in 
the pup (Skoff and Montgomery, 1981; Duncan et al., 1987a; Bartlett and Skoff, 
1986) are characterised morphologically by patchy areas of 
hypomyelination/amyelination constituting a mosaic pattern as a consequence of the 
early inactivation of one X-chromosome (Lyon, 1972; Nesbitt, 1971). However, the 
presentation of this condition is not uniform. Generally the optic nerve is more 
affected than the spinal cord which could be the consequence of the different 
developmental patterns of these tissues. The glial cells in the optic nerve proliferate 
in situ after migration from the brain whereas, the origin of the glial cells in the spinal 
cord is still unknown (see chapter 1 section A.2.). Here, glial progenitors may have
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different division or migrating patterns which may provide a considerable plasticity to 
the clone of oligodendrocytes expressing the non-mutant X-chromosome for the 
partial reparation of the deficiency (Rosenfeld and Friedrich, 1984; Bartlett and 
Skoff, 1986). On the other hand, individual variations can also be found within a 
mutation. For example, only 2/3 of heterozygous jp  females may have amyelinated 
patches, exclusively in the optic nerves (Rosenfeld and Friedrich, 1984; Skoff and 
Montgomery, 1981). Other areas of the CNS, such as the anterior commissure, may 
show a reduced amount of myelin without evidence of patches (Rosenfeld and 
Friedrich, 1984). Also the spinal cord of jp  presents normally and abnormally 
myelinated fibres without a mosaic pattern (Bartlett and Skoff, 1986). In the md rat 
the severity and position of the patches varies considerably along a single optic nerve 
(Duncan et al., 1987a). In the sh pup the patches may be larger in the spinal cord 
than in the optic nerves (Skoff and Montgomery, 1981; Duncan et al., 1987a). 
Thus, the pattern of the phenotypic expression for jp rs^  heterozygotes was 
unpredictable. But, since the mutation is less severe, not so obvious lesions are 
likely.
The results of the morphological study showed changes in the spinal cord of 
jpTsh heterozygous females similar to those in jp  heterozygotes (Bartlett and Skoff, 
1986), particularly around the ventromedian fissure where normally- and abnormally- 
myelinated axons were present, although they were not grouped in patches but 
intermingled. Occasional aggregations of amyelinated small diameter fibres were 
present in younger heterozygotes. However, large diameter fibres, were more 
affected by hypomyelination/amyelination in older jp rsh heterozygotes. 
Morphometric analysis of the cord supported the visual impression demonstrating a 
population of axons with disproportionately thin myelin sheaths. One of the females 
produced from the ( + / +  x  jp™*1/Y) matings demonstrated abnormalities in the optic 
nerves but not the spinal cord. It is possible that this female represented the extreme 
end of the X-inactivation distribution, with most spinal cord oligodendrocytes 
carrying the paternalyp^-X-chromosome in the inactive condition, so allowing most 
myelin to be formed by functionally wild type cells.
The relatively minor changes in optic nerve myelination contrasted with both 
the spinal cord in the same mice and the optic nerve lesions in heterozygotes for jp  in 
the mouse and md in the rat. Findings in the optic nerve of jp™*1 heterozygous 
females were minimal in most of the mice, being detected only by electron 
microscopy. No obvious amyelinated/hypomyelinated patches were observed but 
occasionally amyelinated-fibres, sometimes grouped in small bundles (two to four 
fibres), were identified, being the only indication of mosaicism. Morphometric 
analysis failed to show any difference in myelin sheath thickness relative to axon 
diameter confirming that most myelinated axons had a sheath of a normal thickness.
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This result was supported by the findings in the optic nerves of jp rsh hemizygous 
(jprsh/Y) male and homozygous (jprsh/jp™h) females where only myelinated fibres 
appeared normal and slight abnormalities were present when compared to the spinal 
cord (see chapter 3). Calculation of myelin density using the point counting method 
indicated that the total amount of myelin was reduced in heterozygote optic nerves, 
presumably correlating with the increased number of amyelinated axons. Similar 
myelin reduction in the absence of the mosaic distribution were seen in the anterior 
commissure (Rosenfeld and Friedrich, 1984) and in the myelinated patches of the 
optic nerve (Bartlett and Skoff, 1986) jp  heterozygotes.
Total glial numbers and density were consistently higher in both spinal cord 
and optic nerves of the jp rsh heterozygotes compared to their normal male siblings. 
The differences detected are ascribed to the heterozygous state and not to the different 
sex of the mice, as previous studies in wild type and jp rsh animals demonstrated no 
differences between males and females (Griffiths et al., 1990). The glial cell 
numbers in the heterozygote spinal cord were approximately intermediate of the wild 
type and full jp rsh mutation. The absolute number of oligodendrocytes was elevated, 
although the proportions of cell types (oligodendrocytes, astrocytes, microglia and 
others) in the heterozygotes were similar. However, the increases were relatively 
small compared to the full jp rs^  phenotype, and were significant only in older 
animals. Cell death (Knapp et al., 1990) or the presence of abnormal 
oligodendrocytes (Duncan et al., 1987a), which are associated with the
hypomyelinated patches in other mutants, was not a feature. Oligodendrocytes 
appeared to be metabolically active and "healthy". Occasionally immature 
oligodendroblasts as those previously described for the full jp rs^ mutant were seen 
possibly indicating some oligodendroglial replacement.
jp  carrier females show a progressive repair of the myelin deficit in the brain 
anterior commissure (Rosenfeld and Friedrich, 1984) and in the spinal cord (Bartlett 
and Skoff, 1986), so that by adulthood full recovery has been achieved. However, 
poorly ensheathed areas of the optic nerve did not improve with age (Bartlett and 
Skoff, 1986). The reason(s) for recovery are not fully defined but several factors 
may operate. Although approximately 50% of oligodendrocytes should carry the 
mutation in the active condition due to random X-inactivation it may be that cell 
selection favours precursor cells carrying the wild type allele so that with time cells of 
this lineage will predominate. Additionally, there is evidence that jp  cell survival is 
improved, cell death is decreased and functions of differentiated oligodendrocytes are 
enhanced when jp  and "normal" oligodendrocytes are contiguous in vivo (Knapp et 
al., 1990) or when jp  cells are cultured in medium conditioned by normal glia 
(Bartlett et al. , 1988). It has also been reported that the oligodendrocyte cell division 
rate is increased during early adulthood suggesting that neuroglial cells in jp
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heterozygote brain detect the myelin deficit and respond with a compensatory increase 
in the oligodendrocyte production (Rosenfeld and Friedrich, 1986). jp rs^ 
heterozygotes show an increased oligodendrocyte population in the optic nerve which 
do not occur in the full jp rsh mutant where after 45 days of age the glial cell numbers 
drop below normal values (see chapter 3, section 5.C.). This phenomenon could 
signify that the presence of phenotypically-normal clones of oligodendrocytes may 
stimulate the oligodendrocyte cell division and/or the cell survival as it has been 
described for other mutants (Rosenfeld and Friedrich, 1986; Bartlett et al., 1988; 
Knapp et al., 1990). A similar phenomenon may take place in the spinal cord of the 
jprsh female heterozygote. However, as for yet unknown reasons, the spinal cord 
evolution in full jp rsh involves an over-production of oligodendrocytes, this finding is 
not obvious.
The evolution of the lesions in the spinal cord of jp rsh heterozygote seems to 
follow a similar pattern to jp  heterozygotes where small diameter axons myelinate 
with age. A similar phenomenon has also been described for the full jp rsh mutant 
(see chapter 3.C.) However jp rs^  heterozygote females never achieve full recovery 
as thinly sheathed fibres and were readily detectable in the spinal cord up to the age of 
90 days. These fibres, presumably myelinated by oligodendrocytes carrying the 
jprsh mutation, behaved as expected for those previously described Schwann-cell-like 
oligodendrocytes in the mutant cord (see discussion on chapter 3.C.), thus they 
myelinated a single axon at early myelination.
Findings in jp rs^ heterozygotes could be explained, taking into account that as 
jprsh oligodendrocytes appear metabolically active (on morphological criteria) and 
survive well into adulthood (Griffiths et al., 1990; Fanarraga et al., 1992a; Fanarraga 
et al., 1992b). Hemizygous jp rs^  males and homozygous jp rs^  females demonstrated 
that, altough the mutant spinal cord acquires extra myelin sheaths as the animal ages, 
large fibres, myelinated by Schwann-cell-like oligodendrocytes do not recover. In 
jprsh heterozygotes some of these cells will carry the jp rs^ allele in the active from 
and would successfully compete with those carrying the wild type allele in early 
myelination producing abnormal myelin sheaths thus, preventing subsequent 
myelination by the wild type clone of oligodendrocytes.
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C. STUDY OF THE PROTEIN PRODUCTION IN jp™h HETEROZYGOTE
1. INTRODUCTION AND AIMS
This studies were performed in order to complete the description of the jp rsh 
heterozygote female. Immunostaining for MBP and PLP/DM-20 would provide us 
of valuable information such as whether there is immunodetectable myelin in the area 
of study as well as the protein composition of the myelin sheaths present. ISH 
experiments would reveal the proportion of actively expressing oligodendrocytes. 
These findings could them be compared with the homozygous female and hemizygous 
male jp rs^  mutant and wild type.
2. PAP RESULTS
The majority of the myelin sheaths immunostained for both MBP and PLP. 
Occasionally MBP-positive sheaths failed to immunostain with PLP/DM-20 or sheaths 
reacting with the PLP/DM-20 antiserum were negative with the PLP-specific 
antiserum. Therefore at least three types of immunocytochemically-defined myelin 
sheaths were present in the heterozygotes which were M BP+/PLP/DM 20+/PLP+; 
MBP+ /PLP/DM 20+ /PLP- and MBP+ /PLP/DM20-/PLP-.
Resin-embedded 1 /urn semi-serial sections of the optic nerve and 5-6 /zm 
paraffin-embedded semi-serial sections of the brain were immunostained against MBP 
to detect possible areas of focal hypomyelination/amyelination. No patches in the 
distribution of the myelin were detected.
3. IN SITU  HYBRIDIZATION RESULTS
Visual inspection of autoradiograms from 20 and 30 day-old mice suggested 
no marked differences in either the number of PLP/DM-20 expressing cells or the 
intensity of signal per cell between normal male and heterozygous animals (figure 
96). However, quantitative data identified an increase of 34 and 36% in the total 
numbers of expressing cells in white matter of the cervical cord of the 20 and 30 day- 
old heterozygote females, respectively.
These results indicate that there is no deficiency in the numbers of PLP/DM- 
20 mRNA-expressing cells in jp rsh heterozygotes and suggest a slight increase in 
oligodendrocytes as deduced from the morphological studies. The individual cell
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PLP expression was not analysed on dissociated cells as for the full jp rsh mutant. 
However, visual inspection of the autoradiograms from the spinal cord of the 
heterozygote did not reveal an obviously decreased signal (figure 96).
4. DISCUSSION
Immunocytochemistry of the spinal cord revealed that all the sheaths, reacted 
with MBP antiserum. The majority of myelin sheaths reacted with the PLP-specific 
and PLP/DM-20 antiserum, contrasting with the findings for the homozygous jp rsh 
female and hemizygous male mutants (Griffiths et al., 1990) where reactivity for 
both, and in particular the PLP-specific antiserum, was severely reduced. 
Immunostaining against MBP in serial-sections of several locations of the CNS 
revealed no areas of amyelination/hypomyelination.
The in situ hybridization results indicate that there is no obvious defect in the 
number of PLP-expressing cells in ]prs^ heterozygotes. Oligodendrocytes in the 
amyelinated patches of the optic nerve of the md rat show an absence or severe 
reduction of PLP-expressing cells (Duncan, I.D., personal communication). As 
these patches were not detected in jp rs^  heterozygote females, the location of those 
oligodendrocytes expressing the y/?r^-allele could not be determined, although, 
according to results for the full jp rs^  mutants, cells carrying the active yp^-allele 
would express a lower signal than the oligodendrocytes from the wild type clone.
D. CONCLUDING REMARKS
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Heterozygotes for mutations of the PLP gene represent an interesting target for 
the study of the interactions of mutant and wild type clones of oligodendrocytes 
generated after the inactivation of either X-chromosome thus producing a chimaera 
(Nesbitt, 1971; Falconer and Avery, 1978; Nesbitt and Gartler, 1971; Lyon, 1972). 
This heterozygote condition, which is reflected as a mosaic myelinating pattern for 
other PLP mutations such as jp , md rat and sh pup, did not affect jp rs^  heterozygote 
females in the same way.
The jp rsh heterozygotes which are presumably, also chimaeras for the 
oligodendrocyte population did not show mosaic patches. None of the areas of the 
CNS that were studied demonstrated hypomyelinated/amyelinated areas despite 
showing histological abnormalities and an important myelin reduction which did not 
recover in time. In conclusion, the studies carried out on jp rs^  heterozygote have 
shown several major differences from other X-linked PLP mutants which may be 
attributed to the capability of y/Z^-expressing oligodendrocytes to survive in time 
maintaining their abnormal activity, consequently not being replaced by wild type 
cells.
The elevated oligodendrocyte numbers in the optic nerve of the jp rs^ female 
heterozygotes, which does not take place in the homozygous (jprs^/jprs^) female or in 
the hemizygous (jprs^ /Y ) male, may represent an indication of the increased 
proliferation and/or the improved cell survival of the phenotypically-mutant clones of 
cells under the influence of phenotypically-normal oligodendrocytes as previously 
described for jp  mutants (Rosenfeld and Friedrich, 1986; Bartlett et al., 1988; Knapp 
e ta l.,  1990).
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FINAL REMARKS
jprsh has proved to be a useful mutation of the PLP gene and provides 
compelling evidence for the uncoupling of hypomyelination and premature 
oligodendrocyte death. Other dysmyelinating non-X-linked mutations such as shi or 
qk do not exhibit a similar paucity of oligodendrocytes. Therefore, it has been 
suggested that a product of the PLP gene may be required for cell survival (Gencic 
and Hudson, 1990; Hudson, 1990b; Vermeesch et al., 1990; Nadon et al., 1990). 
Recent investigations have indicated that DM-20 may play additional role(s) involving 
cell survival and/or differentiation which might not be restricted to the 
oligodendrocytes. The expression of DM-20 is developmentally regulated, thus DM- 
20 levels which, in most species, constitute a minor proportion of the total CNS 
proteolipids, show an inverted ratio in embryonic CNS tissue (Schindler et al., 1990; 
Campagnoni et al., 1992). DM-20 mRNA has been detected in embryonic mouse
brain long before differentiated oligodendrocytes appear in the tissue (Timsit et al., 
1992; Ikenaka et al., 1992). All glial cells (Timsit et al., 1992; Kamholz et al., 
1992) in addition to some neuronal cell lines, also express DM-20 (Ikenaka et al., 
1992). However in neuronal cell lines DM-20 mRNA activity dropped when the 
cells differentiated (Ikenaka et al., 1992). Myocardial and spleen cells also express 
DM-20 mRNA (Campagnoni et al., 1992).
These findings point to other possible functions of this protein which are 
absent in all PLP mutants, except jp rsh, and result in the early oligodendrocyte death. 
We do not know why a point mutation in PLPIlel86 affecting the putative fourth 
membrane domain of the PLP and DM-20 molecules demonstrates this different 
phenotype. However, despite jp rs^  producing a mutated DM-20, this protein may be 
functional, allowing jp rs^  oligodendrocytes to survive well into adulthood. Other 
PLP mutants such as sh pup and jpmsd mice ^so  produce detectable DM-20 
(Gardinier and Macklin, 1988; Yanagisawa et al., 1987) yet these point mutations 
may affect other more vital sequences of the protein, impeding its normal folding 
and/or insertion in the membrane. Nevertheless, it must be emphasised that this role 
for DM-20 is still hypothetical and as yet there is no direct proof of its direct 
involvement in cell survival or differentiation.
It is also unknown if DM-20 plays any structural role. It has been commonly 
accepted that PLP maintains the correct spacing between apposed bilayers as a result 
of the homophilic interactions involving the major hydrophilic loop of PLP (Schindler 
et al., 1990). This highly charged sequence of the PLP molecule which plays a key
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role in stabilization of the IPL, is almost entirely missing in DM-20 (Schindler et al., 
1990). Therefore, although DM-20 is inserted in the membrane and would, perhaps 
contribute to the stability of the IPL, it will never be as competent as PLP in 
maintaining this membrane arrangement. PLP-deficient mutants such as jprs'h, that 
produce sufficient DM-20, may take advantage of this structural property. In fact, as 
jprsh produces very little PLP, the intermingling and interaction of both proteins in 
the myelin membrane may be responsible for the final compaction attained in some of 
the sheaths. On the other hand, as the hydrophobic interactions of DM-20 are not as 
suitable as those of PLP, this would be reflected ultrastructurally as an abnormal IPL 
which would be absent, split or vacuolated. The vacuolation observed in jp rsh 
myelin sheaths might be the result of a poor anchoring of the IPL that would split 
either in vivo or perhaps as an artefact as a result of the fixation of the tissue and/or 
the histological processing of the specimen.
Another interesting conclusion derived from the study of jp rsh mutation is the 
evidence of the heterogenicity of the oligodendroglial population. Del Rio Hortega 
silver carbonate stain of oligodendrocytes in 1923 revealed four classes of myelinating 
cells of which type IV would correspond with those recently described Schwann-cell­
like oligodendrocytes seen in the embryonic feline cord (Remahl and Hildebrand, 
1990). These cells responsible for the early myelination of the larger fibres would 
constitute an individual oligodendroglial population. Later in development there 
would be a second wave of myelination involving oligodendrocytes which at this stage 
are still undifferentiated and actively dividing. These cells would eventually 
complete ensheathment of the smaller fibres. Larger fibres in the jp rs^  spinal cord 
show an obvious hypomyelination and this is manifested by poor myelin deposition 
together with vacuolation of the sheath. However, smaller axons, which are initially 
unmyelinated, progressively acquire sheaths of a reasonably normal appearance. The 
possible explanation for this phenomenon, according to those previously-mentioned 
descriptions of oligodendrocytes in the developing CNS, suggests at least two sub­
populations of oligodendrocytes. The early myelin sheaths therefore, correspond to 
oligodendrocytes myelinating in a Schwann-cell-like fashion, explaining the 
histological findings. These sheaths will still be detectable at older ages since jp rs^ 
oligodendrocytes survive into adulthood. The second type of oligodendrocyte that 
differentiates later in development and myelinates the smaller axons, displays its 
myelin deficiency by producing less myelin intemodes per cell, rather than less 
myelin per intemode as in the case of early oligodendrocytes. In this way, those 
myelin sheaths present exhibit normal thickness yet, many axons remain 
unmyelinated. Attending to these characteristics, the second type of oligodendrocyte 
could represent a more immature form than the early type. Thus, they may be 
capable of proliferating provided there are unmyelinated axons and/or the appropriate
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tissue signals until complete myelination. This hypothesis has been partially 
supported by the increased ^H-thymidine labelling of the spinal cord indicating an 
increased cell division rate. However, this contribution of extra oligodendrocytes 
does not seem to occur in the optic nerve where there are plenty of unmyelinated 
axons which do not acquire a myelin sheath. Findings in the dorsal columns of the 
spinal cord, where axons have a similar size as in the optic nerve and there is an 
increased oligodendrocyte proliferation, attain myelin sheaths. Findings indicate that 
the reason for the hypomyelination in the optic nerve is due to the decreased 
oligodendrocyte proliferation, perhaps involving a increased cell apoptosis, which 
may be a consequence of the individuality of these structures where the 
oligodendroglial precursor pool might be smaller and the axonal population 
completely different in origin and nature. These results lead to the conclusion that 
the CNS is very heterogeneous in nature and that each tract is capable of maintaining 
its own idiosyncrasy being particularly manifested in deficient situations.
Tissue culture experiments demonstrated that optic nerve and spinal cord 
oligodendrocytes developed in a similar fashion in terms of MBP and DM-20 
production. However, the cell survival of the optic nerve cells seemed somewhat 
reduced when compared to cells cultured from the wild type optic nerve or the mutant 
spinal cord. Although this finding could be the result of deficient tissue manipulation 
or poor culture conditions, they point to the possibility of a decreased cell survival in 
the optic nerve as wild type oligodendrocytes developed normally under the same 
conditions. On the other hand oligodendrocyte numbers in the optic nerve, which are 
appropriate at myelination, seem to decline after 40-50 days in the mutant showing no 
signs of further replacement. Although cell death was not obvious in any of the 
nerves examined, apoptosis could have taken place with dead cells being cleared from 
the tissue in a very short time (Barres et al., 1992; Raff, 1992), such reasoning could 
explain the findings. Although DM-20 may promote cell survival, it is more likely 
that other signals of unknown nature, present in the spinal cord but not in the optic 
nerve, are responsible for the increased cell division and later myelination, while DM- 
20 may be involved in further differentiation of the newly produced cells. The optic 
nerve in the female heterozygote (jprsh/ + ) showed an increased oligodendrocyte 
population. This may account for the possibility of mutant cell survival and/or 
proliferation being enhanced in vivo when influenced by phenotypically normal clones 
of oligodendrocytes. A similar phenomenon could also occur in the spinal cord. 
However, as the cell population is already increased in full jp rsh mutants this could 
not be determined.
All the previously discussed topics indicate that the role of DM-20 in cell 
survival and development has probably been underestimated so far. Further
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investigations will be necessary to clarify the involvement of this protein in 
embryogenesis and cell differentiation probably not only restricted to the CNS.
jprsh represents one system in which to carry out further studies as DM-20 
production in the CNS is unencumbered by the usually more prominent PLP.
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MONOCLONAL ANTIBODY ANTIGEN DETECTION IN  
SPINAL CORD
03 , 0 4 , 0 5 , 06 sulfatide Postnatal day 0
0 1 , 02 , 07 GalC Postnatal day 0
08 Lipid Postnatal day 0
09 Lipid Postnatal day 0
010 Protein Postnatal day 2
011 Lipid Postnatal day 4
012 Lipid N.D.
Table 2: Properties of the antibodies 01 through 012 and time of detection in the mouse cervical
spinal cord (Sommer and Schachner, 1981; Kuhlmann-Krieg et al., 1988).
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SUBSTANCE HUMAN BOVINE RAT
Total protein 30 24 .7  29  5
Total lipd 70 75.3  70.5
Cholesterol 27 .7  28.1 27.3
Total galactolipids 27 .5  29 .3  31.5
cerebroside 22.7 28.1 27.3
sulfatide 3.8 3 .6  7.1
Total phospholipid 43.1 43  44
ethanolamine phophoglycerides 15.6 17.4 16.7
choline 27.7 28.1 27.3
serine 27.5 29 .3  31.5
inositol 27.5 29 .3  31.5
sphingomyelin 22.7 28.1 27.3
Plasma logen 12.3 14.1 14.1
Table 4: Lipid distribution in human, bovine and rat CNS myelin (Norton and Cammer, 1984).
Protein and lipid figures are expressed as percentage of dry weight; all others are expressed as 
percentage of total lipid weight. Plasmalogens are primarily ethanolamine phosphoglycerides.
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DY8MYELINATING MUTATION EXON/
DISORDER INTRON
AM INO-ACID
CHANGE
jp
jpmsd
sptice site
point mutation
Intron 4
exon 6
exon 5  deleted &6 and 
7 frame shifted
24 2  Ala->Val
md rat
sh pup
point mutation 
point mutation
exon 3
exon 2
74  Thr->Pro
36 His->Pro
PMD*
type I classical 
type I
type II connatal 
jprsh
point mutation 
point mutation
point mutation 
point mutation
exon 4  
exon 5
exon 2 
exon 4
162Trp->Arg  
215  Pro->Ser
14 Pro->Leu 
106 lle->Thre
Table 5: Summary of the most characteristic point mutations in the PLP gene (adapted from
(Hudson, 1990a)). All these alleles, except jp™*1, are lethal disorders characterised by the 
degeneration and death of oligodendrocytes as the primary cause of hypomyelination. In contrast to 
jp , jp mS{*, md rat, sh pup and PMD the jp f8*1 mouse demonstrates that changes of PLP structure can 
cause severe hypomyelination not associated with cell death.
(*) There are other forms of PMD described including a total deletion of the PLP gene 
(Raskind et al., 1991).
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MUTATION
jp
md rat
s/j pup
SIGNS MOSAIC CHANGES
no clinical s ig n s Periphery of the optic nerve;
Periphery of the ventral coium s of the 
spina I cord adjacent to pia.
Anterior commisure: myelin reduction 
in the ab sen ce of patches.
Spinal cord and anterior com m issure 
recover morphologically and 
biochemically
no clinical sig n s Periphery and centre of the optic
nerves.
No m osaicism  present in the spinal 
cord.
som e heterozygotes Periphery of the optic nerve a (tough
mild clinical s ig n s  le s s  noticeable than in the spinal
cord. Spinal cord showing
patches at various levels
Table 8: Review of the main characteristics of the jp, md rat and sh pup heterozygotes (Kemer and 
Carson, 1984; Rosenfeld and Friedrich, 1984; Rosenfeld and Friedrich, 1986; Skoff and Montgomery, 
1981; Bartlett and Skoff, 1986; Benjamins et al., 1989; Duncan et al., 1986; Duncan et al., 1987a).
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0 - 2 A  LINEAGE
0 - 2 A  p e r i n a t a l  0 - 2 A  a a u l t
p r o g e n i t o r  c e l l s  p r o g e n i t o r  c e l t s
P O O F
o l i g o d e n d r o b l a s t
b - F Q F
a d u l t  o l i g o d e n d r o c y t e A s t r o c y t e  t y p e - 2
Figure 1: Proliferation characteristics of 0-2Aperinatal and 0-2Aa^M^  progenitor cells and their
derivatives (adapted from (Wolswijk and Noble, 1989; Noble et al., 1989)). Qji^perinatal are 
bipolar cells which divide symmetrically in the presence of type-I astrocytes which produce PDGF 
(Wolswijk et al., 1991; Raff, 1989). have a characteristic unipolar morphology and divide
and differentiate asymmetrically such that a single clone of cell continues to generate more progenitors. 
Both 0-2APerinata  ^and 0 -2 A ^ M^  progenitors can differentiate into either oligodendrocytes or type-2 
astrocytes. Astrocyte differentiation is induced by exposure to FCS or CNTF. Oligodendrocytes can 
be identified in vitro by their multipolar morphology, their antigenic expression and the lack of 
intermediate filaments which are present in type-2 astrocytes. The antigenic profiles of these cells are 
fully detailed in table 1.
WT
'
Figure 2: Light microscopic appearance of the developing spinal cord from 5-day-old wild type (WT) 
and 1O-day-old jp rs mice (lower panel). Methylene blue/azure II stained resin sections from the C2 
segment of the spinal cord. The myelination of the spinal cord commences with the ensheathment of 
the larger fibres as described by Remalh and Hildebrand (Remahl and Hildebrand, 1990). Processes of 
actively myelinating oligodendrocytes are seen ensheathing several large axons in both types of mice 
(arrows). Although the oligodendrocyte processes in the jp™" mutant contact nearby axons, many do 
not ensheath these fibres (thick arrows). (Approx. magnification: x 2000)
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Figure 3; Light microscopic appearance of 10 and 16-day-old wild type (a, b) and jp™*1 mutant ( c, d) 
spinal cord respectively. Methylene blue/azure II stained resin sections of the ventral white matter 
adjacent to the ventromedian fissure in the C2 segments. Examples of some glial cells which are 
probably suffering apoptosis (Raff, 1992) recognised by the condensed nuclear chromatin (arrow­
heads). No significant increase in apoptotic cell numbers was seen in j ^ * 1. (Approx. magnification: 
x 1000).
Figure 4; Representation of the four types of oligodendrocyte profile recognized by Del Rio Hortega 
in 1928 (Del Rio Hortega, 1922; Del Rio Hortega, 1924), and confirmed by Stensaas and Stensaas in 
1968 (Stensaas and Stensaas, 1968). Type I is presumably related to many small myelin segments 
travelling through the tissue at many different angles. Type II is similar but related to segments of 
myelin within a fascicle containing many axons coursing in the same direction. Type III is related to 
two large segments of myelin and type IV to one large segment. Del Rio Hortega pointed at the 
similarity of the relationship between the type IV oligodendrocyte and the Schwann cell to the 
underlying myelin segments.
Fjfflirs  5; Schematic representation of the hypothetical models of PLP insertion in the myelin 
membrane and PLP mutations, a. (Laursen et al., 1984); b. (Stoffel et al., 1984); c. (Nave et al., 1987); 
d. (Hudson et al., 1989) and e. (Popot et al., 1991). PLP is the predominant integral membrane 
protein of the CNS and has multiple membrane spanning domains. DM-20 differs from PLP in the 
major hydrophilic domain of the 276-amino-acid. The position of the residues 116-150, absent in the 
DM-20 isoform, is indicated by arrowheads. The NH2 end of the PLP molecule has been located at 
the extracellular side of the membrane for all the models. The model of PLP represented in figure 
5.e. also shows the lethal mutations in the jp  mouse (a deletion of the carboxy terminus), in the 
jjpxsd^ jprsh (rsh) and in the m d  rat. The position of other single-residue substitutions including 
several families with PMD are indicated by black circles. The wild type sequence (identical in rat, 
mouse and human) is shown. Putative alpha-helical membrane-associated domains of PLP are 
numbered M l to M5.
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LITTER SIZES
% of total litters
j p r sh  m u ta n t wild t y p e
1
more
mice per litter
Figure 6: Results of the breeding studies. The data correspond to the percentage of the total litters
studied, 394 for jp rs 1^ and 262 for the wild type.
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MI C E  W E I G H T  G A I N
50
40
30
20
0 10 20 30 40 50 60 70 80 90 100
age  (days )
Figure 7: Age-related weight gains for both wild type (triangle) and jprsh mice (filled circle).
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Figure 8: Immunostaining of optic nerves and ventral white matter of the spinal cord from 45-day-
old mice. Upper panel: optic nerves from wild type and jp™*1 mice against MBP (A, E); PLP/DM-20 
(B, F); PLP (C, G) and GFAP (D, H) using the PAP technique on paraffin-embedded sections. A-D 
are from wild type mice and E-H from jp™*1 mice. Lower panel: ventral white matter of the spinal 
cords from 45-day-old wild type and jp™*1 mice as before. Although all the myelin proteins are 
decreased in staining intensity in the jp f  the most profound reduction is seen with the PLP-specific 
antiserum. GFAP is increased in the mutants. (Approx. magnification: upper panel x 175, lower 
panel x 500).
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Figure 9: Immunostaining of optic nerves from 20-day-old from wild type (WT a, b, c) and jp™*1
mice (RSH d, e, f); MBP (a, d); PLP/DM-20 (b, e) and PLP (c, f) using the PAP technique on 
paraffin-embedded sections. At this age the amount of MBP in the mutant is slightly depleted. 
(Approx. magnification: x 90).
Figure 10: Spinal cord resin sections from 90-day-old jp™*1 mouse The sections are immunostained
for MBP (a), PLP/DM-20 (b, d) and PLP (c, e). Numerous myelin sheaths are stained for MBP (a) 
and PLP/DM-20 (b). There is virtually no staining with the PLP specific antiserum except for a very 
occasional small sheaths (c,arrow-heads). Many axons lack a myelin sheath. Adjacent sections (d, e) 
show that the majority of sheaths present are immunostained by PLP/DM-20, whereas identical sheaths 
are not immunostained by the PLP-specific antiserum. The only PLP immunoreactivity present is 
frequently seen localised in clumps at the periphery of axons which may be included in the 
oligodendrocyte cytoplasm (c: arrowheads; e: small arrows). (Approx. magnification: a and c x 1000; 
d and e x 2000)
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Figure 11: PLP/DM-20 immunostain of the optic nerves from 90-day-old wild type (a) and jp rs'1
mice (b) using the PAP technique on paraffin-embedded sections. The PLP/DM-20 immunoreactivity 
at this age is similar to that detected in the wild type animals. There is an artefact present in the wild 
type optic nerve, the degree of staining should be as positive centrally as in the periphery of the 
section. (Approx. magnification: x 140).
Figure 12: Adjacent sections of the spinal cord ventral columns from 90-day-old jprs^ mutant
immunostained by the PAP method against (a) PLP/DM-20 and (b) MBP. The majority of the sheaths 
immunostain for MBP and with a lower intensity for PLP/DM-20. The immunoreactivity is absent in 
occasional groups of smaller fibres (open arrow). (Approx. magnification: x 2000),
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Figure 13: Paraffin-embedded sections of the spinal cord from a one year-old jp™*1 mice (a, b)
immunostained for P0 using the PAP technique. The immunostaining of the myelin sheaths in the 
PNS myelin of the nerve root (nr) is positive as expected. Immunoreactivity against the PQ antibody 
was absent CNS myelin of the jp™*1 mice indicating no Schwann cell invasion of the CNS. The 
arrows point at the PNS/CNS transition zone, (c) Methylene blue/azure II stain of a resin-embedded 
section of the same area of the spinal cord as above. No evidence of PNS Schwann cell invasion or 
remyelination is detected. (Approx. magnification: a x 50; b x 200; c x 2000).
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Figure 14; Spinal cord and white matter areas. Transverse areas of the C2 segment of the cervical 
spinal cord and white matter from the wild type (triangle), jp™*1 mice (filled circle) and jp™*1 
heterozygotes (square). Both jp™*1 and jp™*1 heterozygotes show a marked reduction in the area from 
20 days of age onwards which progressively diminishes. All data represent mean ± SEM; where error 
bars are not seen they fall within the symbol. Asterisks have been placed in values that differ 
significatively from the wild type.
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Figure 15: Light microscopic appearance of 5-day-old jp rs^ spinal cord. Ventral columns from the 
C2 segment of the spinal cord from wild type (WT) and jp rs^ (a). (b) Area adjacent to the
ventromedial fissure in the mutant (the dorsal and lateral columns are also shown in the next figure). 
jprsh shows abundance of "healthy looking" oligodendrocytes actively producing processes that grow 
between the axons (arrow). Occasional oligodendrocytes are also seen embracing individual large 
calibre axons. At this age, the morphological appearance of the mutant resembles that of the age- 
matched wild type. (Approx. magnification: x 1000)
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Figure 16: Light microscopic appearance of 5-day-old jp™*1 mutant spinal cord. Light microscopic
photographs of the dorsal columns (upper panel) and lateral columns (lower panel) from the same jp™*1 
cervical cord section as figure 15. The jp™ mutant oligodendrocytes produce abundant processes 
actively approaching naked axons (arrows). Myelination in the PNS is normal in the mutants (open 
arrow). (Approx. magnification: x 1000).
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Figure 17; Light microscopic appearance of 10-day-old of wild type (WT) and jprsh (a, b) ventral 
columns from the C2 segment of the spinal cord. The abnormalities caused by the mutation start being 
evident around this age. The oligodendrocyte numbers are increased in respect to the wild type and 
there are some hypomyelinated areas. Some condensed nuclei, probably from cells ungoing 
programmed cell death, are an occasional finding (arrows). (Approx. magnification: x 1000)
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Figure 18: Light microscopic appearance of jp  spinal cord at different ages. Methylene
blue/azure II stained resin sections of the ventral white matter adjacent to the ventromedian fissure of 
the C2 segments of the spinal cord of jp rsh at 16 (a), 30 (b) and 50 (c) days of age. Hypomyelination, 
intramyelinic splitting or vacuolation (arrow-heads) and increased cellularity are constant findings at all 
ages. (Approx. magnification: x 1000).
uFigure 19: Methylene blue/azure II stained sections from the 1 year-old jp rs female heterozygote (a) 
and jp rs^  (b) ventral columns of the C2 segment of spinal cords. (a) The majority of axons are 
myelinated by sheaths of normal thickness in the female heterozygote. However, redundant folds of 
myelin (thick arrows) and scattered hypomyelinated/amyelinated axons (arrow-heads) are a common 
finding. (b) The morphological changes in the spinal cord of the 1 year-old full jp rs^ include an 
obviously increased oligodendrocyte population (open arrows) together with vacuolation of some of the 
sheaths (thick arrow) and hypomyelinated/amyelinated large axons. Most small axons are myelinated 
and present sheaths of normal thickness (curved arrows). Both types of mice demonstrate 
morphologically normal myelin sheath around smaller fibres, while large diameter fibres remain 
hypomyelinated or unmyelinated. (Approx. magnification: x 2000).
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Figure 20: Light microscopic appearance of 1 year-old wild type (WT), jp rs^ (a) mouse and jp rs^
female heterozygote (b) methylene blue/azure II stained dorsal columns from the C2 segment of the 
spinal cord adjacent to the ventromedian fissure, (a) The dorsal columns of jprs'1 are well myelinated. 
Occasional large hypomyelinated (arrow-head) or vacuolated (thick arrow) fibres are present. Glial 
cell numbers in the dorsal columns of the spinal cord of jp rs^  are increased, (b) The dorsal columns 
in the jp^s^  female heterozygote present occasional hypomyelinated large axons (arrow-head). 
(Approx. magnification: x 2000).
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Figure 21: Ultrastructure of the ventral white matter from the spinal cord of 30-day-old wild type
(WT) and jp rs^  mice (lower panel) The majority of the axons are surrounded by disproportionately 
thin myelin sheaths, some of which (curved arrow) contain uncompacted areas, and others (small 
arrow) have intramyelinic vacuolation. Oligodendrocytes (arrow heads) are increased in number. An 
occasional microglial cell containing membranous inclusions (large arrow) is also present. Scale bar 
10 pm.
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Figure 22: Electron-micrographs of atypical glial cells, possibly oligodendrocyte precursor cells
observed in 50-day-old jp rs^ ventral columns. Similar cells were also occasionally seen in the female 
(jpTsh/_|_) heterozygote but were never detected in the wild type mice. The contour of the cell in (a) is 
outlined with arrow-heads. Some of the characteristics of these cells include an undifferentiated 
appearance, a rounded nucleus (N) situated at one pole of the cell and a very sparse cytoplasm with 
very few organelles (see figure 23 for more details). Due to the small size of the cell, the low 
cytoplasmic density and the infrequent cell processes these cells are rarely detected at light microscopy. 
Some of these cells seem to be related to hypomyelinated axons although the cell contour becomes very 
indistinct. These cells resemble those termed as "primitive oligoblasts" described in the foetal monkey 
spinal cord (Phillips, 1973). (Approx. magnification: a x 15000; b x 10000).
Figure 23: Electron-micrograph of an atypical glial cell, possibly an oligodendrocyte precursor,
observed in 50-day-old jp rs^  ventral columns exhibiting a pale cytoplasm including mitochondria, 
Golgi apparatus (G), possibly some small filaments (arrow-head). The nucleus (N) contains dispersed 
chromatin. Cell processes are uncommon. These cells are seen frequently in the vicinity of naked or 
hypomyelinated axons which are usually surrounded by astrocytic processes (AST). The 
characteristics of this undifferentiated cell correspond to those termed "primitive oligoblasts" (Phillips, 
1973). (Approx. magnification: x 30000).
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Figure 24: Ultrastructure of the ventral white matter of the C2 segment of the spinal cord from 90-
day-old wild type (WT) and jp rs^  mice. Virtually all the smaller axons have acquired a myelin sheath 
of normal appearance (thick arrow). Larger axons remain hypomyelinated/amyelinated (small arrow). 
Vacuolation of some of the myelin sheaths is also a common finding at 90 days of age. (Approx. 
magnification: x 6000).
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Figure 25: Ultrastructure of the myelin sheaths from 30-day-old wild type (a) and jprs^ (b, c and d)
mice. MDL and IPL lines are clearly distinguishable in the wild type myelin. The periodicity of the 
MDL in the mutant myelin is reduced when identifiable. The IPL of these compacted sheaths is very 
irregular. Scale bar 50 nm.
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Figure 26: Optic nerve areas. Transverse areas of optic nerve sections from wild type (triangle) and
jp rs'1 mice (filled circle). Mutant nerves show a significant reduction in the area at all ages examined 
supporting the visual impression. All data represent mean ± SEM; where error bars are not seen they 
fall within the symbol. Asterisks have been placed in values that differ significatively from the wild 
type.
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Figure 27: Ultrastructure of the optic nerves from 30-day-old jprsh. Nerves from two different mice 
are shown. Most myelinated axons have a larger calibre than the unmyelinated axons which tend to
form bundles. Surprisingly, some 30-day-old mutant optic nerves present more myelin than some 90- 
day-old jp rsh (figure 28). An equivalent wild type section is shown in figure 88 (WT). (Approx. 
magnification: x 9500).
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Figure 28: Ultrastructure of 90-day-old optic nerves from 90-day-old wild type (WT), female
heterozygote (a) and jp rs^ mice (b, c). Heterozygotes do not show obvious mosaic changes in the 
optic nerves at 90 days, however, collections of small unmyelinated axons are detectable (thick arrow). 
The majority of mutant optic nerve axons are amyelinated (b, c). There is some variation in the 
thickness of myelin sheaths relative to axon size, for example one fibre (b, arrow) has a thicker sheath 
than expected. The presence of a thicker sheath is unusual, most being either normal or thinner. 
Astrocyte processes are moderately increased. (Approx. magnification: x 9000).
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Figure 29: Glial cell density in the spinal cord. Values from wild type (triangle), jprs^ (filled circle) 
and jp rsh heterozygote (square). The values refer to cells in the white matter from the ventral columns 
of the C2 segment of the spinal cord. All data represent mean ± SEM; where error bars are not seen 
they fall within the symbol. The female heterozygote show a moderate increase in glial cell density^the 
difference being more pronounced in older mice. However, it is never as marked as in jprs . 
Asterisks have been placed in values that differ sigmficatively from the wild type.
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Figure 30: Total numbers of glial cells in the spinal cord. Values from wild type (triangle), and
jp™h mice (filled circle). Total numbers of oligodendrocytes and astrocytes in white matter are also 
shown individually. Values refer to cells in the white matter from the ventral columns of the C2 
segment of a transverse section from the spinal cord. All data represent mean ± SEM, where error 
bars are not seen they fall within the symbol. Asterisks have been placed in values that differ 
significatively from the wild type.
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Figure 31: Percentages of oligodendrocytes and astrocytes in white matter of spinal cord.
Percentages of the total numbers of glial cell population from wild type (triangle), and jprs mice 
(filled circle). Total numbers of oligodendrocytes and astrocytes in white matter are shown. Mutants 
show an increased percentage of oligodendrocytes after the age of 30 days. Values refer to cells in a 
transverse section from the white matter from the ventral columns of the C2 segment of the spinal cord. 
All data represent mean ± SEM; where error bars are not seen they fall within the symbol.
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Figure 32: Morphometric analysis of the spinal cord. Values from wild type (triangle), and jp rs^
mice (filled circle). The values refer to the ventral columns of the C2 segment of the spinal cord. All 
data represent mean ± SEM; where error bars are not seen they fall within the symbol. Asterisks have 
been placed in values that differ significatively from the wild type, (upper panel) Myelin thickness; 
(centre) g ratio (g ratio defined as ratio of axon diameter to that of the axon plus myelin sheath); (lower 
panel) Myelin density (arbitrary units). These graphs evidence the profound hypomyelination in the 
mutant CNS.
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Figure 33: Scatter graph showing the relationship between axon diameter and myelin thickness in the
white matter from the ventral columns of the spinal cord from 90-day-old jp rs^ mice (filled circles). 
The central line is the linear regression and the curved lines the prediction bands for similar data from 
90-day-old wild type mice. The vast majority of values of jp rsh are below the lower limits of the wild 
type mice. Only occasional smaller fibres are within the limits for the wild type.
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Figure 34; Spinal cord and optic nerve mean axonal diameters from wild type (triangle) and jprs^ 
mice (filled circle). The values refer to axons in the white matter from the ventral columns of the C2 
segment of the spinal cord and mid-point optic nerve. All data represent mean ± SEM; where error 
bars are not seen they fall within the symbol. An asterisk has been placed beside the value that differs 
significatively from the wild type.
167
O P T I C  N E R V E  
G L I A L  C E L L  D E N S I T Y
1500
% 1000 
E
CD
CL
5 0 0
■ ^ 1 -D --------------------
200 40 80 10060
a g e  ( d a y s )
Fieiu’e 35: Optic nerve glial cell density. Values from wild type (triangle), jp rs^ (filled circle) and
jp rs'1 heterozygote (square) mice mid-optic nerve. The glial cell density parameter is quite similar in 
the three types of mice. jp rs^ mice initially show a lower glial cell density that is compensated after 
20 days to became normal at around 45 days of age. Heterozygote glial cell density remained slightly 
higher than the wild type for all the ages examined. All data represent mean ± SEM; where error bars 
are not seen they fall within the symbol.
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Figure 36: Total numbers of glial cells in the optic nerve. Values from wild type (triangle) and jprs^ 
(filled circle) mice mid-optic nerves. Total numbers of oligodendrocytes and astrocytes are also shown 
individually. The total numbers of oligodendrocyte numbers in the optic nerve of the mutant, which 
are initially below the wild type values, became adequate at myelination, then dropping below the wild 
type values at the age of 45 days. Morphological examination of the optic nerve at this age did not 
reveal an increased cell death. Cell density in jp rs 1^ indicates that these results are the consequence of 
the smaller total volume of the mutant nerve and that cell numbers stabilize at normal levels after this 
age. All data represent mean ± SEM; where error bars are not seen they fall within the symbol.
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Figure 37: Percentages of oligodendrocytes and astrocytes in the optic nerve. Percentages from the
total numbers of glial cell population from wild type (triangle) and jp rs^ (filled circle) optic nerve. 
jpfsh  shows a normal oligodendrocyte percentage until the age of 60 days when it increases over wild 
type, being followed by a later drop in the oligodendrocyte percentage accompanied of an increase of 
the astrocyte percentage. All data represent mean ± SEM; where error bars are not seen they fall 
within the symbol. An asterisk has been placed beside the value that differs significatively from the 
wild type.
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Figure 38: Morphometric analysis of the optic nerve from wild type (triangle) and mice (filled 
circle). The values refer to cells in a cross section of the optic nerve mid-way between the globe and 
chiasm. All data represent mean ± SEM; where error bars are not seen they fall within the symbol. 
Asterisks have been placed in values that differ significatively from the wild type, (upper panel) 
Myelin thickness, (centre) g ratio (g ratio defined as ratio of axon diameter to that of the axon plus 
myelin sheath), (lower panel) Myelin density (arbitrary units). The values of the myelin thickness 
and g  ratio reveal that most mutant myelin sheaths produced in this area of the CNS are only slightly 
thinner than age matched wild type fibres. However, myelin density values demonstrate a noticeable 
myelin deficiency in jjP*1 tissue as it includes the amyelinated fibres not included for the myelin 
thickness andg ratio studies.
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Figure 39: Scatter graph showing the relationship between axon diameter and myelin thickness in the
optic nerve from 90-day-old jp rs^  mice (filled circle). The central line is the linear regression and the 
curved lines the prediction bands for similar data from 90-day-old wild type mice. The vast majority 
of the data from jp™^1 mice are within the wild type prediction bands. However, a large numbers of 
completely unmyelinated fibres are also present in mice. The resulting data distribution supports 
the morphological impression (see figure 28b, 28c) demonstrating that myelin sheaths produced in the 
optic nerve resemble those of the wild type, although unmyelinated fibres are abundant. This graph 
can be compared with the equivalent for the spinal cord shown in figure 33.
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Figure 40: Density of PLP-expressing cells in the ventral columns of the C2 segment of the spinal
cord in wild type (triangle) and jp rs^  mice (filled circle). Paraffin sections were hybridized to a ^ S - 
labelled riboprobe recognising both PLP and DM-20 transcripts. jp rs^ mice show a progressive 
increase in PLP-expressing cells. This finding supports morphological observations as well as 
indicating that the progressive increment of the glial cell population is due to an over-production of 
oligodendrocytes and/or oligodendroblast (see figure 84). As cell counts are influenced by any change 
in volume, (which is lower in jprs^  due to the decreased amount of myelin) the glial cell density is also 
presented. All data represent mean ±  SEM; where error bars are not seen they fall within the symbol.
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Figure 41: Total numbers of PLP-expressing cells in the wild type (triangle) and jp rs 1^ mice (filled
circle) spinal cord. Total glial cell numbers in the white matter of jp r increase dramatically after 40 
days as a consequence of the increase of the PLP-expressing cells. Total numbers of glial cells in the 
spinal cord are also shown as cell counts are influenced by any change in volume. All data represent 
mean ±  SEM; where error bars are not seen they fall within the symbol. Asterisks have been placed 
in values that differ significatively from the wild type.
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Figure 42: Percentages of PLP-expressing cells in the wild type (triangle) and jp rs^ mice (filled
circle) spinal cord and optic nerve. All data represent mean ± SEM; where error bars are not seen 
they fall within the symbol. An asterisk has been placed beside the value that differs sigmficatively 
from the wild type. The percentage of PLP-expressing cells in the spinal cord demonstrates that not 
all the cells morphologically resembling oligodendrocytes were actively expressing PLP in the mutant. 
However, by the age of 100 days, the percentages of expressing oligodendrocytes increase according to 
the morphological findings (figure 84. b).
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Figure 43; Density of PLP-expressing cells in the wild type (triangle) and jp  mice (filled circle) 
optic nerve. The values refer to cells in a cross section of the optic nerve mid-way between the globe 
and chiasm. Glial cell density drops at 40 days of age in the mutant, recovering by the age of 100 
days as a result of an increase in the PLP-expressing cells. All data represent mean ± SEM; where 
error bars are not seen they fall within the symbol. As cell counts are influenced by any change in 
volume, (which is lower in jp™*1 optic nerve) the glial cell density is also presented. (@) Shows the 
result obtained from a single experiment.
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Figure 44: Total numbers of PLP-expressing cells in the wild type (triangle) and jp rs^ mice (filled
circle) optic nerve. Values from the wild type and jprs^ mice from the same experiment as in the 
previous figure. Total numbers of glial cells in the mutant drop below wild type numbers after 40 
days of age mainly as a result of a decrease in the PLP-expressing cells. All data represent mean ± 
SEM; where error bars are not seen they fall within the symbol. Morphological data also indicate that 
the oligodendrocyte numbers in the optic nerve drop below normal counts around 40 days of age and 
that there is a increase in the astrocyte numbers (figure 35). Total numbers of glial cells in the 
paraffin-embedded of the optic nerves are also presented as cell counts are influenced by any change in 
volume. All data represent mean ± SEM; where error bars are not seen they fall within the symbol. 
An asterisk has been placed beside the value that differs significatively from the wild type. (@) Shows 
the result obtained from a single experiment.
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Figure 45: Autoradiograms of the spinal cord from 5, 10, 16, 20, 30, 40 and 90-day-old mice. In
situ hybridization for PLP/DM-20 mRNA on paraffin sections from wild type (W) and jp rs^ (R) mice 
at the mentioned ages hybridized and incubated on the same slide and counterstained with haematoxilin 
(some spinal cord sections are missing). Upper panel show details of the 10-day-old wild type (WT) 
and mutant (RSH) mice spinal cords. The intensity of signal per cell as well as the overall expression 
of PLP/DM-20 are decreased in j j?  (see figures 46 and 47 for more detail). (Approx. 
magnification: upper panel x 53, lower panel x 2).
178
Figure 46: Autoradiograms of the in situ hybridization for PLP/DM-20 mRNA of the white matter
from the ventral columns of the spinal cords from 10-day-old wild type (WT) and mutant mice (lower 
panel). Foci of silver grains signifying expressing oligodendrocytes are present in each, but the 
intensity of the signal is less in the mutant. Nuclei of non-expressing cells are also present. (Approx. 
magnification: x 500).
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Figure 47: Autoradiograms of the in situ hybridization for PLP/DM-20 mRNA of white matter from 
the ventral columns of the spinal cords from 30-day-old wild type (WT) and mutant (a, b) mice. The 
individual cell expression of PLP/DM-20 in jp  is more decreased than in 10-day-old spinal cord 
samples (figure 46). There is an evidence of an increased cellularity in the mutant as demonstrated by 
the amount of counterstained glial nuclei. (Approx. magnification: x 400).
Figure 48: In situ hybridization for PLP/DM-20 mRNA in 100-day-old wild type (WT, wt) and jp rs^ 
mice optic nerves. Upper panel shows a general view of the hybridized section of both types of optic 
nerves at the same magnification. Silver grains over the nuclei signify the individual PLP/DM-20 cell 
expression. The individual cell expression as well as the total number of expressing oligodendrocytes 
is decreased in jp rs^  optic nerve in respect to wild type age-matched controls (see figures 43 and 44 for 
quantified data). Cell expression is variable in jp rs^ mice although most cells express very little 
PLP/DM-20 (small arrow-head). Occasional oligodendrocytes show a normal labelling (large arrow­
head). Nuclei of non expressing cells counterstained with haematoxilin are also present in the 
autoradiogram. (Approx. magnification: upper panel x 142, lower panel x 500)
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Figure 49: Autoradiograms of dissociated oligodendrocytes from the ventral columns of the spinal
cords from 16-day-old mutant mice. Cell were dissociated and were allowed to adhere to the coverslip 
for two hours before hybridization for PLP/DM-20 mRNA. Cells were not counterstained, showing 
only expressing oligodendrocytes. The signal of individual cells was measured by densiometry and the 
average message level per cell was significantly reduced. jprs*1 dissociated oligodendrocytes expressed 
variable levels of PLP/DM-20. Although some cells labelled as wild type cells (open arrow), others 
showed a significantly reduced mRNA message (thick arrows). The inset shows a control wild type 
expressing oligodendrocyte. (Approx. magnification: x 450).
Figure 50; Autoradiogram of two wild type immunostained oligodendrocytes from dissociated ventral 
columns of the spinal cord of 7-day-old mice cultured for 7 days and immunostained with GalC. Same 
experiment as figures 51, 52 and 53. (upper panel) GalC immunostained oligodendrocytes, (lower 
panel) Autoradiogram of the same cells. The accumulation of silver grains over the nuclei of the cells 
signifies the PLP/DM-20 expression. In this case the abundance of silver grains blackens the GalC 
immunofluorescence over one of the nucleus (n). (Approx. magnification: x 450).
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Figure 51: Autoradiogram of a wild type immunostained oligodendrocyte. Cell from dissociated
ventral columns of the spinal cord of 7-day-old mice cultured for 7 days and immunostained with GalC. 
Same experiment as figures 50, 52 and 53. (upper panel) GalC immunostained oligodendrocyte, 
(lower panel) Autoradiogram of the same cell. The accumulation of silver grains over the nuclei of the 
cells signifies the PLP/DM-20 expression. (Approx. magnification: x 450).
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Figure 52: Autoradiogram of a jp rs^  immunostained oligodendrocyte. Cell from dissociated ventral
columns of the spinal cord of 7-day-old mice cultured for 7 days and immunostained with GalC. Same 
experiment as figures 50, 51 and 54. (upper panel) GalC immunostained oligodendrocyte, (lower 
panel) Autoradiogram of the same cell. The accumulation of silver grains over the nuclei of the cells 
signifies the PLP/DM-20 expression. (Approx. magnification: x 450). The mutant individual cell
expression is significantly reduced when compared to controls (figures 50 and 51).
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Figure 53: Autoradiogram of a jp rs^  immunostained oligodendrocyte. Cell from dissociated ventral
columns of the spinal cord of 7-day-old mice, cultured for 7 days and immunostained with GalC. 
Same experiment as figures 50, 51 and 53. (upper panel) GalC immunostained oligodendrocyte, 
(lower panel) Autoradiogram of the same cell. The accumulation of silver grains over the nuclei of the 
cells signifies the PLP/DM-20 expression. (Approx. magnification: x 450). Although GalC reveals 
the morphological profile of a mature mutant oligodendrocyte, this cells expresses low amounts of 
PLP/DM-20 when compared to wild type controls hybridized under the same conditions (figures 50, 
51).
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Figure 54; In vitro morphological appearance of live jprs^  oligodendrocytes taken from optic nerves 
of 16-day-old and cultured for 7 days. Mutant cells show no major changes in morphology with 
processes and membranes of normal dimensions being produced at the expected time in a similar 
manner to wild type cells, (a) Astrocytes are occasionally present in the culture dishes (arrow). 
(Approx. magnification: x 450)
Figure 55: Double immunolabelling for GalC and 04 antigens in 120 hour-old cultures of spinal cord 
from 3-day-old jp rs^  mouse from the same experiment as figure 56. GalC (upper panel) is visualized 
by rhodamine (goat-anti-mouse IgGg TRITC) and 04 (lower panel) by fluorescein (goat-anti-mouse 
IgM FITC) labels. Both antibodies were applied to live unfixed cultures. This mutant 
oligodendrocyte exhibits myelin membranes of normal appearance. (Approx. magnification: x 450)
Figure 56: Double immunolabelling for GalC and 04 antigens in 120 hour-old cultures of spinal cord 
from 3-day-old jp rs^ mouse from the same experiment as in the previous figure. GalC (upper panel) 
is visualized by rhodamine and 04  (lower panel) by fluorescein labels. Both antibodies were applied 
to live unfixed cultures. Mutant oligodendrocytes produce abundant processes in culture. (Approx. 
magnification: x 450).
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Figure 57: GalC in vivo and in vitro labelling on spinal cord cell dissociations from wild type and
jp rs mice at different ages cultured for different times (as indicated). Comparison between the in vivo 
and the in vitro development. The development of cultures from 3 and 7-day-old mice are presented. 
Mutant oligodendrocytes are capable of achieving the GalC-f stage in a similar manner to wild type 
cells.
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Figure 58: In vitro development of the antigenic profile of the oligodendrocytes obtained from 3-day- 
old wild type (WT) and jp rs^  mice spinal cords. Values are the mean of a minimum of 2 experiments 
and refer to the percentage of the 04 +  population expressing the represented antigens. The tissue was 
obtained from the ventral columns of the cervical cord, dissociated and left in culture for the indicated 
times.
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Figure 59: In vitro development of the antigenic profile of the oligodendrocytes obtained from 7-day- 
old wild type (WT) and jp rs 1^ mice spinal cords. Values are the mean of a minimum of 2 experiments 
and refer to the percentage of the 04+  population expressing the represented antigens. The tissue was 
obtained from the ventral columns of the cervical cord, dissociated and left in culture for the indicated 
times.
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Figure 60: Antigenic profile of the oligodendrocytes obtained from 10 and 16-day-old wild type (WT) 
and jp rs^  mice spinal cords Values are the mean of a minimum of 2 experiments and refer to the 
percentage of the 04+  population expressing the represented antigens. The tissue was obtained from 
the ventral columns of the cervical cord, dissociated and immunostained 2 hours after plating.
193
OPTIC NERVE
7 day old wt
GalC MBP PLP/DM-20 010 PLP 011
antigens
7 day old jprsh
100
c u l t u r e  t im e
i I 2  h r s
L _ J  2 4  h rs
7 2  h rs
1 2 0  hrs
GalC MBP PLP/DM-20 010
antigens
PLP 011
Figure 61: In vitro development of the antigenic profile of the oligodendrocytes obtained from 7-day- 
old wild type (WT) and jp rs^ mice optic nerves. Values are the mean of a minimum of 2 experiments 
and refer to the percentage of the 04+  population expressing the represented antigens. Asterisks have 
been placed where the result of a single experiment is shown. The tissue was obtained from the optic 
nerves, dissociated and left in culture for the indicated times.
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Figure 62: In vitro development of the antigenic profile of the oligodendrocytes obtained from 10-
day-old wild type (WT) and jp rs^  mice optic nerves. Values are the mean of a minimum of 2 
experiments and refer to the percentage of the 04+  population expressing the represented antigens. 
Asterisks have been placed where the result of a single experiment is shown. The tissue was obtained 
from the optic nerves, dissociated and left in culture for the indicated times.
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Figure 63: Antigenic profile of the oligodendrocytes obtained from 16-day-old wild type (WT) and
jp rs'1 mice optic nerve. Values are the mean of a minimum of 2 experiments and refer to the 
percentage of the 0 4 +  population expressing the represented antigens. An asterisk has been placed 
where the result of a single experiment is shown. The tissue was obtained from the optic nerves, 
dissociated and immunostained 2 hours after plating.
Figure 64: Double immunolabelling for GalC antigen and MBP in 120 hour-old cultures of spinal
cord from 3-day-old jp rs^  mouse from the same experiment as in figures 55, 56, 74 and 75. GalC 
(upper panel) is visualized by rhodamine (goat-anti-mouse IgGg TRITC) and MBP (lower panel) 
protein by fluorescein (goat-anti-rabbit FITC) labels. GalC antibody was applied to live unfixed 
cultures. MBP was immunolabelled after cell permeabilization. jp  oligodendrocytes achieve the 
MBP developmental stage, expressing normal amounts of MBP per cell. However, the percentages of 
MBP+ oligodendrocytes in the mutant are decreased as shown in figure 67. (Approx. magnification: 
x 450).
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Figure 65: Double immunolabelling for GalC antigen and MBP in 120 hour-old cultures of optic
nerve from 10-day-old jp rs^ mouse (same experiment as in figure 66). GalC (upper panel) is 
visualized by rhodamine (goat-anti-mouse IgG3 TRITC) and MBP (lower panel) by fluorescein (goat- 
anti-rabbit FITC) labels. GalC antibody was applied to live unfixed cultures. MBP was 
immunolabelled after cell permeabilization. Optic nerve jp rs^  oligodendrocytes achieve the MBP stage 
expressing normal amounts of MBP per cell. Mutant optic nerve oligodendrocytes also produce 
myelin membranes. (Approx. magnification: x 450).
Figure 66: Double immunolabelling for GalC antigen and MBP in optic nerve cell dissociations of
120 hour-old cultures from 10-day-old jp rs^ mouse (same experiment as in the previous figure). GalC 
(upper panel) is visualized by rhodamine (goat-anti-mouse IgG3 TRITC) and MBP (lower panel) 
protein by fluorescein (goat-anti-rabbit FITC) labels. GalC antibody was applied to live unfixed 
cultures. MBP was immunolabelled after cell permeabilization. Amounts of MBP equivalent to those 
in the wild type controls (not shown) are present in most mutant MBP+ oligodendrocytes. (Approx. 
magnification: x 450).
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Figure 67: MBP in vivo and in vitro labelling on spinal cord cell dissociations from wild type and
mice"at different ages cultured for different times (as indicated). Comparison between the in vivo 
and the in vitro development. The results from 3 and 7-day-old mice cultures are represented. The 
in vivo situation improved the MBP expression in freshly dissociated cells as cultured oligodendrocytes 
never attained the same number of MBP positive cells as the wild type.
Figure 68: Double immunolabelling for 04  antigen and PLP/DM-20 proteins in cell dissociations
from the spinal cord from 10-day-old wild type mouse cultured for 48 hours (same experiment as in 
figures 69 to 73). 04 (upper panel) is visualized by rhodamine (goat-anti-mouse IgM TRITC) and
PLP/DM-20 (lower panel) by fluorescein (goat-anti-rabbit FITC) labels. 04 antibody was applied to 
live unfixed cultures. PLP/DM-20 was immunolabelled after cell permeabilization. (Approx. 
magnification: x 450).
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Figure 69: Double immunolabelling for 04 antigen and PLP/DM-20 proteins in cell dissociations
from the spinal cord from 10-day-old jprs^  cultured for 48 hours from the same experiment as in the 
previous figure. 04  (upper panel) is visualized by rhodamine and PLP/DM-20 (lower panel) by 
fluorescein labels. 04  antibody was applied to live unfixed cultures. PLP/DM-20 was 
immunolabelled after cell permeabilization. Most jp rs^  mutant oligodendrocytes immunostain for 
PLP/DM-20 although the immunoreactivity varies from cell to cell. This figure shows &jprs mutant 
oligodendrocyte poorly immunostained for PLP/DM-20. (Approx. magnification: x 450).
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Figure 70: Double immunolabelling for 04 antigen and PLP/DM-20 proteins in cell dissociations
from the spinal cord from 10-day-old jprs^  cultured for 48 hour-old cultures of spinal cord from 10- 
day-old jp rs^  (same experiment as in figures 68 to 73). 04  (upper panel) is visualized by rhodamine
and PLP/DM-20 (lower panel) by fluorescein labels. 04  antibody was applied to live unfixed
cultures. PLP/DM-20 was immunolabelled after cell permeabilization. Many mutant 
oligodendrocytes exhibit almost normal amounts of PLP/DM-20. This figure shows the maximum 
degree of immunostain achieved by mutant oligodendrocytes in this experiment (see control wild type 
cell in figure 68). (Approx. magnification: x 450).
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Figure 71: Double immunolabelling for 0 4  and PLP in cell dissociations from the spinal cord from 
10-day-old wild type mice (same experiment as in figures 68 to 73). 0 4  (upper panel) is visualized by 
rhodamine (goat-anti-mouse IgM TRITC) and PLP (lower panel) by fluorescein (goat-anti-rabbit 
FITC) labels. 0 4  antibody was applied to live unfixed cultures. PLP was immunolabelled after cell 
permeabilization. These three wild type oligodendrocytes immunostain strongly with the antibody 
recognizing PLP which, at. this stage of development labels circular structures in the cytoplasm 
around the nucleus. (Approx. magnification: x 450).
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Figure 72: Double immunolabelling for 04 antigen and PLP in cell dissociations from the spinal cord 
from 10-day-old jp rs^  cultured for 48 hour-old cultures of spinal cord from 10-day-old jp rs^ (same 
experiment as in figures 68 to 73). 04 (upper panel) is visualized by rhodamine and PLP (lower
panel) by fluorescein labels. 04  antibody was applied to live unfixed cultures. PLP was 
immunolabelled after cell permeabilization. The overall impression is that jp rs^  oligodendrocytes are 
negative when compared to wild type cells grown and immunostained under the same conditions (figure 
71). However, detailed observation of some of these cells reveals small aggregations of the antibody 
at the processes. (Approx. magnification: x 450).
Figure 73: Double immunolabelling for 04  antigen and PLP; in cell dissociations from the spinal
cord from 10-day-old jfP*1 mouse ■ cultured for 48 hours (same experiment as in figures 69 to 73). 
04  (upper panel) is visualized by rhodamine and PLP (lower panel) by fluorescein labels. 04 
antibody was applied to live unfixed cultures. PLP was immunolabelled after cell permeabilization. 
Another example of a mutant oligodendrocyte showing only some PLP staining confined to small lumps 
at the processes. (Approx. magnification: x 450).
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Figure 74: Double immunolabelling for GalC and 010 antigen in 120 hour-old cultures of spinal cord
from 3-day-old jp rs^  mouse from the same experiment as in figures 55, 56, 64 and 75. GalC (upper 
panel) is visualized by rhodamine (goat-anti-mouse IgGg TRITC) and 010 (lower panel) by fluorescein 
(goat-anti-mouse IgM FITC) labels. Both antibodies were applied to live unfixed cultures. Most 
mutant oligodendrocytes do not achieve the 010+ stage. This picture shows two mutant 
oligodendrocytes one of which is positive for 010. However, the degree of 010 expression is very 
poor. (Approx. magnification: x 450).
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Figure 75: Double immunolabelling for GalC and O il antigen in 120 hour-old cultures of spinal cord 
from 3-day-old jp rs^  mouse from the same experiment as in previous figures 55, 56, 64 and 74. GalC 
(upper panel) is visualized by rhodamine and O il (lower panel) by fluorescein labels. Both antibodies 
were applied to live unfixed cultures. Most mutant oligodendrocytes do not achieve the 010+ stage. 
Picture of an 011 positive mutant oligodendrocytes. The degree of Ol 1 expression in positive mutant 
oligodendrocytes is significantly reduced in intensity. (Approx. magnification: x 450).
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Figure 76: PLP/DM-20 in vivo and in vitro labelling. Spinal cord cell dissociations from wild type
and jp rsh mice at different ages cultured for different times (as indicated). Comparison between the in
vivo and the in vitro development. The results from 3 and 7-day-old mice cultures are represented.
209
in v itro /3  day old in vitro /7 day old
%
100
8 0  -
8 0  -
4 0  -
20  -
2 h r * 2 4  h r * 72 h r * 120 h r *
100
8 0  -
8 0  -
4 0 -
2 0  -
2 h r * 2 4  h r* 72 h r * 120 h r *
culture time culture time
%
PLP SPINAL CORD
in vivo
100
j p r s h WT80
60
40
20
0
1673 10
age (days)
Figure 77: PLP in vivo and in vitro labelling. Spinal cord cell dissociations from wild type and jp rs
mice at different ages cultured for different times (as indicated). Comparison between the in vivo and
the in vitro development. The results from 3 and 7-day-old mice cultures are represented.
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Figure 78: 010 antigen in vivo and in vitro labelling. Spinal cord cell dissociations from wild type
and mutant jprsh at different ages cultured for different times (as indicated). Comparison between the
in vivo and the in vitro development. The results from 3 and 7-day-old mice cultures are represented.
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Figure 79: O il antigen in vivo and in vitro labelling. Spinal cord cell dissociations from wild type
and mutant mice at different ages cultured for different times (as indicated). Comparison between the
in vivo and the in vitro development. The results from 3 and 7-day-old mice cultures are represented.
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Figure 80: Cell mitosis in the ventral columns of the spinal cord. Thymidine-labelled glial cell
density. Values from wild type (triangle) and jp rs^  mice (filled circle) white matter of the C2 segment 
of the spinal cord. All data represent mean ± SEM; where error bars are not seen they fall within the 
symbol. (@) Shows the result obtained from a single experiment. The spinal cord oijprs^ shows an 
obviously increased labelled cell density indicating an increased cell proliferation. Dividing cells are 
probably oligodendrocytes or their immediate precursors as demonstrated by the morphological and the 
in situ hybridization results (figures 22, 23, 40). This finding is particularly outstanding in 100-day- 
old mutant labelled for 6 hours.
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Figure 81: Total numbers of thymidine-labelled glial cells in the ventral columns of the C2 segment
of the spinal cord from wild type (triangle) and j j / s^ mice (filled circle). All data represent mean ± 
SEM; where error bars are not seen they fall within the symbol. An asterisk has been placed beside 
the value that differs significatively from the wild type. (@) Shows the result obtained from a single 
experiment.
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Figure 82; Percentage of thymidine-labelled glial cells in the ventral columns of the C2 segment of 
the spinal cord from the wild type (triangle) and jp rs^  mice (filled circle). All data represent mean ± 
SEM; where error bars are not seen they fall within the symbol. An asterisk has been placed beside 
the value that differs significatively from the wild type. (@) Shows the result obtained from a single 
experiment. The percentage of proliferating cells in the mutant spinal cord is noticeably increased 
after 16 days of age. 100-day-old mutant spinal cord shows a high proliferation percentage over 6 
hours which may indicate a faster cell turnover in the mutant tissue. However, cell death was not 
conspicuous at this ages. Presumably, apoptosis of many cells must be taking place in this tissue (see 
figures 83 and 84).
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Figure 83: Autoradiography of 100-day-old jp rs^ spinal cord showing ^H-thymidine labelled cells.
Dorsal (a) and ventral colunms (b, c, d) from a mutant mouse labelled over a period of 6 hours (3 
injections). Arrow-heads point at cells morphologically resembling oligodendrocytes that have 
incorporated the isotope; therefore that were in the S-phase of the mitotic cycle during the labelling 
period (Knapp, 1992). (b) Vacuolation of a sheath is indicated (arrow). (Approx. magnification: x
1000).
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Figure 84: (a) Autoradiography of the 100-day-old jp rs^ spinal cord showing labelled cells, (b) In
situ hybridization for PLP/DM-20 mRNA at the same age. (a) Section from the same mouse as in 
figure 83 showing other dividing cells in the mutant spinal cord such as an endothelial cell (arrow-head) 
and, possibly, an astrocyte (thick arrow); (v= blood vessel). (Approx. magnification: x 1000).
(b) In situ hybridization of the ventral columns from the spinal cord. Foci of silver grains signifying 
expressing oligodendrocytes. Nuclei of glial cells are not counterstained. The individual cell 
labelling indicates that most oligodendrocytes have increased their PLP/DM-20 mRNA levels with 
respect to younger ages (figures 46, 47). The density of PLP/DM-20 expressing cells is also increased 
(see figures 40, 41 for quantified data). (Approx. magnification: x 450).
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Figure 85: Outline of Lyon's hypothesis of X-chromosome inactivation (Lyon, 1972) during early
embryonic development and oligodendrocyte clone formation (Nesbitt, 1971; Falconer and Avery, 
1978; Nesbitt and Gartler, 1971).
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Figure 86: Ultrastructure of 30-day-old wild type (WT), 16 (a) and 30 (b) jprs^ heterozygote female
ventral white matter of the spinal cord. The majority of axons in the female are myelinated although 
the thickness of myelin sheaths is not proportional to the axon diameter. Arrows point at axons with a 
similar diameter exhibiting myelin sheaths of different thickness. Redundant folds of myelin are a 
common finding in most female heterozygotes. No evidence of mosaicism was detected. (Approx. 
magnification: x 5000).
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Figure 87: Ultrastructure of the ventral white matter of the spinal cord from 90-day-old jp rs^
heterozygote female and wild type sibling (WT). Hypomyelinated/amyelinated patches are not evident 
at this age. The majority of the axons are myelinated although the myelin sheaths are in many cases 
disproportionate with respect to the axonal diameter, (a) Axons of similar diameters exhibiting sheaths 
of different thickness (1, 2) are a common finding, (b) Vacuolation of some sheaths is still detectable 
in some myelin fibres at 90 days. No evidence of mosaicism is detected at this age. (Approx. 
magnification: x 5000).
220
Figure 88: Ultrastructure of the optic nerves from 30-day-old jp rs^  heterozygote female (a, b) and
wild type sibling (WT). No obvious mosaic changes in the optic nerve are detected at this age. A 
higher magnification (b) reveals occasional small bundles of naked fibres. Most myelinated axons 
exhibit a myelin sheath of normal characteristics. (Approx. magnification: upper panels: x 5000; b: x 
7500).
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Figure 89: Total numbers of glial cells in white matter of C2 segment of spinal cord in jp™^ 1
heterozygote (square) and wild type siblings (triangle). Total numbers of oligodendrocytes and 
astrocytes in white matter are also shown individually. The growth in the total oligodendrocyte 
numbers is also supported by PLP/DM-20 expressing cell counts. All data represent mean ± SEM; 
where error bars are not seen they fall within the symbol. Asterisks have been placed in values that 
differ significatively from the wild type.
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Figure 90: Total numbers of glial cells in the optic nerve of jp rs^ heterozygote (square) and wild
type siblings (triangle). All data represent mean ± SEM; where error bars are not seen they fall 
within the symbol. An asterisk has been placed beside the value that differs significatively from the 
wild type.
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Figure 91: Percentages of oligodendrocytes and astrocytes in the white matter of the C2 segment of
spinal cord of jp rs^ heterozygote (square) and wild type siblings (triangle). All data represent mean ± 
SEM; where error bars are not seen they fall within the symbol.
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Figure 92: Percentages of oligodendrocytes and astrocytes in the optic nerves of jprs^  heterozygote
(square) and wild type siblings (triangle). All data represent mean ± SEM; where error bars are not 
seen they fall within the symbol.
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Figure 93: Morphometric analysis of the spinal cord of jp  heterozygote (square) and wild type
siblings (triangle). The values refer to the ventral columns of the spinal cord of the C2 segment of the 
spinal cord. All data represent mean ± SEM; where error bars are not seen they fall within the 
symbol, (upper panel) Myelin thickness, (centre) g ratio (g ratio defined as ratio of axon diameter to 
that of the axon plus myelin sheath), (lower panel) Myelin density (arbitrary units). Asterisks have 
been placed in values that differ significatively from the wild type.
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Figure 94: Scatter graph of the relationship between axon diameter and myelin thickness in jprs^
heterozygote female spinal cord (square) at 90 days. The central line is the linear regression and the 
curved lines the prediction bands for similar data from 90-day-old wild type mice. Although the vast 
majority of values of jp rs^  female are lower than the wild type prediction area, a small proportion of 
myelin sheaths fall below much lower than the lower prediction band indicating a disproportionately 
thin myelin sheath or he absence of sheath.
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Figure 95: Morphometric analysis of the optic nerves of jp rs^ heterozygote (square) and wild type
siblings (triangle). All data represent mean ± SEM; where error bars are not seen they fall within the 
symbol, (upper panel) Myelin thickness, (centre) g ratio (g ratio defined as ratio of axon diameter to 
that of the axon plus myelin sheath), (lower panel) Myelin density (arbitrary units). An asterisk has 
been placed beside the value that differs significatively from the wild type.
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Figure 96: In situ hybridization for PLP/DM-20 mRNA in 30-day-old normal male (a) and jp rs^
heterozygote female (b) spinal cords. The intensity of signal per cell appears similar in both cords but 
quantification of cell numbers shows that the total number of expressing cells in the white matter is 
increased by approximately 36% in the heterozygote. The autoradiogram is counterstained with 
haematoxilin. Higher magnification of the same sections demonstrates that the number of expressing 
cells in the heterozygote female is increased and that the individual cell expression is not as affected as 
in jp rs^  mutants (figure 47). (Approx. magnification: upper panel x 65, lower panel x 450).
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Figure 97: PAP control sections. Performed on paraffin-embedded sections of the optic nerves of
wild type. In this experiment antibodies have been replaced by rabbit serum at the same
concentrations; (a) 1:300 (b) 1:400 and (c) 1:1000. (Approx. magnification: x 90).
5
Figure 98: Immunofluorescence control. 1 week-old culture of spinal cord from 10-day-old wild type 
where rabbit Ig was substituted for the primary antibody. Other control experiments where the 
antibody was preincubated with the peptide recognized by the antibody or the primary antibody was 
replaced by BSA showed similar unspecific binding as in the present example (pictures not shown). 
(Approx. magnification: x 650).
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ABBRRVIATTONS
Bq= becquerel(s)
BrdU= bromo-deoxyuridine
CAII= carbonic anhydrase
CBAM = complement-binding and activating molecule
cm = centimetres
CNPase= 2' ,3 ',cyclic nucleotide 3 '-phosphohydrolase
CNS = central nervous system
CNT= ciliary neurotrophic factor
Ci = curies
ddH20= deionised-distilled water
DNA= deoxyribonucleic acid
EGF = epidermal growth factor
EM = electron microscopy
FCS = foetal calf serum
FGF = fibroblast growth factor
FITC = fluorescein isothiocyanate
\i m = micrometers
g = grams
GalC= galactocerebroside
GFAP = glial fibrillary acidic protein
GPDH= glycerol phosphate dehydrogenase
HBSS = Hank's balanced salt solution
hr= hour(s)
IGF-1 = insulin-like growth factor-1
IPL= intra-period line
ISH = in situ hybridization
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JP= Jimpy
jp tn sd - jimpy myelin synthesis deficient
II■S: jimpy rumpshaker
kDa= kiloDalton
1 = litre(s)
L15 = Liebowitz medium
LM = light microscopy
M = molar
MAG = myelin-associated glycoprotein
MBP = myelin basic protein
md r a t- myelin deficient rat
MDL= major dense line
min = minute(s)
mm = millimetres
mM = millimolar
mRNA = messenger ribonucleic acid
NGF = nerve growth factor
0-2 A = oligodendrocyte type-2 astrocyte
°C = degrees centigrade
0D  = optical density
PAP = peroxidase anti-peroxidase
PBS = phosphate buffered saline
PDGF = platelet-derived growth factor
PLP = proteolipid protein
PMD = Pelizaeus Merzbacher disease
PNS = peripheral nervous system
P0A  = pro-oligodendroblast antigen
qk= quaking
RER = rough endoplasmic reticulum
RNA = ribonucleic acid
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RT = room temperature
sec= second(s)
sh pup = shaking pup
sh i— shiverer
shimld= shiverer myelin deficient
t r - trembler
TRITC = tetramethyl rhodamine isothiocyanate
WT = wild type
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